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ABSTRACT 
ErbB transmembrane receptors are a family of 4 receptor tyrosine kinases that interact 
with one another through homo and heterodimer interactions. When these dimers form, 
the kinase domains on the receptor tails interact with one another, transphosphorylating 
one another, initiating a signal cascade. The signaling pathways these receptors 
participate in are responsible for many different cell functions including apoptosis, 
growth, and proliferation. The overexpression of these receptors has been linked to 
various forms of cancer, emphasizing the importance of understanding how these 
receptors interact with one another to trigger these cascades. Single Particle Tracking 
experiments have provided more precise and detailed measures of dimer lifetimes and 
diffusion. A major observation from the experiments is the anomalous diffusion of the 
receptors. One suggested contributor to this anomalous diffusion is confinement zones on 
the membrane. In this work, we develop, validate, and implement a spatial stochastic 
model to study these receptors and uncover how their kinetics and dynamics as well as 
the membrane landscape come together to impact erbB activation.  
We start by focusing on erbB1. Single particle tracking experiments show that 
receptor pairs interact repeatedly over a period of time. One possible explanation for 
vi 
these repeated interactions is to facilitate phosphorylation. An asymmetric 
phosphorylation model is proposed, where one receptor in the dimer pair is responsible 
for activating the other receptor, the receiver, which then in turn phosphorylates the 
original activator. The model shows that the confinement zones on the membrane play a 
critical role in causing repeated receptor interactions and reveals that receptors 
dynamically switch between different activation states over time. Our work continues by 
delving deeper into the membrane landscape. Single particle tracking data is analyzed to 
investigate the characteristics of the observed anomalous diffusion. The analysis gives an 
estimate for the size range of the confinement zones and shows that they are a series of 
domains, not corrals. Taking the single particle tracking analysis one step further, we 
develop a Domain Reconstruction Algorithm that reconstructs confinement zone shapes 
and sizes from single particle tracking trajectories. In the final study, we move on to 
erbB2 and erbB3 interactions. ErbB3, which is traditionally believed to be kinase dead, 
has recently been shown to have weak kinase activity. Through kinase assay experiments, 
we show in the presence of erbB2 and heregulin, erbB3 has measurable kinase activity. 
Using the reconstructed domains from erbB2 and erbB3 data to create a simulation space, 
and experimental data from the kinase assay and single particle tracking, we extend the 
erbB1 spatial stochastic model for this study. We show that erbB2 and erbB3 have 
significantly different interactions with the cellular membrane confinement zones, erbB3 
is dependent on erbB2 activation, and erbB3 homodimer stability inhibits erbB3 
activation. Extension of the model to investigate mutation behaviors in erbB3 receptors 
reveals insights into how a gain of function mutation in the erbB3 kinase domain impacts 
erbB2 and erbB3 interactions. Finally, discovery of a gain of function mutation in the 
vii 
kinase domain of erbB3 is connected to an uptick in erbB3 kinase activity. As a path 
forward from this work, we suggest using the spatial stochastic model to investigate more 
possible mutations in erbB3 receptors to give better insight into which mutations would 
be promising to explore. 
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CHAPTER 1: INTRODUCTION 
1.1 OVERVIEW 
Cellular signaling is mediated through a host of protein interactions. Proteins on the 
cellular membrane interact, become activated, and initiate signal cascades, consisting of 
intracellular proteins, in the cytoplasm. These interactions have long been studied for 
various cellular proteins. Popular protein systems include the ErbB family implicated in 
various forms of cancer (Citri & Yarden, 2006; Yarden & Sliwkowski, 2001), the IgE 
receptor known for its role in allergies, and Toll-like receptors (TLR) that trigger immune 
responses (Akira & Takeda, 2004). A range of experimental procedures is used to study 
these systems, including immunoprecipitation and western blotting. More recently, high-
resolution experiments have been developed that allow for greater molecular resolution. 
These experiments include single particle tracking (SPT) (Low-Nam et al, 2011), 
fluorescence resonance energy transfer (FRET), and transmission electron microscopy 
(TEM) (Radhakrishnan et al, 2012), to name a few.   
Experiments give important insight into how different proteins interact with one 
another. These insights can be extended beyond current experimental capabilities by 
deriving a relevant mathematical model. Building off of the biological model pieced 
together using experiments and incorporating experimental data for model validation, the 
mathematical model can be used to visualize and investigate how multiple processes 
come together. A quick search of PubMed reveals the recent uptick in interest in 
integrating mathematics and biology in the last decade. Figure 1.1 shows the fraction of 
papers published on specific search topics from 1980–2013. Figure 1.1 (left) shows the 
trends for publications with topics based around mathematical modeling and biology,  
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Figure 1.1: Papers published focusing on mathematics and biology. Fraction of papers published on 
specific search topics from 1980-2013.   
3 
mathematical biology, and quantitative biology. Figure 1.1 (right) shows the trends for 
publications with topics focused on different types of mathematical model methods also 
focused on biology. Based on the conclusions of the mathematical model, novel 
experimental methods can be developed to examine the mathematical model outcomes to 
further validate or modify the model. This methodology allows for an efficient cycle of 
experimentation, modeling, and novel experiment development. 
1.2 MOTIVATION 
In this work, we focus on the ErbB family of tyrosine receptor kinases (RTKs). ErbB 
receptors are a group of four tyrosine kinases (ErbB1/2/3/4) that are activated via ligand 
binding and subsequent formation of homo and heterodimers. The main function of the 
ErbB family is to mediate important cellular processes such as homeostasis, pathology, 
and development (Linggi & Carpenter, 2006) as well as the interactions between cells 
(Yarden & Sliwkowski, 2001). Specifically, ErbB receptors play an important part in the 
regulation of cell growth, proliferation, differentiation, and apoptosis (Baselga & Swain, 
2009; Costa et al, 2009b). Given these important roles in normal cell development, it is 
not surprising that in the early 1980’s ErbB1, ErbB2, and ErbB3 were implicated in the 
progression of cancers (Baselga & Swain, 2009; Yarden & Sliwkowski, 2001) including 
breast, lung, and bladder (Britten, 2004). ErbB4’s role in cancer development is currently 
not well understood (Baselga & Swain, 2009). ErbB1, which can form dimers with all of 
the other receptors, typically forms mitogenic homodimers and is overexpressed in non-
small-cell lung cancer (Yarden & Sliwkowski, 2001). ErbB3, which has classically been 
believed to be kinase dead (Berger et al, 2004; Linggi & Carpenter, 2006), dimerizes with 
ErbB2 to form an oncogenic heterodimer (Baselga & Swain, 2009). Both ErbB2 and 
4 
ErbB3 are prevalent in breast cancer (Baselga & Swain, 2009; Yarden & Sliwkowski, 
2001). Due to the strong link between these receptors and various forms of cancers, it is 
crucial to gain a better understanding of how the receptors interact and their signaling 
mechanisms.   
Traditionally, experimental methods are used to understand ErbB signaling. 
Immunoelectron microscopy (EM) has been used to study ErbB receptor distributions on 
the cellular membrane, as well as the adapter protein recruitment (Yang et al, 2007). 
More recently, Single particle tracking (SPT) experiments have been used to visualize 
ErbB behavior within the live cell context. This SPT data has provided improved 
dynamic measures of dimer lifetimes, receptor diffusion, and insight into different 
receptor pair combinations. Low-Nam et al. (2011) published ErbB1 SPT data showing 
strong evidence that transient receptor co-confinement promotes repeated interactions 
between ErbB1 monomers. Steinkamp et al. (2014) recently published new SPT that 
indicates ErbB3 does in fact form a homodimer, as well as other experiments showing 
that the kinase domain of ErbB3 is active. To investigate the observation made from the 
experiments on ErbB1 and ErbB2/3, the parameters from the SPT experiments must be 
used to develop a spatial stochastic model. This model will be able to resolve dynamics 
of receptors that cannot yet be investigated through experimental methods. In a step 
towards making the connection between experiments and modeling stronger, the overall 
goal of this work is to develop and implement a spatial stochastic model using 
parameters from live cell imaging to investigate the kinetics and dynamics of ErbB 
receptors as influenced by the membrane landscape and other ErbB receptors.  
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1.3 MATHEMATICAL SIMULATION OF MEMBRANE PROTEIN 
CLUSTERING FOR EFFICIENT SIGNAL TRANSDUCTION  
1.3.1 Notes 
The work shown in this section, 1.3, was published in Annals of Biomedical 
Engineering in November 2012, Volume 40, Pages 2307-2318. DOI 10.1007/s10439-
012-0599-z. 
Krishnan Radhakrishnan1, Ádám Halász5, Meghan M. McCabe3, Jeremy S. Edwards2,3,4 
and Bridget S. Wilson1,4* 
1Dept. of Pathology, 2Dept. of Molecular Genetics and Microbiology, 3Dept. of Chemical 
Engineering and 4Cancer Center, University of New Mexico, Albuquerque, NM 5Dept. of 
Mathematics, West Virginia University, Morgantown, WV 
*Address correspondence to bwilson@salud.unm.edu 
1.3.2 Abstract 
Initiation and propagation of cell signaling depends on productive interactions 
between signaling proteins at the plasma membrane. These diffusion-limited interactions 
can be influenced by features of the membrane that introduce barriers, such as 
cytoskeletal corrals, or microdomains that transiently confine both transmembrane 
receptors and membrane-tethered peripheral proteins. Membrane topographical features 
can lead to clustering of receptors and other membrane components, even under very 
dynamic conditions. This review considers the experimental and mathematical evidence 
that protein clustering impacts cell signaling in complex ways. Simulation approaches 
used to consider these stochastic processes are discussed. 
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1.3.3 Key Terms  
Clustering; Spatial Stochastic Simulations; Cell Signaling  
1.3.4 Introduction  
Cell signaling, used for both intracellular and intercellular communication, is 
essential for the healthy physiological functioning of multi-cellular organisms. Ligand 
binding to a transmembrane receptor triggers an intracellular signaling cascade that 
results in altered cell behavior. The proper integration of different environmental signals 
is critically important to many biological processes, including cell survival, 
differentiation, proliferation and migration (Bublil & Yarden, 2007; Keating et al, 2008; 
Kitaura et al, 2003; Lo, 2010; Wennerberg et al, 2005; Yang et al, 2007). Aberrations in 
signal transduction have been implicated in numerous pathologies, from allergy and 
asthma to many different cancers (Bublil & Yarden, 2007; Colicelli, 2004; Govindan, 
2010; Hynes & MacDonald, 2009; Keating et al, 2008; Lo, 2010; ten Klooster & Hordijk, 
2007; Vigil et al, 2010; Yang et al, 2007). Signal transduction pathways have therefore 
been studied extensively, and many drugs developed to target them (Bublil & Yarden, 
2007; Friday & Adjei, 2008; Govindan, 2010; Lo, 2010; ten Klooster & Hordijk, 2007; 
Vigil et al, 2010). 
Knowledge of the structure of the plasma membrane and of signaling processes 
continues to improve, due to advances in experimental techniques and imaging 
technologies (Lidke & Wilson, 2009; Wells et al, 2010; Wilson et al, 2010). There is 
considerable evidence for the concept that the cell membrane is compartmentalized into 
microdomains, such as protein islands (Wilson et al, 2007) and lipid rafts (Nagy, 2002). 
Receptor clustering in small or large aggregates (illustrated schematically in Figure 1.2) 
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at discrete locations has been noted in many cell types (Abulrob et al, 2010; Bader et al, 
2009; Hartman & Groves, 2011; Keating et al, 2008; Saffarian et al, 2007; Szabo et al, 
2008; Yang et al, 2007), prompting intense interest in roles for membrane microdomains 
in signal propagation and preliminary mathematical studies to understand both formation 
of clusters and their role in cell signaling (Brinkerhoff et al, 2004; Costa et al, 2009a; 
Costa et al, 2009b; Fallahi-Sichani & Linderman, 2009; Hsieh et al, 2010; Hsieh et al, 
2008; Linderman, 2009; Reddy et al, 2010; Tian et al, 2007; Tian et al, 2010). There is 
general agreement that the composition of these microdomains is quite heterogeneous 
and, further, that their stability is influenced by the dynamic interactions of the cortical 
cytoskeleton with membrane proteins and lipids. The cytoskeleton also limits diffusion of 
membrane constituents by forming “picket fences” and “corrals” (Kusumi et al, 2005b; 
Suzuki et al, 2005). The role of these membrane features in promoting or limiting 
protein-protein interactions remains controversial, since there is strong potential to both 
enhance and inhibit signaling (Allen et al, 2007; Costa et al, 2009a; Miura et al, 2001; 
Pike, 2003). To help resolve these issues, several groups are developing spatially realistic 
mathematical simulations of receptor motion, aggregation/clustering and activation in the 
cell membrane. 
It is important to note that parameters for these mathematical models rely on powerful 
new experimental techniques. High resolution microscopy techniques, such as 
Transmission Electron Microscopy (TEM) and photoactivation Light Microcrosopy 
(PALM), have been applied to map the spatial distribution of signaling molecules in fixed 
cells (Lillemeier et al, 2010; Wilson et al, 2007). These snapshot images of protein 
distributions can be supplemented with powerful new live cell imaging approaches,  
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Figure 1.2: Schematic representation of microdomains and receptor clustering. Left: Cartoon 
representation of features that can subcompartmentalize the plasma membrane, including rafts or 
islands, and the cortical cytoskeletal network. These features are highly dynamic, permitting rapid 
exchange by diffusion. Right: Representation of the distribution of receptors (yellow, blue symbols) 
in and out of domains (pink regions) formed by these features. Arrows point to various states, 
including monomers, dimers, and aggregates. Receptors that are transiently trapped in domains are 
locally crowded (arrow, top right) and appear as clusters by imaging technologies. This molecular 
crowding can be more pronounced upon ligand stimulation, due in part to formation of dimers and 
larger aggregates with decreased diffusive mobility. This review considers the experimental and 
computational evidence that molecular crowding influences receptor dimerization/aggregation and 
recruitment of signaling proteins. 
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including fluorescence resonance energy transfer (FRET), fluorescence lifetime 
correlation spectroscopy (FLCS), and single particle tracking (SPT) experiments (Lidke 
& Wilson, 2009). These techniques can generate key information regarding the kinetics 
of protein-protein interactions, including rates of dimerization, size of receptor aggregates 
and changes in diffusion properties (Low-Nam et al, 2011). These rich data sets support 
the development of more accurate and detailed mathematical models that in turn improve 
understanding of biological results. 
1.3.4.1 Key concepts and definitions relevant to the consideration of protein 
clustering in the plasma membrane 
In this brief review, we focus attention on the mathematical simulation of protein 
clustering in the plasma membrane, an initial step in many signaling pathways. The 
protein species considered may be a surface receptor, that is triggered by binding to an 
extracellular ligand, or could be an intracellular signaling partner, such as an adaptor 
protein or enzyme that propagates signaling through the cell interior. We define 
clustering as the non-random spatial distribution of a membrane species, which can be 
observed and experimentally validated through modern technologies. “Snap-shot” images 
of membrane proteins often capture some level of clustering even before the onset of 
ligand binding to receptors or active signaling (Bader et al, 2009). We hypothesize that 
these basal levels of clustering arise from brief, non-productive interactions among 
proteins as they encounter one another while diffusing in the plasma membrane or when 
proteins are transiently co-confined in a raft, island, or corral (Figure 1.2). Thus 
clustering in this sense is not synonymous with oligomerization, which reflects the direct 
and measurable interaction between membrane components. It is important to point out 
that stable oligomers cannot be distinguished from unstable clusters in imaging 
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techniques using fixed cells, such as TEM and PALM. However, new imaging protocols 
can now accurately measure the dynamics of protein-protein interactions at the molecular 
scale (Lidke & Wilson, 2009). A recent example from our Center is the simultaneous 
single particle tracking (SPT) of pairs of EGFR molecules, each labeled by virtue of 
binding to EGF conjugated to different colors of quantum dot probes; only when two 
EGF-QD-bound receptors were both coincident and exhibited correlated motion, could 
they pass the stringent criteria for oligomerization (Low-Nam et al, 2011). The concept of 
clustering becomes particularly important as we consider the data suggesting that the 
spatial proximity of proteins can promote protein-protein interactions, including 
oligomerization, by increasing the likelihood of productive collisions.   
1.3.4.2 Choosing the right modeling approach  
Mathematical models constructed to date to study signal transduction pathways are of 
varied complexity. They can be classified conveniently as deterministic methods, in 
which inherent temporal and spatial fluctuations in diffusion and reaction rates are 
ignored, and stochastic methods, which attempt to capture these fluctuations (Figure 1.3). 
The simplest modeling approach is to assume that the system of interest is well mixed, 
without any spatial concentration gradients, and describe the reactions by a system of 
ordinary differential equations (ODEs). The utility of ODE modeling is enhanced by 
systematic sensitivity analysis, which examines automatically changes in model behavior 
due to parameter variation (Radhakrishnan, 1991; Radhakrishnan et al, 2009). Such a 
deterministic, well-mixed approach continues to be widely used (Tian et al, 2010), and 
has produced useful results (Brightman & Fell, 2000; Radhakrishnan et al, 2009). 
However, these approaches do not take into account either spatial inhomogeneities or 
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stochastic fluctuations, which can be significant when the number of molecules in the 
region of interest is small. At a slightly higher level of complexity, some spatial 
description is provided by dividing the region of interest into separate well-mixed 
compartments. Additional ODEs are needed to describe inter-compartmental species 
translocation reactions, thus mimicking spatial movement. 
These well-mixed, ODE-based continuum pathway models (Kholodenko et al, 1999) 
were expanded to include spatial inhomogeneity (Brown & Kholodenko, 1999; 
Slepchenko et al, 2003) by solving partial differential equations (PDEs) that include 
molecular diffusion effects. Stochastic methods that assume spatially well mixed systems 
have also been developed to account for temporal fluctuations (Gillespie, 2007; Li et al, 
2008). Stochastic PDEs include both spatial information and temporal fluctuations. The 
most detailed, and thus most complex, models are fully spatial, stochastic methods that 
track the movement of individual molecules (Andrews & Bray, 2004; Burrage et al, 
2007; Costa et al, 2009a; Costa et al, 2009b; Grima & Schnell, 2008; Hsieh et al, 2010; 
Hsieh et al, 2008; Reddy et al, 2010; Tolle & Le Novere, 2010b). However, the 
computational burden increases rapidly with increasing complexity of the modeling 
approach. Figure 1.3 summarizes the various modeling approaches and their range of 
applicability.  
Mathematical simulation of events in the plasma membrane faces unique challenges. 
Membrane proteins are constantly undergoing random motion in the plane of the 
membrane, where the diffusion rate is influenced by the environment, such as hindrance 
by microdomains, and thus varies both spatially and temporally. Optimally, the spatial 
location of every protein needs to be predicted, in order to capture clustering imposed by  
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Figure 1.3: Classes of mathematical models for molecular processes in cells and the scales at which 
they are applicable to signaling processes. A possible quantitative guide is the size of the largest 
element that can be treated as spatially homogeneous (horizontal axis) and the typical number of 
molecules of one species in the element (vertical axis). The suggested spatial resolution is determined 
by the size of the biological element of interest and current computational capabilities. Spatially 
resolved models are resource-intensive, and are therefore generally applied to small subsystems. 
Cell-level models of large signaling networks are typically well mixed; spatial Monte Carlo studies 
rarely scale beyond a few hundred nanometers. A promising approach for multiscale applications is 
a combination of compartment-based models at the large scales and fully spatial simulations focused 
on a few important processes within small structural elements of the membrane. Temporal 
fluctuations arise largely from the discrete and stochastic nature of the underlying molecular 
processes. The relative magnitude of temporal fluctuations (DN) decreases as the number of particles 
increases. The discrete nature of the particle number can thus be ignored when N is significantly 
greater than 1. That is, deviations from the expected average behavior can be neglected when the 
expected magnitude of the fluctuations is small compared to N. 
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membrane topography and to predict the outcomes of both transient and prolonged 
protein-protein binding events. Fully spatial, stochastic methods offer capabilities that 
can capture accurately the dynamics of these events, but can be associated with 
prohibitively high computation cost. Novel hybrid approaches show promise for solving 
some of these computational challenges. 
Finally, this section would not be complete without introducing the unique power of 
rules-based approaches (Faeder et al, 2009; Hlavacek et al, 2006). Here, molecular 
interactions in signaling networks are treated as systems of encoded rules.  Molecules are 
represented as structural objects that have modular domains and associated states 
representing conformations or covalent modifications of these domains.  Importantly the 
input files and model specification blocks are compatible with multiple types of 
computational approaches, including coupled ODEs that result in deterministic solutions 
of reaction kinetics as well as stochastic methods.      
1.3.5 Applications in specific signaling pathways 
Sections below briefly summarize mathematical models that have been developed to 
study signal transduction pathways, with emphasis on methods developed by our group 
and others to capture the influence of clustering and other spatial aspects. We focus on 
three representative signal transduction pathways (EGFR, Ras/MAPK and GPCR) where 
protein clustering has been implicated, and on the modeling approaches used to approach 
this unique set of challenges.  
14 
1.3.5.1 Our group’s focus: spatial aspects of signaling through the epidermal 
growth factor receptor 
A member of the ErbB family of plasma membrane receptors, EGFR is critically 
important to many biological processes, including embryonic development and 
carcinogenesis (Bublil & Yarden, 2007; Keating et al, 2008; Yang et al, 2007). Upon 
binding any one of several ligands, including EGF, the ErbB receptors homo- or hetero-
dimerize. Dimerization is followed by transphosphorylation of tyrosine residues in 
receptor cytoplasmic tails, which enables recruitment of cytosolic signaling proteins. The 
reader is referred to Figures 2,3 in the article by Telasco & Radhakrishnan, for diagrams 
of EGFR/ErbB1 dimerization, phosphorylation and adaptor protein recruitment (Telesco 
& Radhakrishnan, 2012). Subsequently, these complexes activate many different 
signaling cascades, including the Ras-MAPK pathway discussed in the next section. 
There exists considerable experimental evidence for preexisting clusters of resting 
EGFR (Figure 1.4) and for dynamical changes after addition of ligand (Abulrob et al, 
2010; Bader et al, 2009; Keating et al, 2008; Saffarian et al, 2007; Szabo et al, 2008; 
Yang et al, 2007). We have built simulation platforms at different levels of complexity, in 
order to evaluate the impact of EGFR clustering in the plasma membrane.  
1.3.5.1.1 Approaches and methodology 
Our first attempt to develop a spatial model of the EGFR pathway was a simple 
compartmental model that accounted for receptor density differences observed in the 
plasma membrane, with some regions having high-receptor density and others displaying 
low-receptor density (Mayawala et al, 2005b). The focus of this study was to explore 
whether the added computational complexity associated with spatial modeling was 
justified. Our initial goal was to determine if the non-uniform receptor distribution in the 
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cell membrane could account for the experimentally observed, concave-up Scatchard plot 
for binding of EGF ligand to its receptor. We simply optimized the distribution of 
receptors into high- and low-density regions, and were able to determine the parameter 
space that allowed for a concave-up Scatchard plot. This first attempt at 
compartmentalized spatial modeling showed that accounting for the spatial organization 
of receptors was highly valuable, and should be pursued, to enable both qualitative and 
quantitative understanding of cell signaling involving (at least) the EGFR. 
This study convinced us of the utility of spatial modeling of membrane-bound receptors 
and of its importance in understanding cell signaling. We have now accumulated 
extensive experience in developing spatially realistic simulations of the cell membrane 
and also addressed the initiation of signaling (Chatterjee et al, 2005; Costa et al, 2009a; 
Costa et al, 2009b; Hsieh et al, 2010; Hsieh et al, 2008; Mayawala et al, 2004; Mayawala 
et al, 2005a; Mayawala et al, 2005b; Mayawala et al, 2006). Next, we summarize our 
development of lattice-based and lattice-free (or off-lattice) methods, as well as our use 
of hybrid approaches.  
1.3.5.1.2 Lattice-based Monte Carlo (MC) approaches.  
In lattice-based models, molecules are located at discrete grid points in the spatial 
domain and diffusion is restricted to movement to an unoccupied neighboring point. 
Lattice-based MC simulations have become very popular in the physics, chemistry, 
materials and engineering communities, as they provide spatio-temporal information at 
significantly reduced computational cost, compared to off-lattice simulations  
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Figure 1.4: Experimental results and mathematical model predictions of EGFR clustering. (a) 
Experimental evidence for EGFR clustering in absence of ligand. Electron micrograph of gold 
particle-labeled EGF receptors in resting A341 cells (~2 million EGFR/cell), reveals a non-random 
distribution and provides evidence for receptor co-confinement. (b) Spatial domain used in lattice-
free Monte Carlo simulation. The spatial domain simulated by the off-lattice Monte Carlo procedure 
was a square of area 2 lm2, representative of a small region in the plasma membrane. This region was 
modified to include many islands or preferred domains (the gray rectangles within the membrane 
patch), to simulate the receptor-trapping microdomains seen in (a). Movement of receptors into and 
out of the simulated microdomains over a time period of 30 s is indicated by the thin colored tracings. 
Receptor trapping in the microdomains was reproduced mathematically by stipulating that receptors 
had a greater probability of entering these regions than of leaving them. (c) Simulation predictions of 
receptor clustering in absence of ligand. The predicted particle positions after 30 s of simulation time 
are indicated by the black dots. The Hopkins statistical test (inset) was used to test the randomness of 
receptor distribution. The right shift of the distribution (compared to the random or normal 
distribution shown in red) confirms the clustered nature of the receptors. The predicted receptor 
distribution compares well with the experimental observation in (a). (d) Simulations using a coupled 
spatial/nonspatial stochastic algorithm (CSNSA) support the conclusion that EGFR clustering 
promotes activation of the adaptor SOS. ODE models confirm this conclusion, using a fast diffusion 
coefficient to override contributions from membrane spatial organization (from Hsieh et al. and 
Costa et al.). 
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(Auerbach, 2000; Chuan Kang & Weinberg, 1995; Coppens et al, 1999; Gilmer, 1980; 
Zhdanov & Kasemo, 1994). The MC method is a coarse graining of molecular dynamics 
(MD) simulations (Auerbach, 2000), because MD is impractical for rare event dynamics, 
such as hopping between deep minima of a potential energy surface. The MC method 
stochastically solves an underlying master equation using pseudo-random numbers by 
constructing the probability with which the various states of the system have to be 
weighted according to a Markov process. MC simulations can provide continuous time 
information. Gillespie established the foundations of time-dependency for chemical 
reactions in a spatially homogeneous system (Gillespie, 1977; Gillespie, 2007). His 
approach is easily applicable to arbitrary complex computational systems, and is often 
referred to as the kinetic or dynamic MC method. Despite important algorithmic 
implementations (e.g., dependency graphs (Gibson & Bruck, 2000), lists of neighbors, 
binary-tree search, etc.), MC simulations are seriously plagued by (1) the presence of fast 
reactions that occur in large biochemical networks seen in biology and (2) the execution 
of one event at a time.  
Our Spatial Kinetic Monte Carlo (SKMC) method (Mayawala et al, 2005a; Mayawala 
et al, 2005b) utilizes a modified null-event, lattice-based MC algorithm (Costa et al, 
2009a; Mayawala et al, 2006). The spatial domain, representing a small region of the 
plasma membrane, is a two-dimensional square lattice of side ℓ, divided into a large 
number of much smaller square bins of side a (<< ℓ). The SKMC algorithm consists of 
first randomly selecting an occupied lattice site, and then choosing either a successful 
(reaction or diffusion) or unsuccessful (null) event, based on calculated probabilities. If a 
18 
successful event is chosen, it is executed. The transition rate 
€ 
Γi→ j
d  for diffusion of species 
from any site i (i.e., lattice point i) to a nearest-neighboring site j as defined as 
€ 
Γi→ j
d =
1
4 Γ
Dσi 1−σ j( ) , 
€ 
j ∈Bi 
where 
€ 
ΓD = 4D /a2  and D is the diffusion coefficient of the species located at site i. 
The term Bi denotes the set of four possible nearest-neighboring sites to which diffusion 
can occur in two dimensions from site i. Because species are allowed to diffuse only to an 
unoccupied site, we define an occupancy function σj for each of the four nearest-
neighboring sites, in order to simplify the procedure for computing the transition rate for 
diffusion. For any site k (= i or j), σk is set equal to 1 if the site is occupied, or to 0 if the 
site is unoccupied. The transition rate for a chemical reaction at site i, 
€ 
Γi
r depends on the 
reaction type and is directly related to the standard reaction rate. 
The probability 
€ 
pix  of an event	  𝑥 (=𝑟 reaction or	  𝑑 diffusion) at site	  𝑖 is computed by 
using the relation 
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Γmax  is a normalization constant, defined as 
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where the multiplicative factor of 4 accounts for events occurring in the four directions of 
the two-dimensional square lattice. Finally, the time step	   Δ𝑡 used to advance the 
simulation time is computed as 
€ 
Δt =1/Γmax . 
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1.3.5.1.3 Rule-based, non-lattice simulator 
Our non-lattice, stochastic simulator is an alternative approach (Hsieh et al, 2010; 
Hsieh et al, 2008). In the lattice-free method, particles are not confined to discrete points 
in space but are randomly repositioned upon undergoing a diffusion event. Receptors and 
other proteins in the 2D membrane and 3D cytosolic space are represented by sphere-like 
particles with radii determined from experimental data and their coarse-grained molecular 
models. At each time step, species diffusion is simulated as Brownian motion (Figure 
1.4). In addition, species have the potential to react with spatially nearby species. This 
simulator was designed for flexible model development and deployment by a 
modularized and rule-based approach. It tracks the individual reactions of multistate 
molecules and accommodates complex situations.  
1.3.5.1.4 Hybrid approaches 
We continue to improve our basic SKMC algorithm, leading to increased efficiency 
and speed of the simulations. One significant advance was the coupling of our lattice-
based SKMC simulations on the cell membrane to well-mixed stochastic simulations 
within the cytosol (Costa et al, 2009a). In Costa et al (2009a) we describe the 
development of an algorithm that couples a spatial stochastic model of membrane 
receptors with a nonspatial stochastic model of cytosolic reactions. Our novel hybrid 
algorithm provided a computationally efficient method to evaluate the effects of spatial 
heterogeneity on the coupling of receptors to cytosolic signaling partners. Results 
obtained using a compartmental ODE method compared well with those generated with 
our hybrid model. Thus, for sufficiently high receptor copy number, the far simpler ODE 
model may be adequate. However, for spatially inhomogenous systems where the 
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receptors numbers are low, the hybrid method was significantly superior to the ODE 
model.  
1.3.5.1.5 EGFR density, through clustering or overexpression, influences signaling 
output 
We have applied these methods to study the early molecular mechanisms involved in 
EGFR signaling. For example, we applied the lattice-based spatial stochastic model of the 
plasma membrane to examine the influence of cytoskeletal corral openings on EGFR 
clustering (Costa et al, 2009b). Clustering was shown to depend on both receptor 
concentration and picket fence density. For high picket fence densities, clustering 
increased with increasing receptor concentration in the range examined. Conversely, low 
receptor concentrations combined with small corral sizes inhibited clustering; at normal 
to high receptor concentration, maximal clustering occurred at an intermediate corral size 
(~100 nm). These results indicate that both the number of clusters and the average cluster 
size are likely to be complex functions of receptor density and microdomain size. It 
follows that compartmentalization of the plasma membrane could either inhibit or 
enhance signaling, concepts that require further exploration.  
The non-lattice, rules-based simulator allowed us to explore the effect of EGFR 
overexpression and its relation to carcinogenesis (Hsieh et al, 2008). We postulated that 
increased receptor density in membrane microdomains or protein islands might lead to 
more frequent interactions between non-ligand bound receptors, and further, that large 
numbers of these short-lived interactions might explain EGFR signaling known to occur 
even in the absence of ligand (Bader et al, 2009). One important aspect was consideration 
of EGFR extracellular domain conformation, based upon structural studies showing that 
21 
the resting EGFR is predominantly in a “closed” conformation. Binding of ligand is 
proposed to stabilize the extended conformation and expose the dimerization arm. In our 
simulations, we assumed that the resting EGFR “fluxes” between the open and closed 
states, but spends 99% of its time in the closed state. This property translates to a low 
probability that two diffusing monomers will collide under conditions where both expose 
their dimerization arms and are therefore competent to form a complex. The 2D 
simulation space included membrane microdomains that transiently trapped receptors (as 
in Figure 1.4), setting up clusters undergoing dynamic exchange. Remarkably, at levels of 
receptors typical of most normal cells, co-confinement in membrane microdomains 
lowered the threshold for ligand-independent receptor dimerization but resulted in very 
modest signaling output. When the simulation space was populated with densities 
typically seen in tumors with EGFR gene amplification, which can express millions of 
EGFR per cell, the percent of activated receptors could exceed 10% with our parameter 
values. Clustering had little effect in these cases, since the overall density on the 
membrane was already very high. 
We have used both lattice and non-lattice models to consider how spatial aspects 
might affect the recruitment of signaling molecules to the phosphorylated EGFR tail 
(Costa et al, 2009b; Hsieh et al, 2010). In Hsieh et al (2010), we also considered the 
combinatorial complexities associated with the fact that EGFR has multiple 
phosphorylation sites, and further, the fact that each phosphotyrosine site is capable of 
binding multiple partners. We used coarse-grained molecular docking simulations to 
show that steric hinderance can impose important constraints on the composition of 
adaptor proteins capable of docking simultaneously on the EGFR tail. Modeling 
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predictions in Hsieh et al (2010) were quantitatively consistent with experimental data for 
the kinetics of both EGFR phosphorylation and recruitment of adaptor proteins. 
Importantly, both papers provide mathematical support for the conclusion that clustering 
of receptors can amplify signaling by promoting sequential binding of adaptor proteins. 
These results provide confidence in our models, and have led to ongoing studies of other 
growth factor receptors that initiate signaling through dimerization, particularly VEGFR, 
as well the heterodimerizing members of the ErbB family. This field continues to 
advance, as demonstrated by the hybrid approaches of Radhakishnan and colleagues 
(Telesco & Radhakrishnan, 2012) that consider ErbB structural and diffusion properties 
using increasingly complex models. Additional aspects of cell surface topography, such 
as the induction of membrane curvature by endocytic adaptor proteins, are new concepts 
that will provide important insight into the control of signal transduction through the 
biophysical principals of membranes.   
1.3.5.2 Work by others: the case of signaling via Ras/MAPK pathways.  
The Ras superfamily consists of over 100 small GTP-binding proteins (or GTPases), 
which respond to various extracellular stimuli to regulate important signal transduction 
pathways (Vigil et al, 2010; Wennerberg et al, 2005). These proteins, which have low 
intrinsic GTPase activity, “switch” between active GTP-bound and inactive GDP-bound 
conformations. The processes mediated by GTPases include cell division, differentiation, 
apoptosis and migration, cytoskeletal reorganization, and intracellular protein trafficking 
(ten Klooster & Hordijk, 2007). Abnormalities in these pathways are seen in various 
pathologies, including obesity, diabetes, inflammatory diseases, cardiovascular disease, 
neurological disease, and cancer (Colicelli, 2004; ten Klooster & Hordijk, 2007; Vigil et 
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al, 2010). Therefore the pharmacological targeting of GTPases and/or their signaling 
pathways is an active field (Vigil et al, 2010). 
The Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway has been 
investigated extensively, both in the clinic and the laboratory, and by mathematical 
modeling (Brightman & Fell, 2000; Friday & Adjei, 2008; Fujioka et al, 2006; 
Hatakeyama et al, 2003; Hornberg et al, 2005; Kholodenko et al, 1999; Kholodenko et al, 
2010; Orton et al, 2005; Radhakrishnan et al, 2009; Sasagawa et al, 2005; Schoeberl et al, 
2002; Tian et al, 2007; Tian et al, 2010; Wiley et al, 2003). Activation of a number of 
receptors, including EGFR, leads to guanine nucleotide exchange (dissociation of GDP, 
gain of GTP) by membrane-tethered Ras, thereby activating it. The activated Ras in turn 
activates Raf (Ras-associated factor), the first kinase in the cascade. Subsequently, Raf 
activates MEK (MAPK/extracellular signal-regulated kinase kinase), which then 
activates ERK (extracellular signal-regulated kinase). The translocation of 
phosphorylated ERK to the nucleus and activation of transcription factors mediates many 
cellular activities. 
Numerous mathematical models have been developed to study this pathway 
(Brightman & Fell, 2000; Fujioka et al, 2006; Hatakeyama et al, 2003; Hornberg et al, 
2005; Kholodenko et al, 1999; Kholodenko et al, 2010; Orton et al, 2005; Radhakrishnan 
et al, 2009; Sasagawa et al, 2005; Schoeberl et al, 2002; Tian et al, 2007; Tian et al, 2010; 
Wiley et al, 2003). Much of this work uses compartmental models and ODEs to follow 
the temporal evolution of activated ERK, and does not consider clustering in the plasma 
membrane. However, Tian et al (2007; 2010) have mathematically evaluated various 
spatial aspects of Ras signaling, including clustering in the plasma membrane. This group 
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utilized a hybrid approach to simulate reactions in the cell membrane and those in the 
cytosol, enabling them to separate the contribution of the plasma membrane structure to 
the signal. They combined the well-mixed stochastic model of Gillespie (Gillespie, 1977; 
Gillespie, 2007) to simulate reactions in the membrane with an ODE model for the 
cytosolic reactions. They assumed that the number of RasGTP clusters was proportional 
to the EGF concentration, and these clusters served as platforms for recruiting Raf to the 
plasma membrane for activation. The lifetime of RasGTP clusters was assumed to be 
normally distributed over a measured value. Plasma membrane reactions, in addition to 
binding and activation of Raf by RasGTP clusters, included recruitment by activated Raf 
of the KSR-MEK-ERK complex from the cytosol and activation of MEK by activated 
Raf and of ERK (MAPK) by activated MEK. KSR (kinase suppressor of Ras) is a 
scaffold protein that facilitates MAPK activation by providing binding sites for assembly 
of the signaling complex. The recruitment of both Raf and the KSR-MEK-ERK complex 
was modeled as occurring through random collisions with the plasma membrane. With 
dissolution of a nanocluster, all recruited proteins diffused back to the cytosol, where the 
activated MEK and ERK continued their roles. Using this model in conjunction with 
biological experiments, Tian et al. (2007) concluded that RasGTP clustering is essential 
for signal transduction. Moreover, the RasGTP clusters operate as sensitive switches in 
that they produce approximately the same levels of normalized activated ERK over a 
wide range of ligand concentration. One possible explanation for this behavior is the 
establishment of locally high concentrations of recruited proteins and thus the spatial 
restriction of active ERK production to RasGTP nanoclusters, whose generation and 
lifetime are themselves strictly regulated (Tian et al, 2007). Tian et al. (2007) also 
25 
concluded that the production of RasGTP nanoclusters in direct proportion to ligand 
concentration can ensure high fidelity of signal transduction. 
Subsequently, Tian et al. (2010) incorporated models for following the temporal 
evolution of RasGTP clusters in the cell membrane. In particular, they studied K-Ras 
clustering and how it is influenced by the protein Galectin-3 (Gal3). Previous 
experimental work had shown that Gal3 is a scaffolding protein recruited to the plasma 
membrane, where it is necessary for the formation of Ras nanoclusters (Shalom-
Feuerstein et al, 2008). Their mathematical model considered the two species, membrane-
bound RasGTP and Gal3, initially in the cytosol. Once Gal3 is recruited by RasGTP, the 
RasGTP-Gal3 complexes are assumed to diffuse randomly in the plasma membrane and 
react with one another to form complexes of various sizes. 
To simplify the calculation procedure, Tian et al. (2010) allowed for a maximum 
cluster size of ten. The various combinations of possible complexes resulted in a total of 
27 species and 136 reactions in the plasma membrane. In agreement with our earlier 
observation, they concluded that spatial stochastic modeling of such a large system poses 
a considerable computational burden. Therefore they developed an ODE system to follow 
the temporal evolution of complexes of size 1-10, using a spatial stochastic model to only 
deduce collision rates among the complexes (Hsieh et al, 2010; Hsieh et al, 2008). This 
deterministic system was solved with a Runge-Kutta method suitable for stiff ODEs 
(Radhakrishnan, 1991). The collision rates were obtained by initially placing RasGTP 
randomly in a square-shaped representation of the plasma membrane. Recruitment of 
Gal3 produces the RasGal complex. These molecules were allowed to diffuse randomly, 
and a collision was said to occur when the distance between two molecules was less than 
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the sum of their radii. The collisions produced various combinations of Ras-Gal 
complexes. When a nanocluster, defined as a cluster consisting of 5 or more RasGTP 
molecules, formed it was assumed to become immobile in the plasma membrane. During 
the calculation procedure the total numbers of collisions giving rise to all cluster types 
were tracked. At the end of the computational time period, the collision rate constants 
were computed from the total numbers of collisions. Kinetic rate constants for the ODE 
model were then derived from the collision rate constants, by using a genetic algorithm in 
conjunction with experimental data. The validity of this deterministic ODE model was 
checked with results generated with a stochastic simulation algorithm (Gillespie, 1977). 
Presumably due to the large numbers of proteins, the stochastic simulations predicted 
only small fluctuations. This observation supports use of deterministic models when the 
protein copy number is high, in agreement with our observations.  
Using this modeling approach, Tian et al. (2010) studied clustering of K-Ras-GTP in 
the plasma membrane arising from interactions with Gal3 for various KRas and Gal3 
copy numbers. The simulation time period was sufficiently long for the system to 
equilibrate. The time to equilibrate was approximately two minutes, an important result 
because it is in good agreement with the time period required for RasGTP loading in 
response to stimulation (Tian et al, 2007). Their results also successfully reproduced the 
experimental results of Plowman et al. (2005) that approximately 42% of the RasGTP 
were in clusters and the average cluster size was approximately 7. Tian et al. (2010) also 
generated the equilibrium nanocluster number versus size histogram. Their results 
showed that nanoclusters with two to four molecules accounted for only 2.1% of the 
RasGTP, whereas a cluster size of 5 was the most prevalent. Nanoclusters larger than 5 in 
27 
size were progressively smaller in number, approximately inversely proportional to the 
size. The authors speculate that one possible reason for the lowered incorporation of 
RasGTPGal3 complexes into clusters of size 5 or larger is the remodeling of the lipid 
environment of the cluster by the stable pentamer. Their results also suggest that cluster 
formation is only weakly dependent on RasGTP concentration, and is determined by the 
Gal3 cytosolic concentration. Tian et al. (2010) concluded that on the basis of their 
simulations neglecting the formation of clusters with more than 10 RasGTP molecules is 
reasonable. Notably, this work illustrates the difficulty of spatial modeling of systems 
with large reaction networks. 
1.3.5.3 Work by others: G-protein coupled receptors 
The GPCRs constitute the largest family of transmembrane receptors, consisting of 5 
subfamilies (Alberts, 2008; Rosenbaum et al, 2009). These proteins, whose structure and 
function were reviewed recently by Rosenbaum et al. (2009), are characterized by seven 
transmembrane spanning α-helical segments (Alberts, 2008; Fuxe & Kenakin, 2010). 
They regulate many physiological functions such as vision, gustation and olfaction 
(Rosenbaum et al, 2009; Vilardaga et al, 2010). Neurotransmitters, hormones and 
environmental stimuli activate these pathways. GPCRs are also implicated in many 
human diseases, such as inflammation, retinitis pigmentosa, nephrogenic diabetes 
insipdus, and Kaposi’s sarcoma (Fuxe & Kenakin, 2010; Insel et al, 2007; Vilardaga et al, 
2010; Waller et al, 2004). At present, most pharmaceutical drugs used by humans target 
GPCRs by serving as agonists or antagonists (Fallahi-Sichani & Linderman, 2009; 
Vilardaga et al, 2010). 
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Many aspects of GPCR signaling are well established. In the classical view, binding of 
ligand to a GPCR induces a conformational change in the receptor. The activated receptor 
initiates guanine nucleotide exchange (GDP→GTP) in its principal signaling partner, a 
heterotrimeric (αβγ) G-protein complex. Like ras, heterotrimeric G proteins are tethered 
to the cytosolic leaflet of the plasma membrane through covalently attached lipids, and 
assume an active state once bound to GTP. An additional step is required for 
heterotrimeric G proteins: the separation of the GTP-bound Gα subunit from the 
Gβγ subunit, which diffuses into the cytosol. The subsequent activation of downstream 
effector proteins results in various distinct biological reactions.  
Recent work has focused on new aspects of GPCR signaling, such as the evidence that 
at least some GPCRs can form homo- or hetero-dimers (Brinkerhoff et al, 2004; Fuxe & 
Kenakin, 2010; Waller et al, 2004). These dimers can interact further to form oligomers 
(Fallahi-Sichani & Linderman, 2009). Although believed essential for signaling to occur, 
the dimerization mechanism is well characterized for only a few GPCRs (Lambert, 2010). 
Due to the importance of GPCR signaling in healthy and diseased states, GPCR 
interactions, along with membrane organization, and their impact on signaling must be 
well characterized. Mathematical modeling is therefore being used increasingly to help 
unravel the intricacies of this pathway. A useful review of mathematical models that have 
been developed to study GPCR signaling is given by Linderman (2009). 
Brinkerhoff et al. (2004) used triangular lattice-based Monte Carlo (MC) models to 
simulate receptor dimerization and activation in a two-dimensional plane, examining how 
dimerization creates clusters of receptors. Their model demonstrates the applicability of 
MC methods to systems with discrete reactions that are diffusion limited (Brinkerhoff et 
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al, 2004). Randomly selected particles undergo either one of two possibilities at each 
time step: displacement in a random direction by a distance governed by the diffusion 
coefficient or a chemical reaction. Reaction possibilities considered were receptor 
dimerization, binding of ligand by receptor, receptor activation of G protein, and receptor 
phosphorylation. This group’s simulations suggest that clustering arises through both 
dimerization and cross talk between receptors as they approach one another closely and 
are able to share an effector. They also concluded that the resulting clustering enhances 
signaling. 
Fallahi-Sichani et al. (2009) investigated lipid raft impact on GPCR signaling with a 
combination of MC (stochastic) and deterministic models. A lattice-based, kinetic MC 
model was used to establish the effects of low-diffusivity rafts on receptor dimerization 
and cluster dynamics. The stochasticity of the model allowed for receptor distributions to 
be examined, leading to parameter estimations for exploring the effects on downstream 
signaling using an ODE model. The fraction of plasma membrane covered by 
microdomains (rafts), which was varied from 2-30%, had a significant impact on output. 
At 2% coverage, microdomains amplified the overall response, but at higher coverage the 
signal was attenuated. They concluded that dimerization and lipid raft trapping 
cooperatively control the extent and dynamics of GPCR signaling. 
Tolle et al. (2010b) developed an off-lattice, Brownian diffusion-based stochastic 
model, which they used to determine how AMPAR (alpha-amino-3-hydroxyl-5-methyl-
4-isoxazolepropionic acid receptor) diffusion in the dendritic spine affects synaptic 
signaling, specifically Long-Term Potentiation (LTP).(Tolle & Le Novere, 2010a) LTP, 
an increase in synaptic strength, is a well-studied form of synaptic plasticity, the ability to 
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change the strength of a signal (Santamaria et al, 2010; Tolle & Le Novere, 2010a). Tolle 
et al.’s model accounts for the dendritic spine membrane, membrane receptors and 
scaffolding proteins known to bind to membrane receptors (Tolle & Le Novere, 2010a). 
The spatial domain representing the plasma membrane of the synaptic spine was modeled 
as a square of surface area corresponding to the measured volume of the spine. This 
square was separated into two different compartments or domains, in order to account for 
the two physiologically different portions of the plasma membrane: the post-synaptic 
density (PSD) and the extra-synaptic membrane (ESM). The PSD is a protein-rich region 
where AMPARs are concentrated (Santamaria et al, 2010; Tolle & Le Novere, 2010a), 
while the rest of the membrane is classified as the ESM (Tolle & Le Novere, 2010a), The 
transmembrane receptor movement within the ESM was modeled with Brownian-type 
diffusion, while confined motion was used to model the restricted diffusion within the 
PSD. Simulation results indicate that randomly placed receptors quickly localize to the 
PSD, which Tolle et al. (2010a) suggest explains the quick onset of LTP.  
1.3.6 Concluding remarks. 
This review specifically considers the mathematical modeling of protein clustering on 
the plasma membrane and the evidence that signal transduction can be enhanced by 
locally high concentrations of proteins that increase the probability of protein-protein 
interactions. This feature is especially important when the numbers of particles are small. 
When proteins are overexpressed, as in EGFR amplication in certain cancers, clustering 
may not be as significant (Hsieh et al, 2008). The role of membrane microdomains in 
signaling may be quite complex, since both inhibitory and stimulatory effects have been 
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observed experimentally and theoretically (Allen et al, 2007; Costa et al, 2009a; Miura et 
al, 2001; Pike, 2003). 
Mathematical modeling, in conjunction with biological experiments, is providing new 
insights into the mechanisms that govern protein clustering in membranes and the 
resulting impact on signaling. Increasing experimental detail is being matched by 
increasingly complex models that account for previously ignored biological subtleties 
(Chakraborty et al, 2003; Erban & Chapman, 2009; Grima & Schnell, 2008; Li et al, 
2008; Radhakrishnan et al, 2010; Resat et al, 2009; Turner et al, 2004). An important 
goal is to predict the functional responses of whole cells and cell-tissue systems, based 
upon integration of spatial and temporally encoded signals from surface receptors. 
Achieving this goal will necessitate the development of efficient and accurate multi-scale 
simulation capabilities. A daunting challenge to mathematical modeling of cell signaling 
continues to be the scaling up of computationally intense methods developed for studying 
molecular behavior to enable predictive modeling at progressively more complex levels, 
from the cellular to the systemic. 
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1.4 RECEPTOR TYROSINE KINASES: THE ERBB FAMILY  
1.4.1 ErbB1 
ErbB1 is part of the ErbB family of receptor tyrosine kinases (RTK) (Citri & Yarden, 
2006). ErbB1 is not only critical for normal growth and development, but has also been 
implicated in various forms of cancer (Yarden & Sliwkowski, 2001). The ErbB1 receptor 
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fluctuates between a closed and open conformation (Baselga & Swain, 2009), with the 
open conformation being stabilized through ligand binding. When the receptor is in the 
open conformation, the dimerization arm is exposed, allowing the receptor to form 
homodimers with other ErbB1 receptors and hetero-dimers with the other three members 
of the family, ErbB2, ErbB3, and ErbB4 (Yarden & Sliwkowski, 2001). Due to the 
fluctuation of receptor conformation, dimerization between receptors is possible in the 
absence of ligand, forming pre-formed dimers (Schlessinger, 2002). The ability of non-
ligand bound ErbB1 monomers to partner with one another, as well as with ligand-bound 
monomers, leads to multiple ligand:receptor dimer configurations. 
When the receptors form a dimer, the kinase tails form an asymmetric configuration 
connecting the C-lobe of one kinase tail to the N-lobe of the opposite kinase tail. This 
conformation is often referred to as an asymmetric dimer (Zhang et al, 2006). When the 
kinase tails interact, the tails are phosphorylated through transphosphorylation. This 
phosphorylation, sometimes referred to as dimer activation, triggers a signal cascade, 
recruiting different effector and adaptor proteins to the tail (Linggi & Carpenter, 2006; 
Yarden & Sliwkowski, 2001). Macdonald-Obermann et al.’s (2009) study showed an 
alternate view of transphosphorylation in light of the asymmetric dimer configuration. In 
their phosphorylation mechanism, the C-lobe of one receptor, deemed the “activator”, 
activates the N-lobe of the opposite tail, deemed the “receiver”, which then 
phosphorylates the tail of the activator. 
Recent SPT studies published by Low-Nam et al. (2011) give even greater insight 
into the kinetics and dynamics of ErbB1. Using a Hidden Markov Model to analyze the 
SPT data, they were able to separate receptor diffusion in to three distinct states, free, 
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confined, and dimer. This type of resolution allows for more accurate diffusion 
coefficients to be derived from the data. Low-Nam et al. (2011) found that ErbB1 dimers 
diffuse much slower than ErbB1 monomers. Further analysis of the SPT data revealed the 
interaction dynamics between receptor pairs. They were able to calculate dimer off rates 
by studying the characteristics of the distance between two receptors over time. This 
analysis gave insight into the kinetics of the different dimers (preformed, 2 ligand:2 
receptor, and 1 ligand :2 receptor), showing that ligand does in fact stabilize the dimer, 
leading to lower off rates. Finally, studying the distance between receptor pairs lead to 
the observation that a pair of receptors will interact multiple times throughout the course 
of a minute, forming dimers and falling apart again.  
1.4.2 ErbB2 and ErbB3 
ErbB2 is different from the other 3 members of the ErbB family due to its structure. 
While ErbB1/3/4 all are typically in a closed conformation when no ligand is bound, 
ErbB2 is always in the open conformation without the presence of ligand. There is no 
known ligand associated with the ErbB2 receptor (Baselga & Swain, 2009; Linggi & 
Carpenter, 2006). Overexpression of ErbB2 is rampant in breast cancer, making ErbB2 a 
typical target for therapeutics (Baselga & Swain, 2009). ErbB3 has recently become a 
major focus of study for the ErbB family (Baselga & Swain, 2009).  Studies show that 
overexpression of ErbB3 is also linked to breast cancer (Yarden & Sliwkowski, 2001), 
and ErbB3 is now being studied as a target for possible therapies (Baselga & Swain, 
2009). Together, ErbB2 and ErbB3 are known to form oncogenic dimers, with extremely 
potent signal cascades (Zhang et al, 2012).   
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Published works by top ErbB researchers have suggested that the ErbB3 receptor 
cannot form a homodimer (Baselga & Swain, 2009; Berger et al, 2004). However, recent 
SPT experiments published by Steinkamp et al (2014) have suggested that ErbB3 does in 
fact form homodimers, extremely stable homodimers. SPT experiments have shown that 
ErbB2 and ErbB3 form dimers, though they are shorter lived than the ErbB3 
homodimers. Kinase assay experiments by Steinkamp et al. (2014) have also given 
insight into the activation state of ErbB3, showing that there is measurable kinase activity 
in ErbB3 in the presence of heregulin. The current accepted signaling unit is ErbB2-
ErbB3 (Baselga & Swain, 2009; Linggi & Carpenter, 2006; Warren & Landgraf, 2006; 
Yarden & Sliwkowski, 2001), however, the results seen from the SPT experiments, as 
well as kinase assays by Steinkamp et al. (2014), suggest that the main signaling unit may 
in fact be the ErbB3 homodimers. A possible activation mechanism would be that ErbB2 
must first activate ErbB3’s kinase domain through dimerization, then the active ErbB3 
receptor would be able to form a dimer with, as well as activate, another ErbB3 receptor 
and cause the mitogenic signal cascade.  
1.5 RESEARCH FOCUS 
The focus of this dissertation work is the ErbB family of receptor tyrosine kinases. 
Specifically, we look at the kinetics and dynamics of these receptors on the cellular 
membrane through a spatial stochastic model. Recent advancements in experiments, 
mainly in single particle tracking, have been a strong motivation for this work. Many 
exciting and interesting observations have been made through SPT, and we knew 
integrating those results and observations with a spatial stochastic model would enable us 
35 
to look even deeper into the meaning and implications of those results. The methods used 
to create our spatial stochastic model are discussed in Chapter 2. 
We started out by focusing on the homo-interactions of ErbB1 to build our model, 
validate it, and then predict how the observed dynamics are impacted by different factors. 
We proposed that the repeated interactions between ErbB1 receptors, as observed through 
SPT, are a product of the membrane landscape and receptor density. We further 
suggested that the repeated interactions are a mechanism to facilitate phosphorylation 
through an asymmetric phosphorylation mechanism. Finally, we were able to investigate 
how these factors come together and impact the receptor’s activation state over time. This 
work is discussed in detail in Chapter 3.  
We then spent time analyzing the diffusion data from SPT experiments to get insight 
into the membrane landscape and it’s role in receptor diffusion. From our previous work 
and the SPT experiments, we knew that confinement zones on the membrane impacted 
receptor diffusion. We sought to quantitatively understand the observed anomalous 
diffusion by studying the diffusion properties of proteins in the cellular membrane, and 
how different structures on the membrane contribute to these properties. This work is 
discussed in Chapter 4. We then took the diffusion analysis one step further to 
reconstruct the confinement zones encountered on the membrane during SPT 
experiments. We proposed we could estimate the size and shape of the confinement zones 
by converting the dynamic trajectory data into static spatial data and applying a clustering 
algorithm. The “Domain Reconstruction” Algorithm (DRA) is discussed in Chapter 2 
and implemented in Chapter 5. 
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Finally, we extended our spatial stochastic model to a heterogeneous population to 
investigate the dynamics between ErbB2 and ErbB3, and used the DRA to create our 
simulation space. Our focus was to investigate the interactions and phosphorylation 
kinetics between ErbB2 and ErbB3. In this work, we truly integrated experimental work 
and modeling. We set out to investigate the impact of ErbB3 activation on the currently 
accepted ErbB2-ErbB3 interaction model and how the membrane landscape impacts 
those interactions. Our final goal was to then use our ErbB2-ErbB3 spatial stochastic 
model to study possible mutations in ErbB3 and see impact the activation states of ErbB2 
and ErbB3. This work is discussed in Chapter 5. In Chapter 6, we bring all the studies 
together and discuss their significance and impact in the fields of membrane biology and 
ErbB receptors. 
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CHAPTER 2: MODELING METHODS 
2.1 OVERVIEW 
The use of mathematical models to describe and investigate various biological 
systems has been increasing exponentially over the past decade. In response to this, many 
modeling methods have either been applied from other scientific areas or been developed 
out of necessity to describe new behaviors (Andrews et al, 2010). These models range 
from population style deterministic models all the way to intricate single particle 
stochastic models. The system being studied, as well as the questions to be answered, 
dictate the necessary type of model and the level of resolution that model will need 
(Andrews et al, 2010). As experimental methods have been developed over time, the 
resolution of these experiments has also increased. The uptick in single molecule 
experiments and the resulting detailed data call for modeling methods to be further 
developed.    
Here we describe methods for generating a model with spatial resolution and single 
molecule precision utilizing single molecule experimental data. Our approach takes a 
logical progression from initial biological system design through simulation. Important 
spatial aspects must first be determined along with the reaction network of the system. 
Once the model system is well defined, the dynamics and kinetics can be derived and the 
necessary parameters obtained. After the model is completely developed, the relevant 
outputs of the model needed to test the motivating hypothesis can be defined and the 
model can then be implemented. 
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2.2 SIMULATION SPACE CHARACTERIZATION  
2.2.1 Summary 
Introduction of a two dimensional space into a model requires a few extra 
specifications above and beyond those in non-spatial models. The minimum requirements 
to define this surface are the spatial limits and the initial distribution of proteins on the 
surface. Additional details may also be specified, such as membrane obstacles, keeping in 
mind as more and more detail is added to the 2D surface, the expense (time) of the 
simulation increases. 
Generation of the simulation space is based on available physiological information 
about the model system, as well as restrictions of the simulation. Images obtained 
through experiments providing single particle information, such as an electron 
micrograph, can be used to import an initial distribution of the protein of interest. 
Similarly, single particle tracking data can be used to reconstruct confinement zones 
receptors encounter on the membrane. Combining this data with information about the 
receptor population allows for a good estimate for a simulation space and initial 
conditions. Here we discuss in detail the two methods we have developed, an Image 
Importer and Domain Reconstruction Algorithm (DRA), to import and analyze this data 
to recreate physiologically relevant simulation spaces. 
2.2.2 Image Importer 
2.2.2.1 Motivation 
One method used to visualize ErbB receptors on the cellular membrane is electron 
micrography (EM). The receptors are fixed on the cellular membrane, labeled with 
immuno-gold particles, and then imaged (Yang et al, 2007). The resulting EM images 
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give insight into receptor distribution on the membrane. ErbB1 receptors tend to cluster 
on the membrane. These pockets are often referred to as confinement zones or domains. 
This view of receptor distribution on the membrane is one of the observations that lead to 
the addition of spatial resolution to our model. In a first step towards integrating 
experimentally observed receptor distributions for initial spatial conditions, we developed 
a method to import the receptor positions from EM images and estimate domain sizes 
based on the receptor clusters.   
2.2.2.2 Particle Import and Domain Estimation 
The EM image importer uses the Image Processing Toolbox in Matlab. The program 
has been setup to walk the user through importing data through various popup instruction 
boxes. The programs algorithm depicted as a flowchart is shown in Figure 2.1. An 
example screenshot of using the importer is shown Figure 2.2. This algorithm is 
implemented in Chapter 3. 
EM Image Importer Function 
1. Specified image is read in to Matlab. 
2. User specifies if domains will be included, and if so, how many. 
3. Scale bar length is read in. This will give a unit conversion between pixels and the 
physical units the image is in. The units are specified within the .m file. 
4.  x and y limits are read in. These are the absolute boundaries for the simulation 
space. 
5. If domains are to be included, they are read in one at a time until the number of 
specified domains in Step 2 is met. 
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Figure 2.1: EM Image Importer Algorithm Flowchart. 
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Figure 2.2: EM Image Importer Screen Shot. The EM Image Importer walks the user through 
importing receptor and domain positions through a series of prompts. 
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a. Domain x and y limits are read in. These limits are defined by the cluster 
size of receptors in the image. The domain is a rectangle defined by the x 
and y limits. 
b. Receptor x,y positions within the specified domain are read in. 
6. Receptor x,y positions not in domains are read in. 
7. The total number of receptors is calculated and all the data collected is saved to a 
.mat file for later use. 
2.2.3 Domain Reconstruction Algorithm 
2.2.3.1 Motivation 
While the necessity of spatial resolution has been shown and modeling methods have 
been developed to address it, characterization of the simulation space using single 
particle data has not yet been explored. Here we take the addition of spatial resolution 
one step further by directly incorporating single particle tracking data to describe and 
represent the simulation space features and particle distributions. Many studies involving 
single particle tracking have observed a particle diffusion pattern that suggests the 
particles are in a confined area (Kusumi et al, 1993; Low-Nam et al, 2011; Saxton, 1993). 
Taking into account this observation, we have created an algorithm that analyzes single 
particle tracking data to reconstruct the size and shape of these confining areas. A flow 
diagram of the algorithm is shown in Figure 2.3. The algorithm first picks out the points 
in the trajectories determined to be in a confined space, and then performs a cluster 
analysis on the points. The clusters are then converted into contours, which are then 
“inflated” to reconstruct the shape of the confining space. This algorithm is implemented 
in Chapter 5.  
43 
 
Figure 2.3: Domain Reconstruction Algorithm Flowchart. The DRA starts from dynamics single 
particle tracking data. The algorithm ranks the data and compiles the points. The data is then 
converted to static spatial data and used to determine domain size and distribution. The domains are 
reconstructed via a clustering algorithm, contour drawing, and contour inflation. 
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Dynamic Data 
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Confined Point 
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Static Data 
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2.2.3.2 Trajectory Analysis 
One of the major undertakings of this algorithm is the need to transform dynamic 
trajectory data into static spatial data. To accomplish this task, we devised a ranking 
system that sorts every point in an individual trajectory into two groups: confined or free.  
The confined points are what would be considered to be in a confinement zone, while the 
free points are considered to be “free” on the membrane. 
 To rank these points, we first calculate the jump size (displacement) for a selected 
number of time steps (1, 2, 5, 10, 20, 50, 100, 200). The time step is applied moving 
forward through the trajectory as well as backwards through the trajectory. Covering this 
range of step sizes accounts for “holes” that may be in the trajectory data due to 
experimental conditions such as blinking of the quantum dots or quantum dots 
temporarily moving out of the focal plane. These jump sizes are calculated for each 
trajectory in a set of comparable SPT files, then aggregated by step size.  
Once the jump sizes have been compiled, the individual points from each trajectory 
are ranked. For every point, the relative rank is calculated by comparing the point’s jump 
size to all the other points’ jump sizes for a specific step size. The jump sizes for a 
specific step size are sorted in order from smallest to largest.  The rank of a specific point 
is where it falls in that order. This is repeated across all points for each step size.  
Some points may not have a score for all 16 step sizes due to the aforementioned 
holes in the trajectories. To account for this, a weighted average is used to determine the 
overall rank for each point. First, for each point, the forward and backward ranks for a 
step size are combined. The combined ranks for each step for that point are then averaged 
together; this is the final rank for that point.  
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2.2.3.3 Cluster Analysis 
We rely on distance based hierarchic clustering. This approach had been widely used 
in the literature, ranging from ecology and genomics to receptors on the cell membrane 
(Espinoza et al, 2012). Our method is a modified version of that developed by Espinoza 
and coworkers for TEM images of receptors labeled with gold nano-particles. 
Given N points {P1,P2,…,PN} in a plane, with coordinates {(x1,y1),…(xN,yN)}, we 
want to partition them into mutually exclusive groups or clusters in a way that reflects 
their proximity or similarity to each other. This is not a clearly defined notion and the 
appropriate clustering method should be ultimately determined by the experimental 
context. Here, we use the “slow points” identified from jump size distributions as 
indicators of an underlying physical structure (such as lipid rafts); therefore the notion of 
proximity defined by physical distance to the closest members of the cluster is more 
appropriate considering, for instance, an average distance to the entire cluster (this is the 
idea underlying K-means clustering). 
We construct clusters by comparing the distance 
€ 
d P1,P2( ) = x1 − x2( )
2
+ y1 − y2( )
2
between points to a reference length L, sometimes called a “scale”. Two points A, B are 
in the same cluster if their distance 
€ 
d A,B( ) ≤ L ; we denote this relationship by A ~L B. 
We extend the relationship by transitivity: if A ~L B and A ~L C, then B ~L C. It is easy to 
see that the procedure will induce a partition of the set of points. (The ~L relation is 
symmetric and transitive, therefore it is an equivalence relation in the mathematical 
sense; the clusters are the corresponding equivalence classes.)  
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The partition into clusters is unique for a given set of points and length scale L. Any 
two points in a cluster can be linked by a connected path consisting of line segments of 
length ≤ L connecting points from the same cluster (Figure 2.4A). 
2.2.3.4 Contour Drawing  
In order to build a geometric area (shape or footprint) around a given cluster, we start 
with the union of the circles of radius L/2 centered on all members of the cluster. We 
assume the cluster resulted from hierarchic clustering with distance parameter L, so any 
member of the cluster must be reached from any other member through a sequence of 
segments connecting cluster points, such that no individual segment is long than L. The 
connection graph in Figure 2.4 constructed by putting an edge between all pairs of points 
whose distance is ≤ L must be connected, and therefore, the union of the circles (Figure 
2.4B) must form a contiguous area.  
To straighten the boundary of the region defined this way, we extend the area by 
adding rectangles of height L along the contour of the connection graph (double lines 
Figure 2.4C). The reconstructed region is the reunion of the inside of the contour graph, 
and the circles and rectangles around the vertices and edges of the contour (shaded, 
respectively grey areas on Figure 2.4D). 
The contour graph or “tight contour” for a cluster of points is defined by the sequence 
of boundary points and the segments that connect them. The list is constructed by adding 
new points to the contour, based on the existing points and a reference direction. As the 
contour is built, it circles around the points in a counter-clockwise direction, so that all 
the interior points are to the left hand side. When the process is finished, the last point in 
the contour is identical to the first one. 
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Figure 2.4: Clustering Algorithm Walkthrough. (a) The points in a cluster form a connected graph, 
where edges connect points whose distance is less than the length scale L. Circles of diameter L 
centered on two points intersect if and only if the points are connected in the sense described above. 
(b) We want to define the footprint based on the reunion of all the circles of diameter L, centered on 
the points in the cluster. (c) We first identify the outer contour (sometimes a skeleton, with no 
interior) of the cluster graph (double blue shaded lines). We ‘pad’ the area defined by the circles by 
adding rectangles along the edges of the contour graph. (d) The reconstructed region is the reunion 
of the inside of the contour graph (if any), and the circles and padding rectangles around the vertices 
and edges of the contour graph.  
 
L"
L"
(a) (b) 
(c) (d) 
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Contour Building Algorithm 
1. Start with the rightmost point of the group; set the reference direction pointing to 
the right. (Any point on the convex hull is acceptable; the reference direction 
needs to be pointing toward the outside of the hull.) 
2. Add new points: 
a. Identify all the points in a circle of radius L centered on the last point 
added (the current point); these are the candidate points. 
b. Draw line segments from the current point to each candidate point. If this 
intersects a segment in the already identified part of the contour, discard 
respective candidate point. 
c. Order the remaining candidates by the clockwise angle from the reference 
direction to the segment connecting the current point to the candidate; 
choose the candidate with the smallest angle and add it to the list. 
d. Set reference direction to point from the newly added point back to the 
previously added point 
3. The process terminates when the same segment is added to the contour. The same 
point may be visited twice, in opposite directions. Upon successful termination, 
the last point in the list is the same as the first one. 
NOTE: The contour defined this way is not unique, but the algorithm always returns a 
contour that is a refinement of the convex hull of the points, is not self-intersecting, and 
contains no edges longer than L. 
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2.2.3.5 Contour Inflation 
The tight contour or contour graph defines the reconstructed region. This contour is 
often lacking an “inside”, and can have sections that are just a single chain of points. The 
rationale of padding is to represent the area “of influence” of each point in the cluster – 
roughly, the set of geometric locations that are closer to this cluster than to any points 
that are not part of the cluster.  
The padding adds two types of elements to the core contour and its interior:  
1. A rectangle of height L/2 on the outer side of each edge of the tight contour graph  
2. A sector of a circle of radius L/2 at each vertex with a positive (convex) angle 
The contour inflation algorithm constructs a second contour (the outer or padded 
contour) that encloses the first one. Similarly to the tight contour, the padded contour 
defined as a polygonal line; the vertices of the polyline are all auxiliary points, and are 
not elements of the cluster. 
The contour inflation algorithm proceeds along the inner contour, and builds the outer 
contour parallel to it, adding one or more points to account for each vertex of the inner 
contour. If the angle at the respective vertex is positive (convex), we add the corners of 
the padding rectangles and points on the arc of the padding circle centered on the vertex; 
if the angle is negative (concave), then we only add one point, namely the intersection of 
the two padding rectangles. 
Below we describe the algorithm we employed. This algorithm also relies on a 
reference direction, which corresponds to the segment preceding the current vertex (with 
the direction defined by that of the algorithm – counterclockwise in our case). 
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Contour Inflation Algorithm 
1. Start at a point on the tight contour. Moving counter-clockwise along the contour, 
set the reference direction to that of the incoming edge in the counter-clockwise 
direction, and the current direction to the outgoing edge. 
2. The elements of the new contour that are added to represent the current vertex are 
set based on the angle between the incoming and outgoing directions.  
a. If the angle is positive (left turn, convex vertex), then add a sector of a 
circle of radius L/2, centered on the current vertex, and delimited by the 
radii perpendicular to the incoming and the outgoing edges. The sector is 
discretized as a sequence of points starting with the end the radius 
orthogonal to the incoming edge and ending at the other one. At least one 
intermediate point is added at the end of the radius that is the symmetry 
axis of the sector. 
b. If the angle is negative (right turn, concave vertex), we only add the point 
where the two adjacent rectangles intersect. This point is also on the 
symmetry axis (bisector) of the angle on the inner contour. 
3. The algorithm proceeds along the vertices of the inner contour, adding points to 
the outer contour for each of them. The process terminates when the starting 
vertex is reached, and is about to be passed in the same direction as in the first 
iteration. 
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2.3 SPATIAL STOCHASTIC MODEL 
2.3.1 Motivation 
Any of the stochastic modeling methods mentioned previously may be implemented 
with the simulation space derived above. For our work, we chose Smoluchowski 
dynamics with modifications proposed by Andrews and Bray (2004). We felt that this 
model most accurately represented physiological processes of the known available 
models. We opted to develop our own version of Andrews and Bray’s (2004) model, 
instead of directly using their simulator SMOLDYN, for two distinct reasons: 
1. Inclusion of our reconstructed simulation spaces, mentioned above. 
2. Unique Receptors. We needed to be able to keep detailed records about each 
receptor over the simulation time. 
While SMOLDYN is a very effective and efficient simulator, both of the above 
mentioned capabilities were not available in SMOLDYN at the time we started this work. 
We developed the code in FORTRAN 90 for ease of use and the ability to be compiled. 
Here we will go through the steps necessary to define the model as well as how to 
implement the experimental data. 
2.3.2 Biological Reaction Network Definition 
Deriving the reaction network for a system of interest is a very important step. 
Leaving out a reaction or over specifying the system can lead to incorrect conclusions. 
We suggest a bottom up approach, starting as simple as possible and building on to the 
network, as necessary. Our reaction network includes a series of first order reactions and 
second order reactions. 
1. First Order Reactions 
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a. Dimer Dissociation 
b. Phosphorylation 
c. Dephosphorylation 
d. Domain Escape (Confined Receptor ! Free Receptor) 
2. Second Order Reactions 
a. Receptor dimerization 
2.3.3 Particle Diffusion  
Once the simulation space and reaction network have been specified, the diffusion of 
the proteins and the reaction kinetics must be accounted for. Receptor diffusion is based 
on Brownian motion. Brownian motion is represented in a simulation by picking a 
random number from a normal distribution and applying that value to the root mean 
square (RMS) step length, recreating the stochastic nature of diffusion (Andrews & Bray, 
2004; Kusumi et al, 1993; Popov & Agmon, 2001). 
€ 
x(t + Δt) = x(t) + RMSξx
y(t + Δt) = y(t) + RMSξy
RMS = 2DΔt
 
where x and y are the receptor’s Cartesian coordinates, RMS is the root mean square 
step, Δt is the time step, and ξx and ξy are the normally distributed random numbers.  
Periodic boundary conditions are used as a receptor approaches the edge of the 
simulation space.   
Membrane obstacles create a hurdle for the diffusing receptors during the simulation. 
The diffusion depends on the type of membrane obstacle encountered. If the obstacle is 
simply a boundary, the receptor may either “jump” the obstacle or be reflected off the 
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boundary in the opposite direction. If the obstacle is a confining area, sometimes referred 
to as a sticky box or domain, the receptor typically has an easier time entering the 
confinement zone, however needs to pay a higher “toll” to escape. The toll is applied 
using a probability calculation using the transition rate, or escape rate, from one zone to 
the next: 
€ 
P Transition( ) =1− exp −rTransitionΔt( )  
However, this probability has been simplified further to: 
€ 
P Transition( ) = rTransitionΔt  
due to the small time step.  If a confined receptor is set to diffuse out of a 
confinement zone, and this escape probability is not met, the confinement zone assumes a 
reflective boundary condition, trapping the receptor inside. 
2.3.3.1 Boundary Conditions 
There are two sets of boundary conditions encountered during receptor diffusion, 
periodic and reflective. A periodic boundary is used when a receptor reaches the edge of 
the simulation space. As the receptor approaches the edge of the simulation space, the 
jump that takes the receptor across the boundary is split between the remaining distance 
before the boundary and the rest of the jump distance. The jump distance beyond the 
boundary is then transposed to the opposite boundary edge and continued back into the 
simulation space. Conditions and equations for implementing the periodic boundary 
condition are in Table 1.  
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 Minimum Bound Maximum Bound 
Cross y 
Boundary 
€ 
xFinal = xInitial + Δx + LxSimSpace  
€ 
xFinal = xInitial + Δx − LxSimSpace  
Cross x 
Boundary 
€ 
yFinal = yInitial + Δy + LySimSpace  
€ 
yFinal = yInitial + Δy − LySimSpace  
Table 1: Periodic Boundary Conditions. Equations for calculating a receptor’s new position when a 
simulation space boundary is crossed. 
Reflective boundary conditions are used for simulation space confinement zones. 
When a receptor encounters a confinement zone that it cannot cross, the receptor is 
directly reflected away from the obstacle. The receptor jump is split again between the 
distance to the obstacle and the distance the receptor would move beyond the obstacle. 
This second distance is the distance the receptor is moved away from the obstacle. 
Conditions and equations for implementing the reflective boundary condition are in Table 
2. 
 Minimum Bound Maximum Bound 
Cross y 
Boundary 
€ 
xFinal = 2xMinObstacle − Δx − xInitial  
€ 
xFinal = 2xMaxObstacle − Δx − xInitial  
Cross x 
Boundary 
€ 
yFinal = 2yMinObstacle − Δy − yInitial  
€ 
yFinal = 2yMaxObstacle − Δy − yInitial  
Table 2: Reflective Boundary Conditions. Equations for calculating a receptor’s new position when it 
encounters an obstacle in the simulation space. 
2.3.4 Receptor Kinetics 
Modified Smoluchowski dynamics are used to simulate receptor kinetics (Andrews & 
Bray, 2004). The simulator focuses on one receptor at a time, picking every receptor 
once, on average, over a fixed time step. Receptors are picked randomly using a uniform 
distribution, allowing the order the receptors are moved or reacted to be different for each 
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time step. Once a receptor is picked, the possible reactions for that receptor are examined 
and applied as appropriate. There are two types of reactions possible, 1st order and 2nd 
order. 
First-order reactions are implemented through a probability calculated using the 
reaction rate and simulation time step:   
 
€ 
P reaction( ) =1− exp −rreactionΔt( ) 
This probability has been simplified further, as in Hsieh et al. (2008) and Andrews 
and Bray(2004): 
€ 
P reaction( ) = rreactionΔt  
Second-order reactions require more detail to account for two receptors interacting 
with one another. A receptor’s likelihood to react with another receptor is based on a 
distance termed the binding radius. The binding radius takes into account the dimer on 
rate, diffusion coefficient of the receptors that will comprise the dimer, and the 
simulation time step (Andrews & Bray, 2004).  While the binding radius is not a physical 
radius relative to the size of the receptor, the use of this radius allows the simulation to be 
closer to the physical situation than previous methods using probabilities (Andrews & 
Bray, 2004; Erban & Chapman, 2009; Gillespie, 1977; Hsieh et al, 2008; Popov & 
Agmon, 2001). When the chosen receptor is moved, the final position is scanned for 
other receptors within the binding radius. If a receptor is within this distance, the 
receptors will react. Calculation of the binding radius is done through an iterative process 
where the experimentally determined reaction on rate is compared to the simulation’s on 
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rate of reaction. This causes the binding radius to be a function of diffusion coefficients, 
the reaction on rates, and the simulation time step (Andrews & Bray, 2004). 
When a reversible reaction occurs, an unbinding radius is used to set the dissociating 
receptors apart. The unbinding radius is calculated such that the occurrence of an 
unrealistic amount of repeated interactions is minimized:  
 
where σb is the binding radius and σu is the unbinding radius.  The default ratio of binding 
radius to unbinding radius is 0.2 (Andrews & Bray, 2004). 
2.3.5 Parameters 
The necessary parameters become apparent once the diffusion and reaction equations 
have been defined. Ideally, the parameters would come from relevant experimental data 
with single particle precision. This is currently not possible for many systems; therefore 
the next best source would be ensemble data from a relevant experimental system. If 
experimental data is not available for a specific parameter, either through experiments or 
literature, a last resort method would be to fit the parameter. Zhang et al. (2009) showed 
the importance of where parameters come from, and show that mixing parameters from 
different cell lines can cause incorrect conclusions to be drawn from simulations. For this 
reason, we have tried our best to obtain parameters that have all originated from the same 
cell lines relevant to the receptors focused on in each of our models. Our parameters 
mainly come from SPT experiments, however kinase assays were used for the 
phosphorylation/dephosphorylation rates. The specific parameter sets and where they 
came from are discussed in each chapter that implements this modeling scheme. 
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2.4 NOTES 
Matlab scripts for the Simulation Space sections are available in Appendix A. 
Fortran code for the spatial stochastic model is available in Appendix B.  
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3.1 ABSTRACT  
ErbB1 overexpression is strongly linked to carcinogenesis, motivating better 
understanding of erbB1 dimerization and activation. Recent single particle tracking data 
have provided improved measures of dimer lifetimes and strong evidence that transient 
receptor co-confinement promotes repeated interactions between erbB1 monomers. Here, 
spatial stochastic simulations explore the potential impact of these parameters on erbB1 
phosphorylation kinetics. This rule-based mathematical model incorporates structural 
evidence for conformational flux of the erbB1 extracellular domains, as well as 
asymmetrical orientation of erbB1 cytoplasmic kinase domains during dimerization. The 
asymmetric dimer model considers the theoretical consequences of restricted 
transactivation of erbB1 receptors within a dimer, where the N-lobe of one monomer 
docks with the C-lobe of the second monomer and triggers its catalytic activity. The 
dynamic nature of erbB1 phosphorylation state is shown by monitoring activation states 
of individual monomers as they diffuse, bind and rebind after ligand addition. The model 
reveals the complex interplay between interacting liganded and non-liganded species and 
the influence of their distribution and abundance within features of the membrane 
landscape.  
3.2 INTRODUCTION 
ErbB1 (EGFR, Epidermal Growth Factor Receptor) is the canonical member of the 
erbB receptor family (Citri & Yarden, 2006) and a critical player in normal growth and 
development, as well as carcinogenesis (Citri & Yarden, 2006).   ErbB1 signaling is 
initiated by ligand-induced homo- and hetero-dimerization that is mediated primarily by 
engagement of extracellular dimerization arms (Baselga & Swain, 2009).  Structural 
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evidence also suggests that the erbB1 extracellular domain fluctuates between the closed 
and open conformation in the absence of ligand (Baselga & Swain, 2009), transiently 
exposing the erbB1 dimerization arm and permitting transient “pre-formed” dimers to 
occur (Schlessinger, 2002).  We previously used spatial stochastic modeling to predict the 
impact of receptor density, through local receptor trapping in membrane domains or 
receptor overexpression, on the rate of pre-formed dimers (Hsieh et al, 2008).  The ability 
of non-ligand bound erbB1 monomers to partner with each other and with ligand-bound 
monomers leads to a complex mix of dimer configurations.  Once dimers form, the signal 
is propagated by activation of integral tyrosine kinase activity in the receptor cytoplasmic 
tail, trans-phosphorylation of tyrosine residues in receptor tails and recruitment of 
cytosolic signaling partners (Citri & Yarden, 2006).  Both deterministic and stochastic 
mathematical models have been developed to consider the complexity of erbB1 signaling, 
with successive generations of erbB1 models building on ever richer data sets for binding 
kinetics, phosphorylation/dephosphorylation dynamics and adaptor recruitment (Blinov et 
al, 2006; Costa et al, 2009b; Hendriks et al, 2003; Hsieh et al, 2008; Kholodenko et al, 
1999; Kleiman et al, 2011; Radhakrishnan, 2010; Sasagawa et al, 2005; Schoeberl et al, 
2002).  
Not yet considered in mathematical models is the asymmetrical docking and 
activation of erbB1 cytoplasmic kinase domains, which accompanies extracellular 
domain dimer formation (Lu et al, 2012; Macdonald-Obermann & Pike, 2009; Mi et al, 
2011; Zhang et al, 2006). In an asymmetric dimer, the N-terminal lobe of one kinase 
domain in the dimer pair interacts with the C-lobe of the other (Zhang et al, 2006).  
Mutagenesis and biochemical studies support an unusual transactivation model, where 
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activation of catalytic activity is restricted to the monomer whose C-lobe has been 
engaged. Thus, one monomer in the dimer pair is considered to be the “receiver” and the 
monomer contributing the N-lobe is considered to be the “activator”.  A novel aspect of 
the present study is the consideration of restrictions that asymmetrical docking 
theoretically imposes upon ErbB trans-phosphorylation into the spatial stochastic model, 
taking advantage of the flexibility of the model’s rule-based framework.  
Our model also builds on improved measures of erbB1 diffusive behavior and 
dimerization kinetics, made possible through remarkable advances in single particle 
tracking (SPT) methodology (Low-Nam et al, 2011). This recent study by Low-Nam et 
al. (Low-Nam et al, 2011) provided important new parameters for the spatial stochastic 
model. Among these values are the differential lifetimes of dimer pairs, based upon the 
occupancy of the ligand-binding site in each monomer. For example, the authors showed 
that dimer pairs comprised of two ligand-bound monomers have the longest lifetimes, 
compared to lifetimes of pairs comprised of one ligand-bound and one unliganded 
monomer or 2 unliganded monomers (Low-Nam et al, 2011). In addition, data from SPT 
experiments provided strong evidence for repeated interactions between two receptors 
while co-confined in specialized features of the plasma membrane, referred to as 
membrane domains or corrals. Since SPT relies on sparse labeling and captures only a 
minute fraction of receptor dimer events, an important aspect of the spatial model 
presented here is the explicit consideration of the impact of these new measurements on 
population dynamics. The spatial model also yields new insight into the activation states 
of individual monomers after ligand addition, as they cycle through rounds of 
dimerization, asymmetrical kinase activation and phosphorylation/dephosphorylation.   
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3.3 MATERIALS AND METHODS 
3.3.1 Mathematical Modeling  
This ErbB1 model was used as the flagship example while developing the Spatial 
Stochastic Model, as described in Chapter 2. In this instance, an electron micrograph of 
immuno-gold labeled ErbB1 receptors was used to define domains and receptor density 
for the simulation space. This implementation of the SSM includes receptor diffusion, 
domain escape, and four different reactions. Diffusion: At each time step, individual 
monomers can diffuse or react. If unrestricted by domains, receptors freely diffuse.  
Receptors also freely enter domains, with defined values for restriction from exit from 
domain boundaries (Table 3). Escape probabilities are determined through fitting, to 
arrive at similar receptor cluster distributions at any point during the simulation process; 
this parameter was validated by the Hopkins spatial statistic (Hsieh et al, 2008; Zhang et 
al, 2008) and by comparison of jump size distributions with experimental values from 
single particle tracking (Low-Nam et al, 2011). Reactions: Four possible reactions are 
possible: dimerization (2nd order), dissociation (1st order), phosphorylation (1st order), or 
dephosphorylation (1st order). After moving, each monomer’s position is scanned for 
other receptors within the binding radius; dimerization likelihood within this radius is 
based upon a modification of the Smoluchowski approach (Andrews & Bray, 2004) and 
calculated from dimer estimates in Martin-Fernandez et al. (2002). Dimer dissociation is 
implemented through a probability calculated using the dimer off rate and the simulation 
time step. When dimers dissociate, the monomers are assigned an unbinding radius to 
minimize the occurrence of an unrealistic amount of repeated interactions. These binding 
and unbinding radii take into account the kinetics and diffusion of the receptors. Using  
63 
Species 
Diffusion 
Coeff 
[µm2/s]a 
Dimer On 
Rate 
[mm3/s] 
[*1E-04]c 
Dimer 
Off Rate 
[1/s]a 
Domain 
Exit Rate 
[1/frames]a 
Phos Rate 
[1/s]b 
Dephos 
Rate 
[1/s]b 
LR 0.0512 --- --- 0.0121 --- --- 
LRP 0.0512 --- --- 0.0121 --- 0.13 
R 0.0512 --- --- 0.0183 --- --- 
RP 0.0512 --- --- 0.0183 --- 0.13 
LRLR 0.0191 0.9138 0.273 0.00874 0.0733 --- 
LRR 0.0191 0.9138 0.738 0.00874 0.0733 --- 
RR 0.0191 0.9138 1.24 0.00874 0.0733 --- 
LRPLR 0.0191 0.9138 0.273 0.00874 0.0733 0.13 
LRPR 0.0191 0.9138 0.738 0.00874 0.0733 0.13 
RPR 0.0191 0.9138 1.24 0.00874 0.0733 0.13 
LRPLRP 0.00563 0.9138 0.273 0.00874 0.0733 0.13 
LRPRP 0.00563 0.9138 0.738 0.00874 0.0733 0.13 
RPRP 0.00563 0.9138 1.24 0.00874 0.0733 0.13 
Table 3: ErbB1 Model parameters. Set of experimental parameters used for each of the species 
during simulations. a – Low-Nam et al (Low-Nam et al, 2011), b – Kleiman et al (Kleiman et al, 
2011), c – Back-calculated using SMOLDYN (Andrews & Bray, 2004) 
the binding and unbinding radius as the inner and outer bound of this region, respectively, 
minimizes instantaneous rebinding (Andrews & Bray, 2004). Phosphorylation occurs 
only during dimerization intervals and is based upon a rule where one monomer in the 
dimer is assigned at random as the activator and the other monomer in the dimer is the 
receiver. Phosphorylation is estimated as a 1st order reaction based on the assumption of 
excess phosphate. Dephosphorylation occurs at the same rate irrespective of monomer or 
dimer state (Table 3). Supporting equations and mathematical methodologies are 
available in the Supporting Material. 
3.3.2 Single Particle Tracking  
Detailed methods for tracking and analyzing erbB1 motion are described in Low-
Nam et al. (Low-Nam et al, 2011). In brief, erbB1 were tracked with two-color quantum 
dots (585 and 685 QDs, Molecular Probes) conjugated with either VHH monomeric 
antibody fragments (non-competing with ligand) or with EGF-conjugated QDs. A431 
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breast cancer cells were serum starved for a minimum of 2 hrs and observed on an 
Olympus IX71 inverted microscope equipped with a 60 x 1.3 N.A. water objective and an 
electron multiplying CCD camera (Andor iXon 887). Samples were maintained at 34-
36oC by an objective heater (Bioscience Tools, San Diego CA).  QD probes were applied 
at picomolar concentrations to achieve sparse labeling required for single particle 
tracking. A 3-state Hidden Markov model was used to identify transition rates between 2 
distant monomers (free), co-confined pairs and dimerized receptors. From these rates, the 
states of receptor pairs in the raw data could be extracted.   
3.4 RESULTS AND DISCUSSION 
In this work, we began with modifications to our existing spatial stochastic model 
(Hsieh et al, 2010). Receptors are represented as discrete particles and move through a 2-
D simulation space with Brownian motion and under periodic boundary conditions. An 
improvement in the model is the use of modified Smoluchowski dynamics to govern 
reactions, as described in Methods. Similarly to Hsieh et al (Hsieh et al, 2010; Hsieh et al, 
2008), this simulation approach follows the molecular transformations and Brownian 
motion of individual particles; however, each dimerization and dissociation reaction type 
is implemented using a single, pre-calculated geometric parameter, yielding both faster 
execution and increased physical accuracy. 
Dimerization reactions in this simulation environment are diffusion-limited. 
Individual particles move independently and randomly at each time step, with normally 
distributed jump sizes. At the end of each move, a scan of the surrounding area within a 
defined radius of the particle determines where a binding event will occur. This “binding 
radius” was based upon simulations that reproduce results of Martin-Fernandez et al 
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(Martin-Fernandez et al, 2002) and takes into account measured reaction rates and 
diffusion coefficients (Low-Nam et al, 2011), with 1 µsec simulation time steps. The 
model tracks all particles in the simulation at every step. Rather than monitor binding of 
ligand, these simulations are initiated with a predetermined percent of ligated receptors as 
a simplification strategy. Table 3 summarizes the experimental values for dimer off-rates, 
phosphorylation and dephosphorylation, used to calculate probabilities for events to 
occur at each time step in the simulation.   
The conformational states of erbB1 are specifically represented by dimerization rules 
in the model, as illustrated schematically in Figure 3.1A.  In the absence of bound ligand, 
receptors (R) are presumed to predominantly assume the bent state, with a 1% probability 
at each time step of fluxing to the open state that exposes the dimerization arm (Hsieh et 
al, 2008; Schlessinger, 2002). Ligand-bound receptors (LR) are assumed to be in the 
extended conformation as long as ligand is bound.  Thus, there are three possible types of 
erbB1 homodimers: two ligand-bound receptors (LRLR), one ligand bound receptor and 
one non-liganded receptor (LRR), and two non-liganded receptors (RR, the “preformed” 
dimer state).   
An important feature of the model is the introduction of membrane domains that 
transiently confine receptors. Figure 3.1B-C illustrates how the area and distribution of 
domains are initialized based upon immunogold-labeling of erbB1 decorating the 
membrane of A431 breast cancer cells. As described in Methods, both domain location 
and receptor density are imported directly from EM images through a graphical user 
interface.  By limiting the probability of exit from domains, receptors are confined within 
them for discrete periods but explore much of the membrane landscape over a period of 
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Figure 3.1: ErbB1 species, simulation space, diffusion and off-rate validation (A) Monomer and 
dimer species accounted for in the spatial stochastic model.  R is a resting monomer with no ligand 
bound.  Resting receptors spend 99% of simulation time in a tethered conformation, with 1% 
probability to flux to the extended conformation.  LR is a ligand bound monomer and stabilized in 
the open conformation.  RR is a preformed dimer, formed by encounters between two monomers in 
the open conformation.  LRR is comprised of one unliganded monomer and one liganded monomer.  
The LRLR dimer is comprised of two ligand bound monomers. (B) TEM image used to initialize the 
starting positions of ErbB1 receptors and estimate size and density of confinement zones. (C) 
Simulation interpretation of the TEM image, including static confinement zones in black boxes. (D) 
Sample trajectory of three different receptors over a 4-minute simulation. (E) Monomer diffusion 
coefficient calculated from simulation data.  Simulation diffusion coefficients match the diffusion 
coefficients from SPT experiments. (F) Histograms of dimer lifetimes for 2:2 dimers.  Each 
histogram is fit to determine the specific dimer off rate.  The red line is the simulation data fit and 
the blue line is the experimental data fit (Low-Nam et al, 2011). 
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seconds to minutes (Figure 3.1D).  Diffusion coefficients used in the model are based 
upon SPT measurements (Low-Nam et al, 2011).  ErbB1 monomers are assigned the fast 
diffusion rate of 0.0512 µm2/s for unconfined receptors, slowing to 0.0191 µm2/s upon 
dimerization. Fully phosphorylated dimers further slow to 0.00563 µm2/s, approximating 
the slowdown attributed to assembly of docking partners and remodeling of the local 
environment (Low-Nam et al, 2011). The diffusion rates for unphosphorylated dimers 
were based upon tracking of erbB1 dimers in the presence of the kinase inhibitor 
PDI53035 (Low-Nam et al).  It is noteworthy that we did not assign the slowest diffusion 
rate to partially phosphorylated dimers that could also slow further when recruiting 
docking partners, based on comparisons indicating that implementation of further 
slowdown had no significant impact on the results. 
  Figure 3.1E summarizes the spread of jump sizes for receptors diffusing and 
dimerizing within the domain-studded simulation landscape, reported as a CPA 
(cumulative probability analysis) plot.  This analysis compares favorably with CPA plots 
generated from single particle tracking data for erbB1 bound to QD-probes (Low-Nam et 
al, 2011).  Figure 3.1F shows that the distribution of lifetimes for simulated dimers also 
closely matches experimental data. The model thus captures the essential features of 
anomalous diffusion, as well as the stochastic nature of dimer dissociation, observed for 
erbB1 receptors in living membranes. 
3.4.1 Membrane domains promote repeated interactions between monomer pairs  
Figure 3.2A illustrates the reproducible observation that pairs of erbB1 monomers, 
tracked with 2 colors of QD-EGF, can bind and rebind multiple times during live cell  
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Figure 3.2: Membrane domains influence repeat interactions between receptors. (A) Separation 
distance over time between two QD-labeled receptors during a single particle tracking experiment.  
The receptors are initially in a dimer state, dissociate and redimerize several times, as indicated by 
the state line overlay.  (B) Separation distance over time between two ligand bound receptors during 
a simulation demonstrating the same pattern of repeat interactions. (C) Summary of repeated 
interactions over an entire simulation for all possible receptor pairs. A few individual receptors 
interact with one another more than 100 times during a single 4-minute simulation. (D) Time 
between rebinding interactions of two receptors are shown for LRLR dimers. Many rebinding 
interactions occur below the frame rate, 20 frames/second, used in SPT experiments (Low-Nam et al, 
2011) as indicated by the arrow. While most rebinding incidents occur within 50 seconds, time to 
rebinding can occur more than 150 seconds later. 
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imaging. This characteristic behavior has been attributed to co-confinement, based upon 
the unlikely probability of repeat encounters if dissociated monomers diffuse rapidly 
away from their original contact site (Low-Nam et al).  We tested this notion by 
examining the trajectories and binding events between receptors in the spatial stochastic 
model, using a simulation space with membrane domains and 50% ligand-bound 
receptors.  Representative results are shown in Figure 3.2B, where two receptors interact 
multiple times during a 50 second simulation.   
Figure 3.2C reports results of this analysis applied to the entire population of 
receptors in the simulation space over a 4 minute time course. The number of repeat 
interactions between each pair of receptors varies broadly, with a high value of 141 
binding interactions between a given pair.  
Another prediction arising from these simulations is the average time to rebinding.  A 
large number of rebinding reactions (28%) occur within 0.05 seconds (Figure 3.2D, 
arrow), which is equivalent to the frame rate of the data collection in (Low-Nam et al).  
Since simulation results are analyzed with millisecond resolution, it suggests that the 
number of repeated encounters may be underrepresented during image acquisition.   
3.4.2 Implications of the asymmetric model for receptor transphosphorylation 
We next consider the implications of asymmetric kinase orientation within erbB1 
dimers. The cartoon in Figure 3.3A illustrates the basic scheme used to create rules for 
trans-phosphorylation when kinase activation is restricted to only one monomer in a 
given pair.  Here, the N-lobe of the “activator” monomer is in contact with the C-lobe of 
the “receiver” monomer.  We make the theoretical assumption that the now active  
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Figure 3.3: Impact of asymmetric receptor phosphorylation (A) A model for receptor 
phosphorylation shuffle.  When a dimer forms, due to the configuration of the N and C lobes, only 
one tail of the dimer may be phosphorylated.  In order for a dually phosphorylated dimer to occur, a 
phosphorylated receptor and an unphosphorylated receptor must dimerize in the correct 
configuration such that the unphosphorylated receptor is phosphorylated. (B) Example of a ligand 
bound receptor state over a 4 minute simulation (top) and the average percent of time spent in each 
state for all of the ligand bound receptors during the simulation (second row).  Ligand bound 
receptors spend the majority of time in the dimer state. (C) Sample receptor state of a non-ligand 
bound receptor (top) and the average percent of time spent in each state for all of the non-ligand 
bound receptors during the simulation (second row).  Non-ligand bound receptors also spend a large 
fraction of time in the dimer state, however they are also found to be in the monomer state much 
more often than ligand bound receptors. (D) Phosphorylation state of non-liganded and liganded 
species, independent of receptor state.  Less than 40 percent of non-liganded species are 
phosphorylated, on average, compared to the almost 60 percent of phosphoylated liganded species. 
(E) Percent of LRLR dimers in different phosphorylation states. LRLR is an unphosphorylated 
dimer (blue), LRPLR is a singly phosphorylated dimer (green), and LRPLRP is a dually 
phosphorylated dimer (red).  A quasi-steady state is reached in the first minute of the simulation. 
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“receiver” then trans-phosphorylates its partner; the probability of this enzymatic 
modification is a function of the dimer lifetime for the pair. 
This fundamental premise leads to an interesting prediction:  As dimers dissociate and 
rebind in a stochastic process, it improves the likelihood that each erbB1 monomer has 
the opportunity to be both receiver and activator. The predicted outcome of this receptor 
“shuffle” process is illustrated in Figure 3.3B, in the context of a simulation with 50% of 
receptors bound to ligand at the onset. The graph traces the transition states of a single 
ligand-bound erbB1 receptor in the simulation space over 250 seconds. Collectively, the 
ligand-bound receptors in this simulation achieved the dimer state approximately 90% of 
the time. The predominant dimer type is LRR, due to an equilibrium shift from equal 
amounts of available LR and R monomers to an equilibrium that favors R monomers (See 
Figure A.2). Receptors cycle rapidly through all possible dimerization and 
phosphorylation states, spending 58% of the time as a phosphorylated species (Figure 
3.3D).  
In contrast, Figure 3.3C tracks the transition states of an unliganded receptor in the 
same simulation. The unliganded receptors in this simulation participated in dimer events 
frequently, spending only 9% of the simulation period as free monomers.  However, due 
to the short dimer lifetimes for RR and LRR, only 35% of unliganded receptors are 
phosphorylated on average (Figure 3.3D).     
In order to reconcile transient interactions with sustained signaling, we next analyzed 
the potential for accumulation of phosphorylated dimers over the same stochastic 
simulation time course (Figure 3.3E). At early times, the asymmetric model predicts that 
the predominant dimer state is LRPLR, where only one erbB1 monomer is 
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phosphorylated. Dimers achieving phosphorylation of both liganded monomers 
(LRPLRP) reach similar levels with a short delay (red traces in Figure 3.3E). We 
conclude that rapid receptor re-encounters permit the system to quickly reach 
equilibrium, providing a significant pool of phosphorylated receptors for recruitment of 
signaling partners.   
In Figure 3.4, we compare steady state phosphorylation for liganded (LRP) and 
unliganded (LP) receptors over a range of ligand doses and for two different receptor 
densities. Results for the high density situation are shown in Figure 3.4A, again for A431 
cells where the erbB1 gene is amplified and there are an estimated 4 million receptors per 
cell. At low ligand doses (10-20% occupancy), between 30-40% of the phosphorylated 
species are unliganded receptors (RP) that interacted with liganded receptors (LRP).  As 
the ligand dose increases, the ratio drops dramatically without raising the overall levels of 
phosphorylation. The failure to achieve 100% phosphorylation is due to the combined 
effects of phosphatase activity and the lower availability of free monomers.  Plots in 
Figure 3.4B report ratios of phosphorylated species where erbB1 expression levels were 
more normal at 30,000 receptors per cell. In this case, the simulation landscape was 
initialized with erbB1 receptor distributions acquired from immuno-gold labeled Hec50 
cells (see Figure 3.5C). At the lowest doses of ligand (10-30%) occupancy, almost 50% 
of the phosphorylated species are unliganded receptors. We attribute this to the lower 
availability of liganded monomers in the sparsely populated membrane. These results 
offer insight into the lateral propagation hypothesis of Bastiaens and colleagues (Verveer 
et al, 2000) and the observations that 1:2 dimers are signaling competent (Liu et al, 
2012). They suggest that initiation of a global response by low doses of ligand is unlikely  
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Figure 3.4: Ratio of Phosphorylated receptors, LRP to RP.  (A) Percent of phosphorylated LR and R 
for increasing amounts of receptor ligand occupancy for A431 cells.  Initially, at low levels of ligand 
bound receptor, the percentage of phosphorylated non-ligand bound receptors increases.  As 
liganded receptor percentage increase, unliganded receptor phosphorylation decreases. (B) Percent 
of phosphorylated LR and R for increasing amounts of receptor ligand occupancy for HEC50 cells.  
A similar trend of LRP and RP are seen for HEC50, however the sparseness of the receptors on the 
membrane creates a larger deviation between simulations. 
A
B
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Figure 3.5: Membrane landscape impacts receptor state. (A)-(D) Receptor density and distribution 
for simulations. (A) Initial simulation space imported from an immuno-gold labeled EM image of an 
A431 cell.  Static confinement zones based on receptor cluster size are included.  (B) Randomized 
distribution of the same number of receptors in (A), after diffusion simulations in the absence of 
confinement zones.  (C) Initial simulation space imported from an immuno-gold labeled EM image of 
an HEC50 cell.  Static confinement zones based on receptor cluster size are included.  (D) 
Randomized distribution of the same number of receptors in (C), after diffusion simulations in the 
absence of confinement zones.  (E) Receptor state for simulation conditions represented in the 
matching simulation space and 0% ligand bound receptors.  The presence of domains impacts how 
often receptors will encounter one another. The simulations with domains present have a higher rate 
of dimer occurrence, as well as a large number of phosphorylated receptor species. (F) Receptor state 
for simulation conditions of 10% ligand bound receptors and corresponding simulation space.  
Similarly to the 0% ligand bound simulations, the occurrence of dimers and phosphorylated species 
is increased in the presence of domains.  The presence of ligand also allows for the formation of 
species not present in 0% ligand bound receptor simulations.  (G)-(H) Number of phosphorylated 
species, on average during a simulation, present and scaled to whole cell values for A431 cells (G) and 
HEC50 cells (H).  The presence of domains has a clear impact on the number of phosphorylated 
species.  (I) Repeated interactions of receptors on HEC50 cells with 10% ligand bound receptors 
present.  Simulations with domains and without domains were performed. 
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when the fast dephosphorylation rates measured by Kleiman et al. (2011) are coupled 
with fast off-rates for LRR (Low-Nam et al, 2011). 
3.4.3 The membrane landscape impacts receptor state 
Our next goal was to evaluate the impact of membrane domains and receptor density 
upon phosphorylation efficiency, integrating both the improved dimer life-time 
measurements and the asymmetric model. Results are shown in Figure 3.5, where the 
panels in A-D illustrate the four different conditions initialized into the simulation 
landscape. We first compared the impact of domains upon the rate of so-called “pre-
formed” dimers that occur in the absence of ligand. These events rely on encounters 
between monomers that have both randomly fluxed up to the extended conformation; 
since each monomer is assumed to flux at a rate of 1%, there is a 0.01% probability for 
dimerization at each encounter. Results are compared for ligand-less erbB1 diffusing and 
transiently getting trapped in domains, versus the same number of receptors diffusing 
with unrestricted Brownian motion. Results show that domains are particularly influential 
on the predicted levels of “pre-formed” dimers.  As described above, the binding radius 
was parameterized based upon the observations of Martin-Fernando et al. (2002), who 
estimated steady state levels of pre-formed dimers on A431 cells at 14%. Thus, as 
expected, simulations are consistent with this value in the corresponding domain 
landscape, Figure 3.5E. When domains are removed, dimerization reaches levels of only 
2%. At normal receptor density represented by Hec50 cells, up to 10% percent of 
receptors achieve dimerization in the domain-studded landscape.  Remarkably, 
dimerization of unliganded receptors at this lower density is a very rare event in the 
absence of domains, with estimates below 0.2%.    
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Figure 3.5F next compares the dimerization frequencies where 10% of the receptors 
are ligand bound and subject to the same four initial conditions (high density +/- 
domains; normal density +/- domains). Results again demonstrate the potential influence 
of domains, which is particularly impactful on the rate of dimer formation at normal 
receptor expression levels.  
Results in Figure 3.5G-H illustrate the relative impact of domains and receptor 
density on signaling output, represented by the number of receptors predicted to be 
phosphorylated at steady state.  In the case of high receptor density (Figure 3.5G), up to 
3% (~150,000) of receptors are phosphorylated in the absence of ligand on A431 
membranes with domains.  At 10% ligand occupancy, this value rises dramatically to an 
estimated 1 million phosphorylated receptors.  In the absence of domains, these estimates 
drop to 18,000 and 587,000 phosphorylated receptors respectively.   
For the case of Hec50 cells with normal erbB1 receptor density (Figure 3.5H), 
predicted values of phosphorylation attributed to pre-formed dimers is modest even in the 
presence of domains, at only 1400 phosphorylated receptors.  Without domains, receptor 
phosphorylation of ligand-less receptors is exquisitely low (17 total). Values in the case 
of 10% ligand occupancy are also reported in Figure 3.5H, with 8,500 phosphorylated 
receptors in the domain landscape and only 1,200 in the absence of domains.    
As a final demonstration of the impact of domains, Figure 3.5I compares the 
predicted frequencies of repeated interactions in Hec50 membranes, with and without 
domains and 10% ligand occupancy. Repeated interactions occur often when receptors 
are co-confined, even at this low density of receptors. In the absence of domains, 
repeated interactions between the same pair of receptors are much more rare events.  
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3.5 CONCLUDING REMARKS 
Dimerization is a key event for many growth factor receptors, including erbB1 and its 
closely related family members (Lemmon & Schlessinger, 2010).  Previous work by us 
and others have established that erbB1 dimerization is rapidly reversible (Chung et al, 
2010; Kawashima et al, 2010; Low-Nam et al, 2011), leaving open important questions 
regarding the sustainability of signaling. Here we specifically consider receptor 
dimerization as a diffusion-limited process, with an emphasis on the impact of receptor 
co-confinement in plasma membrane domains or “rafts”. Our approach is based upon 
mathematical modeling, using a spatial stochastic framework that incorporates the 
concepts of membrane domains. This approach was validated by its close approximation 
of receptor diffusion characteristics, including the range of jump distributions measured 
by single particle tracking. In addition to experimentally determined diffusion behavior, 
model parameters for dimer dissociation and phosphorylation/dephosphorylation are 
estimated from quantitative measurements in live cells (Hsieh et al, 2010; Kleiman et al, 
2011; Low-Nam et al, 2011). As suggested in our earlier work (Hsieh et al, 2008; 
Radhakrishnan, 2010), simulations confirm that transient receptor domain confinement 
can effectively raise local receptor density and enhance the likelihood for productive 
receptor encounters.  
This work has strong implications for the field of membrane biology, where the 
influence of “receptor clustering” remains a matter of considerable debate. ErbB1 and its 
family members are among the best studied examples of plasma membrane 
nanoclustering, with evidence for erbB1 homoclustering in resting cells from a wide 
variety of techniques including electron microscopy (Hsieh et al, 2010; Hsieh et al, 2008; 
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Yang et al, 2007), scanning near-field optical microscopy (Nagy et al, 1999), homo-
FRET (Yeow & Clayton, 2007), cross-correlation (Costantino et al, 2005; Keating et al, 
2008), proximity ligation assay (Soderberg et al, 2006), multispectral plasmon coupling 
microscopy (Wang et al, 2011), number and brightness (Nagy et al, 2010), and single 
molecule techniques (Ariotti et al, 2010; Low-Nam et al, 2011; Orr et al, 2005). The 
phenomenon of membrane protein clustering crosses many cell types.  A partial list of 
examples include MHC molecules (Lavi et al, 2012; Singer & Nicolson, 1972), C-type 
lectins and viral proteins (Cambi et al, 2004; Itano et al, 2012), TCR, BCR and Fc 
receptors (Lillemeier et al, 2006; Pierce & Liu, 2010; Wilson et al, 2000), CD36 
scavenger receptors (Jaqaman et al, 2011), and GPI-anchored proteins (Brameshuber et 
al, 2010; Varma & Mayor, 1998).    
The observation of nanometer scale proximity of membrane proteins, typically from 
microscopy methods, is sometimes interpreted as a reflection of oligomerization state.   
Here, we do not make the assumption that “clusters” observed by immunoelectron 
microscopy are accurate reporters of the oligomeric state of erbB1.  Rather we assume 
that these images capture a mix of non-random receptor distributions that principally 
result from monomers diffusing in and out of membrane domains.  Productive encounters 
between monomers can lead to formation of dimers.  Since we have yet to experimentally 
observe or quantify larger erbB1 oligomers (Clayton et al, 2007) with single particle 
tracking, we do not explicitly consider that interesting possibility here.  
There is evidence that membrane domains arise through complex mechanisms, 
including cytoskeletal barriers (Andrews et al, 2008; Jaqaman et al, 2011; Kusumi et al, 
1993; Lavi et al, 2012), the partitioning of saturated lipids and cholesterol (Simons & 
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Gerl, 2010), and ionic protein-lipid or protein-lipid interactions (Douglass & Vale, 2005; 
Lillemeier et al, 2006; Spira et al, 2012; van den Bogaart et al, 2011).  Due to this 
complexity, we do not make assumptions here about the primary mechanism underlying 
the domains that cause erbB1 clustering. The assignment of membrane domain area 
based upon EM images can be considered a “coarse-graining” approach, where clustering 
is both maintained throughout the simulation period and satisfies the essential 
characteristics observed experimentally for receptor motion. In our current simulation 
framework, domains are held to be static in size and location. This strategy lowers 
computational costs and follows the observation of Douglass and Vale (2005) that some 
slow-diffusing membrane proteins can serve as reporters for relatively stable domains. 
However this simplification likely does not reflect the true dynamic nature of protein-rich 
domains, that may diffuse as entities in the membrane, themselves encountering 
cytoskeletal barriers and cycling between growth and dispersion at the nanometer or 
submicron scale (Lavi et al, 2012).  
Our model explicitly considers the mounting experimental evidence for erbB 
structural rearrangements associated with dimerization. Like the integrins, the 
extracellular domains of erbB receptors are now well known to exist in both bent and 
extended confirmations (Burgess et al, 2003; Cho & Leahy, 2002; Ferguson et al, 2003; 
Ferguson et al, 2000; Garrett et al, 2003; Ogiso et al, 2002), where ligand binding 
stabilizes the upright form and exposes the dimerization arm.   To integrate this concept 
into mathematical models, we assume that unliganded receptors are predominantly in the 
bent confirmation and that ligand receptors are fixed in the dimerization competent 
conformation (Hsieh et al, 2010; Hsieh et al, 2008). A primary goal of the current study 
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was to incorporate the critical discovery that erbB catalytic activation is dependent upon 
an asymmetrical orientation of their kinase domains (Jura et al, 2009; Macdonald-
Obermann & Pike, 2009; Zhang et al, 2006). These landmark papers established that 
contact of the N-lobe of the “activator” with the dimer partner’s C-lobe relieves 
autoinhibition of the kinase domain solely in the “receiver” (Zhang et al, 2006).  
Conclusions of these crystallographic structure studies have supported by electron 
microscopy analysis of negatively-stained full length EGFR, in the presence and absence 
of ligand and/or kinase inhibitors (Lu et al, 2012; Mi et al, 2011). These studies indicate 
that the conformational orientations of dimerized erbB kinase domains are dominated by 
the active asymmetrical orientation, as opposed to the inactive symmetrically orientation 
(Landau et al, 2004), although kinase inhibitors can shift the class averages for the two 
orientations.   
We consider the implications of the asymmetric erbB1 activation scheme in its 
simplest form, by assuming that during the lifetime of the dimer only one member of the 
dimer pair becomes catalytically competent for transphosphorylation of its partner.  
Consistent with evidence that dimers composed of 1ligand:2receptors are signaling 
competent (Liu et al, 2012), the activation state of erbB1 in our simulations is not 
governed by ligand occupancy per se but rather by the lifetime of dimers determined 
experimentally (Low-Nam et al, 2011).  The probability for productive interactions is 
highest for 2:2 receptors, since the off-rate is slowest, followed by 1:2 receptor pairs and 
by 0:2 preformed dimers that have very fast off-rates. We do note that the number of 
phosphorylated receptors is increased above the total value for ligand-bound receptors, 
through repeated interactions and the productivity of 1:2 dimers. This amplification, 
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combined with transient dimerization, does allow for phosphorylation of unliganded 
receptors in 1:2 dimers that then dissociate and later interact with other unliganded 
monomers. However, the shorter lifetimes and reduced interaction probability associated 
with unliganded receptors results in very few productive 0:2 dimer events. 
Since our simulations are initiated with a fraction of monomers bound to ligand, our 
current model does not consider the potential for negative cooperativity (Adak et al, 
2011; Macdonald-Obermann & Pike, 2009; Tynan et al, 2011). If ligand binding were to 
be considered in the spatial stochastic model, it would lower the probability for an 
additional ligand to bind to a 1:2 receptor pair only during its relatively short lifetime (koff 
= 0.738s-1)(Low-Nam et al, 2011).    
One notable prediction of the simple asymmetric model considered here is that fast 
dissociation of dimers effectively promotes signaling, because re-encounters increase the 
likelihood that each monomer has repeated, equal opportunities to become 
phosphorylated by the “receiver”. We note the recent work of Pike and colleagues, who 
used a novel luciferase fragment complementation assay to provide compelling evidence 
for asymmetric and sequential activation of kinases in erbB homo- and heterodimers 
(Macdonald-Obermann et al, 2012).  These authors also raise the possibility that 
reciprocity could occur during the lifetime of the same dimer event, if the kinase domains 
can reorient while the monomers remain bound.  This intriguing possibility is not 
explored here, due to lack of information about energetic requirements and feasibility of 
such a reorientation on the time scale relevant to even the most stable 2:2 dimer (<10 
sec).       
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This work adds to a growing appreciation that cell signaling is markedly influenced 
by the spatial organization of the plasma membrane, where lateral segregation in the 2D 
environment influences interactions between signaling proteins and the propagation of 
positive signaling or associated negative regulatory networks (Casaletto & McClatchey, 
2012; Dehmelt & Bastiaens, 2010; Harding & Hancock, 2008). Our simulations predict 
that ligand-bound erbB1 cycle rapidly through all possible receptor states, generating 
pulses of signaling competent states. The potential for short-lived components to generate 
robust, system-level output has been coined “digital signaling” (Harding & Hancock, 
2008).   We expect that the impact of membrane spatial organization will vary widely in 
disease and normal settings, even for a single species of receptor such as erbB1.   For 
example, we show here that cells expressing very high levels of erbB1 (typical of gene 
amplification in certain cancers) are less dependent on domain co-confinement for 
productive encounters than cells with modest levels of surface receptors.  Cell-type 
variable factors that could alter the stability of domains and extend receptor capture 
events include lipid composition, the extent and dissociation kinetics of cortical 
cytoskeletal connections with membrane anchors, and the lipid-protein ratio.  Since lipid 
remodeling, protein macromolecular assembly, and cytoskeletal rearrangements often 
accompany signaling, the organization of the plasma membrane is subject to alterations 
over important time and length scales. Highly diffusible products of signaling cascades, 
such as reactive oxygen species proposed to inhibit phosphatases acting on erbB1 and 
enhance lateral propagation (Reynolds et al, 2003), would not be subject to the same 2D 
restrictions. Exploring the impact of the evolving 2D and 3D landscape through creative 
imaging and mathematical approaches is a future challenge for the field. 
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4.1 SUMMARY 
The anomalous diffusion of membrane receptors has been linked to trapping in 
transient confinement zones, which may be due to restrictions imposed by the cortical 
cytoskeleton or by lipid- and protein-defined nanodomains. Single particle tracking (SPT) 
experiments reveal subdiffusion properties, where the apparent diffusion constant 
decreases with the observation time and reflects confinement at length scales below 500 
nm.  High resolution imaging of fixed receptors show a non-random distribution, with 
clusters that range from a few to hundreds of receptors. It is unclear if these clusters are 
synonymous with lipid rafts or protein islands, which have size estimates in the range of 
20-100 nm.  Also unknown are the relative exchange rates of receptors diffusing between 
these clusters. Herein, we investigate SPT data from FcεRI receptors, performed at a rate 
of 20 frames per second. While the time dependence of the mean square displacement 
exhibits subdiffusion, the apparent diffusion constant derived from the distribution of 
displacements over a fixed time duration increases with the jump distance. We show 
through simulations that this feature can be the consequence of a combination of factors. 
If the frame interval is comparable to the diffusion time scale through a confining 
microdomain, free movement inside the domain is not directly observable. We were able 
to closely reproduce the observed fixed duration distributions from Monte Carlo 
simulations, performed in a landscape of small, confining domains of ≈100 nm diameter 
that cover a few percent of the membrane area. These simulations also exhibit 
subdiffusion. Simulations in a landscape of uniformly semi-permeable barriers but no 
confining domains produced qualitatively different distributions. 
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4.2 INTRODUCTION 
In the original fluid mosaic model (Singer & Nicolson, 1972), membrane proteins 
were assumed to move more or less freely along the membrane. As experimental methods 
improved, it became clear that the plasma membrane has a complex structure with lipid 
rafts (Edidin, 2001; Simons & Ikonen, 1997; van Meer & Simons, 1982), aggregations of 
receptors and other membrane proteins (Lillemeier et al, 2006), and elements of the 
cytoskeleton (Kusumi & Sako, 1996). Studies of the mobility (Axelrod et al, 1976; de 
Keijzer et al, 2008; Feder et al, 1996; Low-Nam et al, 2011; Schütz et al, 1997) and 
localization (Bobroff, 1986; Gelles et al, 1988; Ober et al, 2004; Schmidt et al, 1995) of 
membrane receptors and other transmembrane proteins have been a continued source of 
information on the rich structure of the cell membrane. 
Studies based on single particle tracking (SPT) techniques have revealed deviations 
from normal Brownian motion (Sako & Kusumi, 1994; Sako & Kusumi, 1995; Simson et 
al, 1995; Simson et al, 1998), consistent with transient confinement in areas of 
characteristic length in the range of 300-600 nm.  These results give rise to the model of 
hop-diffusion, where particles are embedded in a network of microdomains separated by 
actin filaments and other elements of the cortical cytoskeleton; diffusion within a 
microdomain is normal, but crossing between domains is partially restricted. This model 
was further refined by theoretical and simulation studies of diffusion in the presence of 
various types of obstacles, including trapping in corrals, as well as by non-specific 
binding sites (Niehaus et al, 2008; Saxton, 1995; Saxton, 2008).  In general, the predicted 
behavior is subdiffusion, where the effective diffusion constant decreases as the 
observation time or distance increase. Complementary to SPT methods that focus on a 
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small number of molecules at high temporal resolution, protocols such as superresolution 
and immunogold transmission electron microscopy provide “snap-shot” position data of a 
large number of molecules of interest. These approaches (Lillemeier et al, 2006; Nagy, 
2002; Veatch et al, 2012; Wilson et al, 2000; Wilson et al, 2001; Yang et al, 2007) have 
revealed clustering of receptors in areas consistent with a structure of quasi-randomly 
distributed microdomains that in total comprise a small fraction of the cell membrane. 
Small clusters are observed even in the absence of ligand stimulation, with diameters in 
the range of 20-100 nm. The connection between the proposed mechanisms underlying 
subdiffusion and these smaller receptor clusters is not well understood. 
Recent results using sophisticated imaging techniques indicate that most yeast 
membrane proteins tend to segregate, self-organizing into separate domains (Spira et al, 
2012). Proposed mechanisms for membrane protein clustering in higher eukaryotes relate 
it to lipid rafts and/or a corral structure induced by the cytoskeleton. Cytoskeleton-
induced corrals are consistent with larger (≈ 200 nm) domains and can preserve, but not 
induce, local concentrations of specific proteins. A plausible mechanism for the 
origination of protein clusters relies on vesicle trafficking of proteins newly delivered to 
the membrane (Gheber & Edidin, 1999; Lavi et al, 2007; Lavi et al, 2012). On the other 
hand, lipid rafts (Parton & Hancock, 2004; Rao & Mayor, 2005) have a complex 
chemical structure and may attract specific membrane proteins. Lipid rafts have been 
generally associated with “nanodomains” as small as 20 nm, which exhibit high mobility 
(Brameshuber et al, 2010). The variety of membrane associated proteins and of the 
observed spatial and temporal scales of clustering suggests that there are several, perhaps 
overlapping mechanisms at work (Saikh & Edidin, 2006). One such mechanism is the 
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transient confinement (Simson et al, 1998) of specific proteins by specialized 
microdomains. 
Recent SPT results with FcεRI (Andrews et al, 2008) as well as EGFR (Low-Nam et 
al, 2011) demonstrate transient co-confinement of pairs of receptors, clearly 
distinguishable from correlated motion due to dimerization. The concept of transiently 
confining microdomains has been implemented in computer simulations of the movement 
of membrane receptors. Simulations of diffusion in a landscape of small confining 
microdomains (consistent with the locations of clusters derived from static TEM images) 
successfully recapitulate the observed signal initiation kinetics (Hsieh et al, 2010; Hsieh 
et al, 2008; Pryor et al, 2013). This prompted us to consider the impact of confining 
domains on diffusion properties of receptors, and compare it with mobility statistics from 
SPT experiments. 
Here we seek a quantitative understanding of anomalous diffusion through 
comparative results of simulations incorporating transiently-confining domains with 
authentic SPT trajectories of quantum-dot (QD)-labeled FcεRI receptors.  SPT data were 
taken at intervals of 50 ms, in the absence of ligand stimulation (Figure 4.1). The time 
dependence of mean square displacements is consistent with subdiffuson but the 
distribution of displacements at fixed duration exhibits limited movement at short 
distances and faster diffusion at longer distances, in apparent contradiction with the 
confinement hypothesis. We show through numerical simulations that this is qualitatively 
consistent with a structure of small, transiently confining domains in the range of 30-250 
nm (comparable to the diffusion length corresponding to frame interval τ). The observed 
distributions can be closely duplicated by model simulations. 
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Figure 4.1: Experimental results. Displacement statistics for the aggregate of 1685 reconstructed 
trajectories, derived from 21 movies. Both the mean square displacement (MSD) as well as the step 
(jump) distributions over fixed time (duration) exhibit deviations from classic Brownian motion. A. 
MSD versus the observation time. The dependence is sublinear (has a decreasing slope) for short 
time intervals. The slope becomes constant for Tobs = 1 s, up to 14 s; this regime is well approximated 
by a linear dependence with an intercept. B. Distribution of linear (x and y) displacements over time 
intervals of 0.25 s, (5 recording intervals). Compared to a normal distribution with the same MSD, 
there is an excess of short (and very long) jumps. C. The distribution of square displacements at fixed 
time illustrates the deviation from Brownian behavior more clearly. The logarithm of the probability 
density (Eq.2) as a function of the value of the square displacement should follow a line with slope 
−1/(4DTobs); instead, the square displacement distributions at fixed duration have a characteristic 
upward curved shape. 
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Figure 1: Experimental results. Displacement statistics for the aggregate of 1685 reconstructed trajectories, derived
from 21 movies. Both the mean square displacement (MSD) as well as the step (jump) distributions over fixed time
(duration) exhibit deviations from classic Brownian motion. A. MSD versus the observation time. The dependence
is sublinear (has a decreasing slope) for short time intervals. The slope becomes constant for Tobs ? 1 s, up to
⇡ 14 s; this regime is well approximated by a linear dependence with an intercept. B. Distribution of linear (x and
y) displacements over time intervals of 0.25 s, (5 recording tervals ⌧ ). Com ared to a normal distribution with the
sam MSD, there is an excess of short (and very long) jumps. C. The distribution of square displacements at fixed
time illustrates the deviation from Brownian behavior more clearly. The logarithm of the probability density (Eq.2) as
a function of the value of the square displacement should follow a line with slope  1/(4DTobs) ; instead, the square
displacement distributions at fixed duration have a characteristic upward curved shape.
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4.3 MATERIALS AND METHODS 
4.3.1 Background 
Molecules in a homogeneous environment typically execute a random walk, a 
succession of discrete steps interspersed with random changes of direction and speed. A 
point particle is said to execute Brownian motion in two dimensions (d = 2) if its 
displacements (x, y) after time, t, are random and normally distributed, according to the 
probability density function (PDF) 
     
€ 
f x,y;t( ) = 14πDt exp −
x 2 + y 2
4Dt
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ ,                                      ( 1 ) 
where D is the (isotropic) diffusion constant. Eq. (1) implies two easily verifiable 
properties regarding the displacement r ≡ (x2 + y2)1/2. First, the distribution P(r2) of square 
displacements r2 after a fixed time t is exponential: 
            
€ 
P r2( ) = 12σxy2
exp − r
2
2σxy2
⎛ 
⎝ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ ⎟ ,                                             ( 2 ) 
where the standard deviation σxy of the displacement in either the x or y direction 
satisfies σ2xy = 2Dt. Second, the mean square displacement (MSD), defined as the 
expectation of the square of the displacement vector, <r2> = <x2> + <y2>, is proportional 
to the time (duration), t, over which the displacement takes place. The slope is 
determined by the diffusion constant, 
     
€ 
r2 = 2σxy2 (t) = 4Dt  .                                                 ( 3 ) 
Single particle tracking experiments provide estimates of the coordinates (xk, yk) of 
individual particles in a sequence of frames taken at some time interval τ. These can be 
used to construct distributions of step sizes at fixed observation times (durations) Tobs, 
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corresponding to integer multiples of the frame interval (Tobs =  τ, 2τ, …), as well as to 
derive the dependence of MSD values on the observation time. 
SPT results often reveal anomalous diffusion that deviates from standard Brownian 
motion. The presence of obstacles, either a network of barriers (Sako & Kusumi, 1994; 
Saxton, 1995), or a set of trapping locations (Saxton, 2008), typically results in a 
behavior that is consistent with unimpeded diffusion at time and spatial scales below that 
of the obstacles, and slower diffusion at larger scales.  The classic signature is 
subdiffusion, a sub-linear dependence (decreasing slope) of the mean square 
displacement as a function of time. 
Turning to distributions of step sizes over time intervals of a given length, obstacles 
should result in faster movement over short distances, and limited (slower) movement 
over long distances.  This is to be expected if the characteristic size of the barriers B is 
larger than the diffusion length, σ = 2 (DTobs)1/2, associated with the observation interval 
Tobs  (given by a frame rate). Traditionally, the σ < B condition is considered necessary 
for the observation of confinement, requiring high-speed recording capabilities (Saxton, 
2009). With moderate frame rates, the effect of confinement is readily identifiable, albeit 
more subtle. 
When comparing trajectories obtained from single particle tracking with model 
simulations, one must take into account the sources of error due to the experimental 
techniques used to obtain the trajectories. Step size distributions derived from imaging 
are potentially impacted by a localization error (Pezzarossa et al, 2011; Saxton, 2009), 
due to the uncertainty affecting the position measurements. The position analysis of 
quantum-dot (QD) tracking data relies on fitting a curve to the intensity distribution 
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recorded in several pixels, over the observation time. Position uncertainty adds a 
normally distributed error to the true position. If this error is independent from the true 
position, it will result in a normally distributed apparent displacement added to the true 
distributions, and a constant added to the corresponding MSD. Another source of 
uncertainty affecting positions is due to time averaging; the signal generated by the light 
detected by each pixel is recorded continuously, and the intensities reported for each 
frame are derived from the time-integrated signal over the entire frame interval. In our 
analysis, we simulated the effect of localization uncertainty and time averaging on the 
positions of particles (Figure A.4). 
Fluorescent imaging techniques rely on the performance of the fluorescent tag 
(fluorophore) used in the experiments. All fluorophores have a finite lifetime due to 
photobleaching. Quantum dots provide superior performance in this respect, but are 
subject to blinking, short, random intervals when they do not emit their characteristic 
light; thus individual QDs cannot be detected in a subset of the images captured during an 
experiment. The resulting tracks are fragmented, but can be reliably re-assembled if the 
density of fluorophores is appropriately low (Smith et al, 2010). The fragmentation 
results in an incomplete record of the positions of the respective particle; this is taken into 
account when sampling the displacements at various numbers of multiple steps (Figure 
A.3C). 
4.3.2 Single Particle Tracking (SPT) Data and Analysis 
4.3.2.1 Cell preparation, data acquisition, and tracking.  
SPT experiments were performed on RBL-2H3 cells labeled with QD-IgE as 
previously described (Andrews et al, 2008). In brief, QD-IgE binds to its high affinity 
93 
receptor (FcεRI) expressed on the mast surface, permitting single molecule tracking. QD-
IgE is prepared by mixing biotinylated IgE with streptavidin QDs (Invitrogen) at a 1:1 
ratio. Cells were primed with 100 pM of each color of QD-IgE (585 and 655 nm) for 10 
minutes at 37 °C. QD-IgE primed cells were imaged using an Olympus IX71 with 436 
nm excitation (mercury lamp with 436/10 nm band-pass) and emission collected through 
a QuadView image splitter (Optical Insights) with 655/40 and 585/20 nm band-pass 
filters for simultaneous imaging of 2 channels (Low-Nam et al, 2011). Imaging 
temperature was maintained at 34-36 °C by an objective heater (Bioscience Tools). Data 
was acquired at 20 fps (50 ms exposure time) for a total of 1000 frames. Single-
molecule localization and trajectory connections were performed as previously described 
(Andrews et al, 2008; Low-Nam et al, 2011). Short tracks were elongated (concatenated 
after particle identification) using the procedure described in (Low-Nam et al, 2011). 
4.3.2.2 Step size distributions.    
For each trajectory identified as described above, the X and Y coordinates were 
recorded for every frame (time step) when an identification of the respective particle was 
made. We collected x and y displacements for every integer multiple Tobs  = NT·τ of the 
frame interval τ = 50 ms from NT = 1 to at least NT = 200 by selecting pairs of 
observations of the same particle separated by the respective number of time steps. To 
ensure statistical independence, the pairs were selected so that the corresponding time 
intervals for the same NT would never overlap, but could share endpoints, as illustrated in 
Figure A.3C. 
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4.3.3 Numerical Simulations 
4.3.3.1 Brownian motion in the presence of barriers 
Basic Brownian motion is simulated in a fixed time step algorithm that replicates the 
mathematical definition. Given the position (Xk, Yk) of a particle after k iterations, the 
displacements (x, y) are each selected from the distribution defined by Eq. (1) with t set 
equal to tsim, the simulation time step. The position vector is then set to: (Xk+1 , Yk+1) = 
(Xk + x, Yk + y). In the absence of obstacles or boundaries, this algorithm is exact. 
In order to separate the observation and simulation time scales, and to avoid 
discretization artifacts in the diffusion process, the simulation time step tsim was set as a 
fraction of the lesser of the observation time Tobs and the characteristic time tdiff = B2/D 
for diffusion through the barrier spacing length unit B: 
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2B2
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⎟ ,                                      ( 4 ) 
with Nsteps ≥ 100. The step distributions had a weak dependence on the simulation time 
step, but stabilized when tsim << τmin. We verified that our results were essentially 
unchanged upon decreasing the simulation time step by up to three orders of magnitude 
(Figure A.4). 
Similarly to (Niehaus et al, 2008; Saxton, 1995; Wieser et al, 2007) and others, semi-
permeable barriers are implemented as line segments with no thickness. Barriers are 
characterized by a dimensionless permeability or crossing probability, pcross ≤ 1. When, 
during a simulation update, the next position of a particle would result in crossing a 
barrier, the move is accepted with probability pcross and is rejected otherwise (Figure 
A.4A). If the move is rejected, the position of the respective particle stays the same. In a 
departure from similar work in the literature (Heinemann et al, 2013; Saxton, 2007; 
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Wieser et al, 2007), we let the same barrier have different permeabilities for crossing in 
one or the other direction. Barriers with 100% permeability are equivalent to free 
movement. We use asymmetric barriers to model confining domains; crossing into the 
domain is allowed with permeability 1, but exit from the domain has pcross ≈ 1 − 5 %. 
4.3.3.2 Corrals and confining domains 
In all the simulations presented here, the barriers form a rectangular network, with 
sets of barriers parallel to each axis, as illustrated in Figure A.4B. The network is defined 
by two sequences of barrier coordinates, {X1B, …, XBNB} and {Y1B, …, YBNB}, each 
arranged in increasing order. The simulation area is thus partitioned into rectangles Rjk = 
[XjB, Xj+1B] × [YkB, Yk+1B], which represent our domains. The rectangular geometry 
allows for an implementation of the Brownian simulation at a moderate computational 
cost. The simulation area is subject to periodic boundary conditions. 
We used the assignment pattern of barrier permeabilities to emulate two types of 
membrane landscapes. In the corral configuration (Figure 4.2A, inset), boundaries are 
uniformly semi-permeable and each of the N2B domains represents a corral separated 
from its neighbors by such boundary segments. In the confining domain configuration 
(Figure 4.2B, inset), only a subset of the rectangles (one in a patch of N2B) has semi-
permeable boundaries. The boundaries of a confining domain are semi-permeable (pcross = 
1−5%) for particles exiting the domain, and are fully permeable (pcross = 100%) for 
particles entering; all other boundary segments are turned off (set to full permeability, 
thus not interfering with particle motion). 
The barrier coordinates are specified in terms of an intrinsic distance unit B. In 
simulations with uniform barrier spacing (Figure 4.2AB), the barriers were located at 
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Figure 4.2: Simulations of Brownian motion in the presence of semi-permeable barriers. A. 
Distribution of individual square displacements (ISD) for different observation times (durations), in 
a rectangular grid of evenly spaced (B =1 in simulation units), uniformly permeable (pcross = 0.01) 
barriers. The barriers induce a pattern of alternating faster and slower apparent diffusion. If the 
diffusion length corresponding to the observation time is smaller than the barrier spacing, the 
alternation begins with fast diffusion, slowed down at the barrier, then faster, and so on. For larger 
observation times, the initial fast diffusion regime is washed out , and the curve begins with slow 
diffusion, followed by fast. B. The clean upward curved shape, not seen with repeated barriers, is 
typical of the single trapping domain configuration. These simulations also exhibit an initial faster 
regime. However, this regime is not visible in the simulations shown in Figure 4.4, which did not use 
identical, square shaped domains. C. Outline of the barrier landscape used in the simulations shown 
in Figure 4.4. To avoid quasi-periodic behavior, the barrier spacings were chosen from a normal 
distribution (centered on B = 2.5). The barriers are generally semi-permeable; the domains outlined 
with thick lines were partially confining (free entrance, small exit permeability). The configuration 
shown here was repeated using periodic boundary conditions. 
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Figure 2: Simulations of Brownian motion in the presence of semi-permeable barriers. A. Distribution of individual
square displacements (ISD) for different observation tim s (durations), in a r ctangul grid of evenly spaced (B=1
in simulation units), uniformly permeable (pcross = 0.01) barriers. The barriers induce a pattern of alternating faster
and slower apparent diffusion. If the diffusion length corresponding to the observation time (  ⌘ 2pD0 · Tobs) is
smaller than the barrier spacing, the alternation begins with fast diffusion, slowed down at the barrier, then faster, and
so on. For larger observation times, the initial fast diffusion regime is washed out , and the curve begins with slow
diffusion, followed by fast. B. The clean upward curved shape, not seen with repeated barriers, is typical of the single
trapping domain configuration. These simulations also exhibit an initial faster regime. However, this regime is not
visible in the simulations shown in Fig.4, which did not use identical, square shaped domains. C. Outline of the barrier
landscape used in the simulations shown in Fig. 4. To avoid quasi-periodic behavior, the barrier spacings were chosen
from a normal distribution (centered on B = 2.5). The barriers are generally semi-permeable; the domains outlined
with thick lines were partially confining (free entr nce, small exit permeability). The co figur tion shown here was
repeated using periodic boundary cond tions.
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multiples of B: XB = YB = {0, B, 2B, 3B, …}. To avoid spurious effects due to 
periodicity, we introduced non-uniform barrier spacing selected from a normal 
distribution centered on the average spacing. 
The geometry of the simulations discussed in Figure 4.4 is depicted in Figure 4.2C. 
The basic patch of 10B ×10B is divided into 4 × 4 = 16 domains (thus ∆XB ≈ ∆YB ≈ 
2.5B) , using the following barrier coordinates: XB ≡ {0, 2.70, 6.56, 7.01, 10.00} × B;  YB  
≡ {0, 3.16, 4.50, 6.81, 10.00} × B. This primary pattern of barriers was repeated once in 
each direction, for a total simulation area of 20B × 20B with 64 domains. In each instance 
of the elementary pattern, one the 16 boxes (initially chosen at random but kept the same 
throughout the different simulations) was confining. The full 20 × 20 area was subject to 
periodic boundary conditions. 
All our simulations and analysis were implemented in Matlab. In a typical simulation, 
we used 104 particles and a total simulation time to 103 times the characteristic time τmin 
defined in Eq. (4). For corral simulations, particles were initially distributed uniformly in 
the simulation area. The initial states for confining domain simulations had a 
proportionally higher fraction of the particles distributed uniformly inside the confining 
domains. 
4.3.3.3 Units, scales, conversions     
The simulations are performed using intrinsic (or simulation) time and length units, 
with a diffusion constant of D(sim) = 100 and barrier spacing length scale B(sim) = 1. 
Individual simulation runs are characterized by the configuration type, barrier geometry 
(XB, YB), permeability pcross, simulation time step tsim, and the observation time Tobs. The 
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dimensionless ratio between the barrier spacing length scale B and the diffusion length 
corresponding to the observation time, 
 
€ 
σrel =
2 D⋅ Tobs( )
1/ 2
B                                                     ( 5 ) 
 
is independent of the units, hence it also corresponds to the ratio of the physical 
diffusion length and barrier spacing scale (or domain size parameter), B(phys). In 
simulation units (where B = 1), σrel coincides with the diffusion length. 
Conversion to physical units requires setting the time and length conversion factors, 
defined as follows: 
 
€ 
t phys( ) = αT ⋅ t sim( );x phys( ) = αL ⋅ x sim( )                                       ( 6 ) 
The time conversion factor is determined from the requirement that the observation 
time in the simulation correspond to the physical one: 
 
€ 
Tobs = αTTobssim( ) →αT =
Tobs
Tobssim( )
                                          ( 7 ) 
In principle, the length conversion factor could be determined using a known physical 
distance, for example by setting the barrier spacing scale B based on the typical linear 
size of a microdomain. A more practical option is to use the apparent diffusion constant, 
defined by the slope of the mean square displacement versus time plot, 
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4.4 RESULTS 
4.4.1 SPT tracking confirms FcεRI motion is non-Brownian, with two distinct 
anomalous features 
We analyzed a dataset of 1685 traces reconstructed from high resolution imaging of 
quantum dots conjugated to IgE (QD-IgE), which attach to FcεRI receptors on 
unstimulated RBL cells. The data was collected in three experiments that resulted in sets 
of 686, 319, and 653 trajectories respectively. Each set contains 7 recordings (or movies) 
of 1000 frames each; each movie resulted in a number of trajectories obtained 
simultaneously, in the same image field of a biological sample. The images were taken at 
an interval of τ = 50 ms, corresponding to a frame rate of 20 fps. While the general 
aspects of the trajectories are those of a random walk (Figure A.3A), the step size 
distributions (Figure 4.1) deviate from standard Brownian behavior. 
We analyzed the displacements of the particles over a range of 1 to 200 consecutive 
time steps, corresponding to observation times from Tobs = 50 ms to 10 s. The mean 
square displacement (MSD) increases with Tobs (Figure 4.1A); the slope initially 
decreases, then stabilizes at Tobs  ≥ 1 s. The expected dependence for Brownian motion 
(Eq.3) is linear, <r2> = 4D·Tobs. A diminishing slope corresponds to an effective diffusion 
coefficient that decreases with the observation time, from an initial value of D’eff = 0.058 
µm2/s to an average of D’eff = 0.033 µm2/s. This non-Brownian behavior is generally 
associated with reduced mobility or confinement at larger distances. 
Distributions of individual displacements corresponding to a fixed duration Tobs do 
not immediately support this interpretation. Compared to a normal distribution with the 
same variance, individual displacements have an excess of short and very long values 
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(Figure 4.1B). The deviation is more clearly illustrated by the distribution of the 
individual square displacements (ISD). For Brownian particles, the ISD distribution is 
exponential, Eq. (2); therefore plots of log P(r2) should be linear, with slope −1/(4D·Tobs). 
Experimentally (Figure 4.1C) the log-ISD distribution displays an upward curvature. This 
may be interpreted as an effective diffusion constant that gradually increases with 
distance, in apparent contradiction with the MSD time dependence described above. 
Sub-linear time dependence of the MSD of membrane bound molecules typically 
reflects the presence of obstacles that limit their random movement. Corrals resulting 
from elements of the cytoskeleton (Niehaus et al, 2008; Sako & Kusumi, 1994; Saxton, 
1995), small confining domains consistent with lipid rafts (Simson et al, 1998), or 
localized trapping sites (Saxton, 2007) may all limit movement at larger distances, 
resulting in relatively higher mobility at short distances. The reduced short distance 
mobility seen in the ISD distributions is puzzling; a possible explanation is that the 
observation time Tobs is too large compared to the typical time it takes the particles to 
cross an obstacle (Kusumi et al, 2005a); but then subdiffusion should also be missed by 
the MSD time dependence.  
4.4.2 The anomalous features of experimental ISD distributions are reproduced by 
Brownian simulations in a landscape of attractive domains, but not in a 
landscape of corrals 
In order to understand the observed behavior, we performed simulations of two-
dimensional Brownian motion in the presence of semi-permeable barriers. Particle 
movement was simulated using a fixed time step Brownian motion algorithm with 
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periodic boundary conditions; barriers allowed or blocked individual crossing attempts by 
particles in a probabilistic fashion, based on a pre-defined permeability, pcross ≤ 1. 
We used two types of barrier configurations, corrals and confining domains. Corrals 
(Figure 4.2A, inset) represent a cytoskeleton induced partition of the membrane into 
domains that have similar physico-chemical properties; in our simulations they are 
separated by boundaries of uniform permeability pcross, that does not vary between 
domains or with the direction of particles crossing it. Confining domains (Figure 4.2B, 
inset) represent lipid rafts that have an affinity for the membrane proteins of interest. 
Simulated confining domain cover a few percent of the membrane surface; their 
boundaries are fully permeable to particles entering and have permeability pcross  ≈ 1 − 
5% to particles exiting the domain.  
First, we performed simulations in a corral landscape, with barriers evenly spaced at 
distance B = 1. Keeping the same permeability, we varied the observation time Tobs so 
that the corresponding diffusion length σ = 2(DTobs)1/2 probed a range of values around 
B. All resulting log-ISD distributions (Figure 4.2A) exhibit the expected signature of 
confinement, in that the apparent diffusion coefficient decreases as r2 increases toward 
the barrier spacing B2 = 1. However, the apparent diffusion constant increases again at r2 
> B2 and the alternating pattern is repeated around r2 ≈ 4B2. Also as expected, the 
confinement signature weakens as Tobs increases. For σ values above B, the slowdown at 
r2 ≈ B2 is increasingly overshadowed by the higher mobility regime B2 < r2 < 4B2, and by 
the second reduced mobility interval at r2 ≈ 4B2. In summary, the log-ISD distributions 
generated in the corral configuration could explain the absence of higher mobility at low 
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distances, but none of them exhibited the upward curvature in Figure 4.1C, consistent 
with higher mobility at larger distances. 
This prompted us to consider the confining-domain configuration. The log-ISD 
distributions in Figure 4.2B were generated using the same algorithm, with permeability 
and Tobs values as the set in Figure 4.2A, but with a single, square shaped attractive 
domain of size B2 in the simulation area. Distributions with longer Tobs (such that σ > B) 
have consistently increased mobility for r2 > B2. The signature of confinement is also 
present, with a noticeable but transient decrease in mobility for r2 ≤ B2. For smaller σ 
values, both features are less pronounced; still, the large distance mobility (or effective 
diffusion coefficient) is higher than for the corresponding distributions for corrals. 
The network of barriers constituted a uniform periodic grid in the corral simulations 
of Figure 4.2A, and the attractive domain used for Figure 4.2B was a unit square. To 
eliminate possible artifacts due to the regular geometry, we repeated the simulations in 
landscapes where the barrier spacing were taken from a random distribution, centered on 
the same average spacing of B = 1; in the corresponding attractive-domain simulations, 
the attractive domain was one of the rectangles from the corral geometry. We used the 
same permeability of 1% in the two types of geometries. The resulting ISD distributions 
(Figure 4.3A-D) are smoother, without pronounced slope variations at r2 = B2 and 4B2. 
They confirm that the corral geometry does not result in consistently increased long 
distance mobility, while the attractive-domain geometry always does. In both types of 
simulation, the MSD versus observation time curve had a decreasing slope. For small 
Tobs, the effective diffusion constant (Figure 4.3F) starts close to the value (D0 = 100  
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Figure 4.3: Simulations in corral and confining domain landscapes with non-uniform barrier 
spacing. A-D. Individual square displacement (ISD) distributions in corral (AC) and confining 
domain (BD) simulations, performed in two different barrier landscapes (AB and CD) with non-
uniform barrier distances. The confining domain in B is one of the corral domains from A and the 
one in D is one of the domains from C. Both types of simulations had the same permability value of 
1%. Dashed lines indicate the range and mean of corral spacings (AC), respectively the size of the 
attractive domain (BD). Variable barrier spacings eliminate the pronounced slope variations from 
the corral simulations. Unlike the confining domain results, the corral simulations do not exhibit an 
overall increasing slope. The confining domain simulations are sensitive to the geometry of the 
domain (which is closer to a square in B and is more elongated in D). E-F. The dependence of the 
mean square displacement R2 on the observation time (E) exhibits a decreasing slope in both types of 
simulations. The decreasing slope is more pronounced in the corral geometry. At short observation 
times, both simulations are consistent with pure Brownian diffusion (F) and the effective diffusion 
constant Deff (derived from the slope of the MSD versus time curves) approaches the microscopic 
value of 100 (simulation units). 
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Figure 3: Simulations in corral and confining domain landscapes with non-uniform barrier spacing. A-D. In-
dividual square displacement (ISD) distributions in corral (AC) and confining domain (BD) simulations, performed
in two different barrier landscapes (AB and CD) with non-uniform barrier distances. The confining domain in B is
one of the corral domains from A and the one in D is one of the domains from C. Both types of simulations had the
same permability value of 1%. Dashed lines indicate the range and mean of corral spacings (AC), respectively the
size of the attractive domain (BD). Variable barrier spacings eliminate the pronounced slope variations from the corral
simulations. Unlike the confining domain results, the corral simulations do not exhibit an overall increasing slope.
The confining domain simulations are sensitive to the geometry of the domain (which is closer to a square in B and
is more elongated in D). E-F. The dependence of the mean square displacement  R2 on the observation time (E)
exhibits a decreasing slope in both types of simulations. The decreasing slope is more pronounced in the corral ge-
ometry. At short observation times, both simulations are consistent with pure Brownian diffusion (F) and the effective
diffusion constant De↵ (derived fro the slope of the MSD versus time curves) approaches the microscopic value of
100 (simulation units).
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sim.units) corresponding to pure Brownian motion, decreases, then remains constant for 
Tobs > 0.01. 
4.4.3 Experimental displacement statistics are closely approximated by 
simulations in a landscape of partially confining domains 30-250 nm in 
diameter 
Next, we wanted to see whether the observed ISD and MSD distributions can be 
approximated by Brownian motion in the presence of a system of barriers.  To avoid the 
artifacts of a periodic barrier structure, we defined a network of unevenly spaced, 
rectangular barriers (Figure 4.2C). 
Compared to the SPT data, simulations in this geometry using the corral 
configuration (uniformly semi-permeable barriers) exhibited weaker deviations from the 
ideal Brownian behavior. We obtained a consistently better match to the data with 
simulations using the attractive-domain configuration, where only a subset of the 
rectangular compartments were surrounded by barriers, which only impeded exit from the 
respective domains. We performed simulations with a range of permeability and diffusion 
length values, in order to match as closely as possible the experimental distributions from 
one of the three data sets. Direct comparison with the experimental results for the fixed 
time step distributions reveals a strong qualitative similarity, as illustrated in Figure 4.4A 
and C. The simulations shown in Figure 4.4 were obtained using a permeability of pcross = 
5% and 
€ 
σ = 2B . The barrier coordinates are XB ≡ {0, 2.70, 6.56, 7.01, 10.00} × B and 
YB ≡ {0, 3.16, 4.50, 6.81, 10.00} × B, resulting in ratios of σ/∆X and σ/∆Y in the range 
of  (0.44 … 3.14). 
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Figure 4.4: Comparison between experiment and simulations. Random sized, trapping (attractive) 
domains lead to step size distributions that are qualitatively similar to those observed experimentally. 
A. Distributions of simulated displacements at fixed time closely approximate the experimental 
result, with a larger discrepancy for small times. B. MSD versus observation time. We used the slope 
(apparent diffusion constant) of this dependence to convert from simulation to physical units. The 
discrepancy in the fixed duration distributions (A. and C.) is really due to the differences between the 
time dependence of the mean square displacement (MSD). The simulation exhibits a smaller vertical 
offset than the experimental data. C. The distribution of square displacements at fixed time allows 
for a better comparison. The simulation matches the data better for intermediate observation times. 
For short times, the simulation underestimates the number of long jumps. D. Simulated trajectories. 
One aspect that could be improved is the simple geometric shapes we used in these simulations, 
which should better reproduce the likely varied size and contorted shape of the actual domains 
(compare with trajectories shown in Figure A.3). 
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Figure 4: Comparison between experiment and simulations. Random sized, trapping (attractive) domains lead to
step size distributions that are qualitatively similar to tho e observed experimentally. A. Dist ibutio s of simulated
displacements at fixed time closely approximate the experimental result, with a larger discrepancy for small times.
B. MSD versus observation time. We used the slope (apparent diffusion constant) of this dependence to convert
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differences between the time dependence of the mean square displacement (MSD). The simulation exhibits a smaller
vertical offset than the experimental data. C. The distribution of square displacements at fixed time allows for a better
comparison. The simulation matches the data better for intermediate observation times. For short times, the simulation
underestimates the number of long jumps. D. Simulated trajectories. One aspect that could be improved is the simple
geometric shapes we used in these simulations, which should better reproduce the likely varied siz and contorted
shape of the actual d mains (compare w th trajec ori s shown in Fig. S1).
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The simulation results were converted to physical units by identifying the observation 
time with 50 ms and setting the length scale so that the long-term slope of the MSD 
versus time curve (Figure 4.4B) matched the experimental slope of 0.132 µm2/s (effective 
diffusion constant of Deff = 0.033 µm2/s). This corresponds to B = 77.2 nm, giving barrier 
sizes of ∆X = {208, 298, 35, 231} nm, ∆Y  = {244, 103, 178, 246} nm. The highlighted 
values correspond to attractive domains (Figure 4.2C), whose diameters thus ranged from 
35 to 246 nm. 
There are discrepancies between the simulated and experimental statistics. Simulated 
ISD distributions at longer observation time over-estimate the number of small steps. 
While the simulated MSD distribution (Figure 4.4B) does exhibit sub-diffusion, the 
initial slope of the experimental curve (D’eff = 0.058 µm2/s) is not matched by the 
simulation. It is interesting to note that the microscopic diffusion constant used in the 
simulation (D0 = 0.059 µm2/s) is very close to this value, but results in a smaller vertical 
offset. 
4.5 DISCUSSION 
The particle tracking data discussed here exhibits two types of deviations from 
Brownian diffusion, sublinear dependence of the mean square displacement (MSD) on 
the observation time, and slow apparent diffusion at short distances exhibited by 
individual square displacements (ISD) at fixed time. Subdiffusion has long been 
recognized as a likely consequence of obstacles to free movement, such as a network of 
domains separated by semi-permeable barriers (Kusumi et al, 2005b; Saxton, 1995), or 
transient trapping (Saxton, 2008). The peculiar features of ISD distributions have been 
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noted previously, most recently in a careful statistical analysis of FcεRI mobility data 
(Espinoza et al, 2012). 
The present analysis provides a plausible explanation of both features, based on the 
hypothesis of a collection of small, partially confining domains that occupy a fraction of 
the membrane area. We propose a model of anomalous diffusion that reconciles the 
original hop-diffusion model (Kusumi et al, 2005b) with the inhomogeneous, frequently 
clustered distribution of receptors (Lillemeier et al, 2006). 
In the original hop-diffusion model, the membrane is divided (partitioned) into 
microdomains, mostly by elements of the cytoskeleton that act as semi-permeable 
barriers to the movement of receptors. Receptors perform Brownian motion with 
diffusion coefficient D0 within microdomains, but their movement between domains is 
limited, except for rare “hop” events. As a result, free diffusion is limited by the typical 
domain size B. It should be observable in SPT experiments with a high enough frame rate 
(so that Tobs << B2/4D0). Displacements over distances r > B are unlikely, and the mean 
displacements over time scales that exceed B2/4D0 are bounded or increase consistently 
with a smaller, effective diffusion constant Deff < D0. By the same logic, individual 
square displacement (ISD) distributions should exhibit decreasing mobility for distances 
exceeding the diffusion length σ = (4D0Tobs)1/2. We found that this picture was consistent 
with the experimentally derived MSD curves (Figure 4.1A), but not with the individual 
square displacement (ISD) distributions, which exhibited increased mobility at higher 
distances. 
The experimental ISD distributions (Figure 4.1C and Figure 4.4C) are likely affected 
by the relatively long observation time (50 ms), which corresponds to a diffusion length 
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of ≈ 100 nm. To better understand the implications of the hop-diffusion model, we 
performed simulations of diffusion in a network of domains (corrals) separated by semi-
permeable barriers. The resulting ISD distributions exhibited decreasing mobility only for 
shorter observation times, indicating a more complex behavior than described above. 
However, they did not reproduce the monotonically increasing mobility observed 
experimentally. By contrast, this feature was clearly matched by simulations where all 
boundaries were fully permeable, except for only one of the domains, which had semi-
permeable boundaries in the outgoing direction (Figure 4.2). This led us to formulate a 
modified version of hop diffusion. 
In our proposed model, the microdomains of interest are small, and occupy in 
aggregate only a fraction of the membrane area; they are partially confining, in that their 
boundaries are more easily crossed inbound than outbound. By contrast, the rest of the 
membrane is non-confining and allows high[er] mobility. This model has been implicitly 
used in (Hsieh et al, 2010; Hsieh et al, 2008; Pryor et al, 2013), in Monte Carlo 
simulations of signal initiation; however, to our knowledge, it has not been rigorously 
evaluated for faithful reproduction of receptor mobility characteristics. 
The confining domain hypothesis can explain both of the non-Brownian features 
observed experimentally. Receptors will spend most of their time in a confining domain; 
rare “hop” events will place a receptor in the open area where it can diffuse quickly until 
it is trapped by another confining domain. The distribution of individual square 
displacements (at fixed observation time) results from the overlap of two populations, 
confined particles with limited movement and escaped particles that diffuse quickly. The 
former dominate short displacements and the latter dominate long displacements, hence 
109 
the steep slope (low mobility) at short distances and lower slope (high mobility) at large 
distances. Simulations also reproduce the sublinear dependence of the mean square 
displacement. We performed simulations in a landscape of rectangular shaped domains as 
described above, in a variety of geometries and mobilities, and were able to obtain a good 
match to the experimental distributions (Figure 4.4) over a range of observation times. 
Similarly to the original hop-diffusion model, unimpeded Brownian behavior is 
recovered in our model at short observation times (equivalent to a high frame rate). The 
upward curved shape of the logarithmic individual squared displacement (ISD) 
distributions and the decreasing slope in the MSD time dependence are robust features of 
the model; however, the precise shape of both sets of curves is sensitive to the geometry 
of the barriers, especially to the size and diameter of the attractive domains. Thus, it is 
very likely that closer matching simulations can be obtained by using varying sizes for 
the domain barriers, a combination of permeabilities, and irregular shaped domains.  This 
effort should be guided by a theoretically motivated procedure to extract the 
characteristic parameters from the experimental results. 
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5.1 ABSTRACT  
Members of the erbB family of receptor tyrosine kinases are capable of both homo- 
and hetero-interactions. Because each receptor has a unique set of binding sites for 
downstream signaling partners and differential catalytic activity, subtle shifts in their 
combinatorial interplay may have a large impact on signaling outcomes. Overexpression 
and mutation of erbB family members are common in numerous human cancers and alter 
the balance of activation within the signaling network. Here we report the development of 
a spatial stochastic model that addresses the impact of varying ligand concentrations and 
erbB2-erbB3 ratios on erbB3 homo and hetero-interaction dynamics and phosphorylation 
state. We also report experimental and computational analysis of an erbB3 gain-of-
function mutant, located in the C-lobe asymmetric dimerization interface, which shows 
enhanced phosphorylation at low ligand dose associated with increased kinase activity. 
5.2 INTRODUCTION 
The ErbB family of receptor tyrosine kinases consists of four related receptors that 
form both homo- and heterodimers (Lemmon & Schlessinger, 2010), as well as 
potentially higher-order oligomers (Kozer et al, 2013). This work focuses on the unusual 
properties of erbB3, that are markedly dependent upon engagement with a 
heterodimerizing partner for its transphosphorylation and upregulation of its inherently 
weak catalytic activity (Shi et al, 2010; Steinkamp et al, 2014). Previous studies have 
suggested that erbB3 favors erbB2 over other erbB family members for 
heterodimerization (Zhang et al, 2009) and erbB2/erbB3 interactions are important in 
both normal developmental processes (Yarden & Sliwkowski, 2001), as well as cancer 
initiation and progression (Liu et al, 2007; Vaught et al, 2012). Although erbB3 and 
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erbB4 share heregulin/neuregulin 1 as a ligand (HRG/NRG1) and can form heterodimers 
(Monsey et al, 2010), it is only the erbB3/erbB2 complex that is implicated in melanoma 
growth and survival (Zhang et al, 2013). ErbB3 expression has been linked to resistance 
of tumors to tyrosine kinase inhibitor therapies (Huang et al, 2012; Lee et al, 2014; Sato 
et al, 2013; Sergina et al, 2007), motivating more comprehensive analyses of erbB3 
dynamics and signaling capabilities.  
  Mathematical modeling has emerged as a powerful method to explore the 
complexity of erbB family signaling (Andrews & Bray, 2004; Blinov et al, 2006; 
Kholodenko et al, 2010; Kleiman et al, 2011; Radhakrishnan, 2010; Zhang et al, 2009), 
particularly when supported by high quality, quantitative measurements at different time 
and length scales (Pryor et al, 2013; Shankaran et al, 2013). Most prior computational 
studies have neglected erbB3 as a significant catalytic entity. A notable exception is the 
work of Telesco et al. (2011), who suggested that even the minimal level of basal erbB3 
autophosphorylation could alter the dynamics of erbB signaling pathways and contribute 
to drug resistance. Recently, we demonstrated that tyrosine kinase activity is significant 
in immuno-isolated, intact erbB3 after binding heregulin (HRG), providing that erbB2 is 
co-expressed (Steinkamp et al, 2014).   High resolution imaging methods, such as single 
particle tracking (SPT), captured erbB3-erbB3 and erbB3-erbB2 interactions in real time 
and revealed that ligand-bound erbB3 engaged in homointeractions that were 3-4x more 
stable than when bound to erbB2 (Steinkamp et al, 2014). These observations raised the 
intriguing questions: Under what conditions might erbB3’s catalytic activity be 
important? And, further, what is the potential impact of spatial organization and serial 
engagements of both homo- and heterodimer configurations upon signaling?  
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We approach these questions through a stimulation platform designed to reflect 
characteristics of the membrane landscape, that underlie the anomalous diffusion 
characteristics of erbB receptors (Low-Nam et al, 2011; Steinkamp et al, 2014) as well as 
the random nature of receptor encounters in the 2D fluidic membrane. Recently applied 
to the study of erbB1/EGFR homodimerization (Pryor et al, 2013), our spatial stochastic 
simulation method incorporates a Rule-Based approach that explicitly considers 
important structural features that control erbB signaling.  These features include the 
stable upright configuration of the extracellular domain of erbB2 or ligand-bound erbB3, 
rendering them dimerization competent throughout the simulation. In contrast, the 
unstable flux of resting erbB3 from the bent state to a dimerization-capable state is 
represented by a probability term; at each microsecond time step in the simulation only 
1% of resting erbB3 receptors are upright and available to dimerize. The model also 
assumes that the asymmetrical orientation of kinase domains in each dimer is a random 
process, such that each monomer in the pair is assigned as a receiver or an activator 
respectively. This simulation strategy sets up a scenario where individual receptor 
monomers swap their status as a receiver or activator exclusively through a stochastic 
process of dissociation and rebinding. During these encounters, the model tracks the 
phosphorylation state of each receptor monomer, adding an experimentally estimated 
multiplier for increased catalytic activity so long as the monomer remains 
phosphorylated. The simulation is governed by experimentally-defined rate constants for 
phosphorylation, dephosphorylation, and dimer dissociation. ErbB receptors cycle 
through many encounters during these simulations, revealing properties that drive signal 
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propagation and pointing to important influences such as the relative ratios of each 
receptor species, density, and dwell times.  
A novel addition to the model is the use of single particle tracking data to estimate the 
size of membrane domains (“confinement zones”) (Simson et al, 1995) that transiently 
trap erbB2 and erbB3, incorporating previously described overlap of these domains 
(Hsieh et al, 2008) with their respective dwell times. These factors translate in the model 
to probabilities for escape from confinement. Finally, we utilize the model to analyze 
experimental data collected in cells expressing a novel gain-of-function mutation in 
erbB3. Located within the C-lobe of the erbB3 kinase domain, the E933Q mutation was 
initially discovered by us as a heterozygous mutation in the SKBR3 breast cancer cell 
line. We show that erbB3E933Q expressed in CHO cells is more readily phosphorylated at 
low ligand dose than wildtype erbB3 (erbB3WT), with accompanying higher catalytic 
activity. Since SPT data showed that the gain-of-function status was not linked to longer 
homodimer lifetimes for erbB3E933Q compared to erbB3WT and ligand binding was 
unaltered, the model was utilized to provide an estimate of the mutant’s increased 
catalytic activity. This work sets the stage for mechanistic profiling of the entire spectrum 
of erbB3 oncogenic mutations (Jaiswal et al, 2013), which are distributed across both the 
extracellular and kinase domains and may each have unique contributions to dimer 
stability or kinase activity.     
5.3 RESULTS 
5.3.1 ErbB3 dephosphorylation shows a lag after acute inhibition of erbB2 
catalytic activity  
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Ligand-dependent erbB3 phosphorylation requires erbB2, since it can be abrogated 
by pretreatment with pertuzumab or lapatinib (Steinkamp et al, 2014; Zhang et al, 2009). 
However, it is not known whether erbB2 activity is also required to maintain erbB3 
phosphorylation after stimulation has upregulated erbB3 activity. Figure 5.1AB shows 
results obtained in CHO cells expressing HA-tagged erbB2 (erbBHA) and GFP-tagged 
erbB3 (erbBGFP). Cells were serum starved and stimulated for short duration with 12 nM 
heregulin β (HRG), followed by treatment with lapatinib to acutely inhibit erbB2 kinase 
activity. Lysates were collected at defined time intervals after adding lapatinib and 
western blots were probed with phospho-specific antibodies against erbB3 tyrosine 1280 
(PY1289) or erbB2 tyrosine 1248 (PY1248) to measure receptor dephosphorylation over 
time. Results show that HRG stimulation alone led to elevated levels of PY1289 on 
erbB3, which were maintained for up to 30 minutes after stimulation (Figure 5.1A). The 
plot in Figure 5.1B (blue line) shows that addition of 10 µM lapatinib caused rapid 
dephosphorylation of erbB2 PY1248 with a half-life (t ½) of ~14 seconds, comparable to 
reported values (Kleiman et al, 2011). The drop in erbB3 phosphorylation at PY1289 
demonstrated a lag, with a half-life of ~3.5 minutes (orange line, Figure 5.1B).   
A potential explanation for this lag is that erbB3 phosphorylation is sustained for 
short periods after erbB2 shutdown through its own improved autophosphorylation 
capacity. To evaluate this, we developed a Rule-based non-spatial model using 
BioNetGen (Faeder et al, 2009), that incorporated erbB3/erbB2 heterodimer and 
erbB3/erbB3 homodimer lifetimes determined by SPT (Steinkamp et al, 2014) and equal 
expression levels of both receptors, with 50% ligand bound erbB3. These and other 
parameters for our dimerization models are listed in Table 4, along with sources for each 
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Species ErbB2 ErbB3 ErbB3-EQ 
ErbB2.
ErbB2 
ErbB2.
ErbB3 
ErbB3.
ErbB3 
ErbB3EQ.
ErbB3EQ 
Diffusion 
Coefficient 
[um^2/s]1,2 0.0272 0.0310 0.0621 0.0150 0.0150 0.0185 0.0139 
Dimer On Rate 
[um^3/s]3 - - - 0.0034 0.0034 0.0034 0.0034 
No-Ligand Dimer 
Off Rate [1/s]1,2 - - - 0.4360 0.4360 0.4360 0.436 
Phosphorylation 
Rate [1/s]4,5 0.0730 0.00008 - - - - - 
Dephos. Rate 
[1/s]1 0.0725 0.0725 0.0064 - - - - 
Phosphorylation 
Multiplier 
[Unitless]1 2 0.53 varied - - - - 
Ligand Dimer 
Off Multiplier 
[Unitless]1 - - - - 0.9358 0.3 0.30 
Phos Diffusion 
Multiplier 
[Unitless]1 - - - 1 0.31 0.15 0.48 
Table 4: Parameters for ErbB2/3 and erbB2/ErbB3E933Q simulations. 1 – Experimental data in this 
paper, 2 – Steinkamp et al (2014), 3 – Shankaran et al. (2013),  4 – Kleiman et al (2011), 5 – Shi et al. 
(2010) 
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Figure 5.1: ErbB3 kinase activity and dephosphorylation (A) CHO cells expressing exogenous HA-
erbB2 and erbB3 were stimulated with 12 nM HRG for 2 minutes at 37oC and then treated with the 
erbB2 kinase inhibitor, lapatinib.  ErbB3 phosphorylated at Y1289 or erbB2 phosphorylated at 
Y1248 were detected using phospho-specific antibodies. Levels of phospho-receptors were 
normalized to the total receptor levels. (B) The normalized phosphorylation levels for erbB2 and 
erbB3 were plotted over time. Phosphorylation levels of both receptors were set to 1 for the two 
minute time point (maximum HRG stimulation).  Points were fit to a one-phase exponential decay 
curve to determine the dephosphorylation half-life (C) Western blot of immunoprecipitated erbB2 or 
erbB3 from CHO cells expressing ErbB2-mYFP (left two lanes) or ErbB3-mCitrine (right two lanes). 
The kinase activity of immunoprecipitated samples was then normalized to the levels of phospho-
receptor. Comparison of the relative kinase activity of erbB2 and erbB3 +/- HRG after 
normalization. ErbB2 kinase levels were set to 1. Data shown is the average of two independent trials 
+/- STDEV. (D) Phosphorylation reactions. Our model allows phosphorylation to occur between all 
dimer types. The phosphorylation rate (or kinase activity) is varied based on the dimer type. 
Unphosphorylated ErbB33 homodimers have an extremely low phosphorylation rate (Lemmon), 
while phosphorylated ErbB22 homodimers have a high phosphorylation rate (Steinkamp). We 
employ the phosphorylation shuffle mechanism used in Pryor et al. (2013). (E) Results from the 
BioNetGen model predicting a similar erbB3 dephosphorylation curve when erbB3 kinase remains 
active after lapatinib treatment. 
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value. In the simulation, phosphatase activity against both erbB2 and erbB3 were 
equivalent. Kinase activity for each monomer is governed by a set of rules, including 
dimerization competency based on ligand occupancy (for erbB3).  ErbB2 kinase activity 
was based upon published estimates for the basal rate (Kleiman et al, 2011), adjusted by a 
multiplier when phosphorylated (Shankaran et al, 2006). To estimate a corresponding 
multiplier value for erbB3, we compared catalytic activity in erbB2 immune complexes 
versus erbB3 immunoisolated from resting or HRG-stimulated cells (Figure 5.1C); results 
were normalized for loading based upon immunolabeling with the commercial pan-
reactive anti-phosphotyrosine antibody, PY20. In the simulation, lapatinib addition 
converted erbB2 kinase activity immediately to zero. ErbB3 kinase activity is insensitive 
to lapatinib (Shi et al, 2010). Therefore, in the simulation, erbB3 kinase activity is set at 
its multiplier of 0.56 of the phosphorylated erbB2 receptor phosphorylation rate, as long 
as erbB3 remains phosphorylated.   
Figure 5.1D illustrates some of the possible dimer configurations that occur in the 
simulation, to include homodimers of erbB2 (red-red), erbB3 (blue-blue) and erbB3-
erbB2 heterodimers (red-blue). During the simulation, there is a random assignment of 
the orientation of their cytoplasmic tails such that only one monomer is upregulated 
through contact of its N-lobe with the C-lobe of the activator. In this cartoon, ligand 
bound to erbB3 is represented by orange ovals while phosphorylation is indicated by 
colored features in the cytoplasmic tails. The arrows for each reaction depicted scale 
according to the phosphorylation rate associated with the dimer state of the specific 
reaction. Results of the simulation (Figure 5.1E) match well with the experimental 
results:  erbB2 phosphorylation drops off rapidly while erbB3 phosphorylation declines 
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slower due to encounters between erbB3 monomers that have been phosphorylated 
(primarily by erbB2) in a prior binding event.  
 
5.3.2 Single particle tracking of erbB3 and erbB2 diffusion indicates that receptors 
transiently reside in partially overlapping confinement zones  
Our spatial stochastic model includes the capability to consider the impact of 
membrane topography on diffusion-limited reactions between receptors. Our previous 
models relied on “snap-shot” images of erbB receptor distributions on fixed cell 
membranes, as observed by immuno-electron microscopy, to populate the 2D simulation 
landscape with domains that transiently confined receptors. Our next goal was to expand 
on this concept by using SPT data to estimate the area and shapes of confinement zones, 
as well as to address the possibility that erbB3 and erbB2 receptors might exhibit 
individual characteristics such as domain dwell time and distribution. For this portion of 
the study, we used data sets acquired using 2-color quantum dot (QD) tracking on stably 
transfected CHO cells, where erbB2HA was tracked with anti-HA-FAB-QD585 and erbB3 
was tracked with HRG-conjugated QD655. An example of trajectories from a single 
observation area is shown in Figure 5.2A, where three erbB2 and two erbB3 were tracked 
simultaneously (defined by color coding in the legend to Figure 5.2A).   
To analyze multiple datasets containing 2-color trajectories, we developed and 
applied a Domain Reconstruction Algorithm (DRA). The DRA converts dynamic 
trajectories to static spatial data that can be used to approximate the size and contours of 
confinement zones occupied by erbB3 and erbB2 on the CHO cell membranes. The 
algorithm is fully described in Chapter 2. In brief, SPT trajectory data is first sorted into 
two groups that reflect either the confined or freely diffusing state. For each point, a  
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Figure 5.2: (A) Sample of trajectories from SPT data showing overlap of ErbB2 and ErbB3 
receptors. This is the initial data form before DRA analysis. (B) Compiled ranks for all the points 
from the SPT data for ErbB2 and ErbB3. A bimodal distribution is apparent for both species. The 
local minimum between the two modes was used to estimate the cutoff rank to group the points into 
long and short points. Compilation of the ranks for SPT experiments where ErbB2 was tracked using 
QD-585 and ErbB3 was tracked using QD-655. (C and D) Characteristic length study used to 
determine the characteristic length for clustering. The average domain perimeter was calculated over 
a range of characteristics lengths. The minimum of the average domain perimeter was used to 
determine the optimal characteristic length. (C) is the characteristic length study for ErbB2 and (D) 
is the characteristic length study for ErbB3. (E) Box plots of characteristic lengths calculated during 
the characteristic length study for each SPT data file. ErbB2 characteristic length is compared to 
ErbB3. Using the Kruskal-Wallis Nonparametric Test, the characteristic lengths for ErbB2 and 
ErbB3 are statistically different, p value = 0.0000545. (F) Average total areas of domains and 
explored membrane for ErbB2 and ErbB3. The explored membrane was calculated using the DRA 
and setting the characteristic length to the localization error of the SPT experiments. While ErbB2 
domains appear to be larger on average, ErbB3 receptors tend to explore more of the open 
membrane. (G) Box plots of the ratio of domain area to explored membrane area for ErbB2 and 
ErbB3. Using the Kruskal-Wallis Nonparametric Test to compare between ErbB2 and ErbB3, the 
ratios are found to be statistically different, p value = 4.88e-10. 
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ranking system is applied that compares the preceding and subsequent jump sizes in the 
trajectories against one another. When these ranks are compiled and sorted into a 
histogram, a bimodal distribution becomes apparent (Figure 5.2B). The local minimum of 
the bimodal distribution is then used to determine a cutoff rank to separate the confined 
points from the freely diffusing points. The analysis was applied to 25 SPT data sets to 
generate the plots in Figure 5.2B. Results were comparable when applied to 13 SPT data 
sets where the QD probes were reversed as an important control measure since there is a 
slight difference in localization accuracy for the two classes of QDs (QD655 and QD585; 
Figure A.6). Based upon these results, a cutoff score of 6.5 was utilized for further DRA 
analyses.   
 An estimation of domain size was our next goal, incorporating a clustering algorithm 
based on work by Espinoza et al. (2012) that assigns a reasonable length parameter as the 
maximum distance between two points for them to be considered in the same cluster. The 
average perimeter of all the clusters in a single file is computed over a range of clustering 
characteristic lengths. This average perimeter is then compared across all the SPT 
tracking files. Figure 5.2C and Figure 5.2D show the average perimeter of domains for 
each characteristic length from the ErbB2 tracking data and ErbB3 tracking data, 
respectively. We defined the average characteristic length of the clusters for each 
receptor based on the local minimum in these plots. This local minimum corresponds to a 
minimum of domain perimeters. “Inflating” the perimeter points in each cluster by one-
half the characteristic length creates the final confinement shape and area.  
Based upon the DRA results, we are able to compare the membrane domain 
characteristics for ErbB2 and for HRG-bound ErbB3. We used the Kruskal-Wallis 
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nonparametric test, which does not assume any specific distribution type, only that the 
data sets being compared come from the same distribution. We find that the characteristic 
lengths for ErbB2 and ErbB3 domains are statistically different (p = 0.0000545). Box 
plots of the two data sets are shown in Figure 5.2E, confirming that the characteristic 
lengths for erbB2 and HRG-bound erbB3 clusters on CHO membranes are 57nm and 
30nm, respectively. We note that cluster size and total domain area for these receptors 
may vary in different cell types (Nagy et al, 2010; Yang et al, 2007).  
The next important membrane characteristic to take into account is the density of 
domains on the membrane. A hallmark of SPT experiments is the sparse labeling of 
receptors to allow for single particle resolution. One method to compensate for this sparse 
labeling is to estimate the total area of the membrane explored by labeled receptors from 
a single SPT data file and compare it to the total domain area of the membrane from the 
same SPT data file. To calculate the area of the membrane explored by a receptor, the 
DRA was used to analyze the SPT data using a characteristic length equal to the average 
localization error of the SPT experiment. Computing the ratio of Total Domain Area to 
the Total Explored Membrane Area allows the sparse SPT domain reconstruction 
information to be applied to the full cell membrane. As shown in Figure 5.2F,G, the ratio 
of Total Domain Area to Total Explored Membrane Area can be computed for each SPT 
data file for each receptor. This ratio can be compared between ErbB2 and ErbB3 to 
determine whether both receptors explore the same membrane space. Using the Kruskal-
Wallis Nonparametric Test, we find that this ratio is also statistically different between 
ErbB2 and ErbB3 (p = 4.88x10-10). The results of these two sets of tests suggest that 
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motion of ErbB2 and ligand-bound ErbB3 is differentially constrained within the 
membrane landscape.  
5.3.3 The simulation landscape is studded with overlapping domains consistent 
with experimental results.  
Figure 5.3 shows the final simulation space created using the cumulative information 
from the DRA analyses. The simulation space includes a defined number of ErbB2 and 
ErbB3 receptors, as well the domain spaces in which they are transiently confined. 
Density of receptors was determined by calculating the number of receptors per µm2 of 
membrane surface in a CHO cell, reported to be 588 µm2 (Miyagi & Maruyama, 2010). 
Given our estimates of ~500,000 of each receptor species in these stably transfected cells, 
we derive a receptor density of ~850 copies of each receptor per 1 µm2 of membrane – or 
a total of 1700 receptors/µm2. During the stochastic simulations, every receptor is 
accounted for individually. This level of detail in simulations significantly increases the 
computational costs when running simulations. To reduce the computing time, the 
simulation space was converted to a total surface area of 0.1 µm2, equating to ~170 of 
each type of receptor.  
Note that while the domains are statistically different, analysis of the single particle 
tracking data also revealed an overlap between the two types of domains. This result is 
consistent with the findings from our prior immuno-electron microscopy study (Yang et 
al, 2007). Next, the ratio of the Domain Area to Explored Membrane Area ratio was used 
to determine the amount of domain cover for the desired surface area. The reconstruction 
of these irregular domains is depicted by blue (erbB2) and orange (erbB3) contours in 
Figure 5.3. During the simulations, receptor species exhibit no preference to enter their 
125 
 
Figure 5.3: Reconstructed Simulation Space (A) Simulation Space Constructed based on the DRA 
analysis. Domains from a SPT data file were used, and then domains from the same file were added 
until the domain area to explored membrane area ratio was met. The receptor density was calculated 
using the approximate number of receptors per cell and average surface area of a CHO cell, then 
scaling to the simulation space area. 
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respective domains but a penalty for escape is imposed such that at steady state receptors 
occupy free and domain spaces according to the DRA cutoff score (65% in domains, 35% 
unconstrained).    
5.3.4 Receptors cycle repeatedly through heterodimer and homodimer reactions.  
Results of spatial simulations are shown in Figure 5.4. In Figure 5.4A,B, the relative 
ratios of erb2 and erbB3 were equal and 50% of the erbB3 were prebound to ligand at the 
start for simplicity. By illustrating the dimer and phosphorylation events for a single 
erbB2 monomer (Figure 5.4A) or HRG-bound erbB3 monomer (Figure 5.4B), the plots 
illustrate the essential stochasticity of the system. The erbB2 in 4A spends time as a 
monomer, as an erbB2-erbB2 homodimer and as an erbB2-erbB3 heterodimer, with the 
phosphorylation state of each monomer in the pairs tracked throughout. Similarly, the 
erbB3 receptor in 4B cycles through monomer, homodimer and heterodimer states. Due 
to the more stable lifetime, erbB3 homodimers are a predominant feature.  
Simulations were also performed varying the ratios of erbB2 to erbB3, as well as the 
ligand dose. In Figure 5.4CD, a scenario of 20-fold excess erbB3 over erbB2 was 
considered. Here, the representative plot of an erbB2 shows it to cycle predominantly 
through heterodimer reactions, with short durations as an unphosphorylated monomer. 
The plot of one of the erbB3 species in the simulation follows it through at least one 
binding event with erbB2, leading to dual phosphorylation, followed by relatively stable 
periods as a homodimer and short periods as a monomer. Finally, the plots in Figure 
5.4E,F show results for the case of equal ratios of receptors but a lower ligand occupancy.  
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Figure 5.4: Receptor States over time. (A and B) State changes for ErbB2 and ligand bound ErbB3, 
respectively, for simulations with equal amounts of ErbB2 and ErbB3, and 50% ligand bound ErbB3 
present. (C and D) State changes for ErbB2 and unliganded ErbB3, respectively, for simulations with 
1/20th the amount of ErbB2 to ErbB3, and 50% ligand bound ErbB3 present. (E and F) State changes 
for ErbB2 and unliganded ErbB3, respectively, for simulations with equal amounts of ErbB2 and 
ErbB3, and 15% ligand bound ErbB3 present. 
   
128 
5.3.5 Steady state analysis of erbB phosphorylation reactions underscores the 
dependency of erbB3 activation on erbB2 and a potentially significant role 
for erbB3 kinase 
Figure 5.5 presents summary data for a series of spatial stochastic simulations, 
varying conditions such as receptor ratio and dose. The graphs report the total 
phosphorylation state of each species and the kinase species responsible for the 
transphosphorylation reactions. As shown in Figure 5.5A, when erbB3 is the only species 
in the simulation (total 170), there is no phosphorylation. When the simulation 
parameters are set to equal erbB3-erbB2 levels (total 340), measurable erbB3 
phosphorylation results after encounters between erbB3 that “flux” to the upright position 
and bind erbB2. The number of ErbB3 phosphorylation events at 15% and 50% ligand 
occupancy are 40 and 45, respectively. At 100% ligand occupancy, the number of 
phosphorylation events involving an ErbB3 receptor nearly doubles, to 77 events.  
Results in Figure 5.5BC show the relative contributions of each receptor for 
transphosphorylation of the same species (while in homodimers) or of the opposite 
species (while in heterodimers) is a dose-dependent. For example, Figure 5.5B shows 
erbB2 homointeractions drive most of the erbB2 and erbB3 phosphorylation events when 
there are equal numbers of both receptors. By comparison, erbB3’s catalytic activity 
mediates 10-24% of erbB2 phosphorylation events and less than 5% of the erbB3 
phosphorylation events. Figure 5.5C reports results when erbB3 outnumber erbB2 20-
fold. Here erbB2 densities are low and erbB homodimerization/transphorylation events 
are infrequent. However, erbB2’s phosphorylation of erbB3 is a critical step, since it 
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governs the erbB3 activation step. ErbB3 receptors do not start phosphorylating other 
receptors until they 
 
Figure 5.5: Spatial Stochastic Simulation Results. (A) ErbB3 phosphorylation events. When ErbB2 is 
not present, ErbB3 receptors fail to phosphorylate other ErbB3 receptors. As the amount of liganded 
ErbB3 increases, the number of ErbB3 phosphorylation events also increases. (B and C) 
Phosphorylation events by activator species for varying amounts of liganded ErbB3. (B) Equal 
amounts of ErbB2 and ErbB3. Each bar in a group represents a ligand percentage for ErbB3, 0%, 
15%, 50%, and 100% respectively. The majority of ErbB3 phosphorylation comes from ErbB2. 
ErbB3 receptors only phosphorylate other receptors once phosphorylated themselves. (C) Low 
amount of ErbB2 receptor (5%) compared to ErbB3 receptors. Each bar in a group represents a 
ligand percentage for ErbB3, 0%, 50%, and 100% respectively. Majority of ErbB3 phosphorylation 
still comes form ErbB2, however there is higher activity in ErbB3 homodimers. 
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have been phosphorylated first. Activated erbB3 is responsible for the large majority of 
phosphorylation events where there is 0 or 50% ligand occupancy. Note that, at 100% 
ligand occupancy, erbB3-erbB3 transphosphorylation is not significant. This is explained 
by the long lifetime – and the likelihood that repeated interactions of erbB3 pairs in 
homodimers renders it less likely for a productive “activating” dimerization event with 
erbB2.     
Note that elevated basal levels of erbB2 phosphorylation were noted previously in 
cultured cells overexpressing erbB2, along with a slight reduction upon stimulation with 
HRG (Steinkamp et al., 2014; Yang et al., 2007). Thus the simulation results for erbB2 
phosphorylation point to a high degree of erbB2 homodimerization and activation at high 
surface density and are in good agreement with experimental results.  
5.3.6 Computational approaches offer tractable methods to evaluate impact of 
mutations on erbB3-mediated signaling.   
We next extended out model to look into how mutations that impact erbB3 activation 
would impact these dynamics. To replicate a mutation in erbB3 that causes the kinase 
domain to become more active, we added another multiplier to the model. This multiplier 
is applied on top of the experimentally determined multipliers for erbB2 and erbB3. In 
the simulation, when a mutant erbB3 is chosen to be an activator, the multiplier is applied 
to the phosphorylation rate. This simulates an increase in activity to the C-lobe of the 
receptor. 
In Figure 5.6AB, the impact of the multiplier on the percent phosphorylation of erbB2 
and erbB3 over time is shown. These simulations used equal amounts of erbB2 and 
erbB3, with a low amount of ligand-bound erbB3 present (15%). The simulated mutation 
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Figure 5.6: Gain of Function Impact on Receptor Phosphorylation for Low Amounts of Ligand. (A 
and B) Percent receptor phosphorylation over time for ErbB2 and ErbB3, respectively. (A) Initially 
the GOF mutation has a negative impact on ErbB2 phosphorylation. Overall, the GOF mutation 
does not show a large impact on the amount of ErbB2 phosphorylation. (B) ErbB3 phosphorylation 
increases slightly with a modest increase in phosphorylation rate multiplier, and jumps drastically 
with a multiplier of 10. (C) Phosphorylation events by activator species for increasing 
phosphorylation rate multipliers. Each bar in a group is a specific multiplier, 1, 2, 10, and 100, 
respectively. Each group indicates what species the receiver was and what species the activator was 
for a specific phosphorylation event. When the multiplier reaches 10, ErbB33 homodimers begin to 
be active without needing to interact with ErbB2 first. 
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appears to have little impact on erbB2 phosphorylation, however erbB3 phosphorylation 
is greatly impacted. Figure 5.6C shows the relative distribution of phosphorylation events 
broken into groups based on which receptor was the activator and which receptor was the 
receiver. Each bar in a group is for a multiplier of 1, 2, 10, and 100, respectively. Overall, 
this figure shows that erbB phosphorylation events increase with the multiplier, as would 
be expected. An interesting observation highlighted by this figure is that when the 
multiplier reaches 10, erbB3 begins to overcome its reliance on erbB2 for activation, as 
indicated by the unphosphorylated erbB3 contributing to the phosphorylation of other 
erbB3 receptors.   
5.3.7 Substitution at erbB3-E933Q is a gain-of-function mutation that amplifies 
the PI3 kinase/AKTsignaling pathway. 
We discovered a novel amino acid substitution mutation in one of the erbB3 alleles in 
the widely-used SKBR3 breast cancer cell line (Figure A.7).  To evaluate the possibility 
that this was an activating mutation, CHO cells were transfected with vectors for 
expression of mCitrine-fusion proteins bearing either erbB3WT or erbBE933Q. After 
selection to ensure comparable surface expression of the two fluorescent erbB3-fusion 
proteins, cells were challenged with a series of HRG doses, lysed, and subjected to SDS-
PAGE and western blotting to measure levels of erbB3 phosphorylation at PY1289. 
Robust phosphorylation of mutant erbB3 was consistently detected at the lowest dose of 
HRG, with 2 to 3 fold stronger phosphorylation than wild type erbB3 at suboptimal 
ligand concentrations (Figure 5.7A).   
We reasoned that the robust phosphorylation of ErbB3E933Q in response to low doses 
of ligand might amplify downstream signaling by increased recruitment of Class I A  
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Figure 5.7: The gain of function mutant erbB3 E933Q demonstrates increased sensitivity to ligand 
and increased kinase activity when expressed in CHO cells. (A) CHO erbB3E933Q-mCitrine cells have 
high levels of erbB3 phosphorylation even at the lowest dose of HRG (3 nM). (B) 
Immunoprecipitated erbB3 E933Q co-immunoprecipitates more p85, a PI3kinase subunit, in the 
presence of ligand. (C) Increased levels of phosphorylated Akt that lead downstream of PI3kinase 
indicates an overall upregulation of the erbB3 signaling network in CHO erbB3E933Q-mCitrine cells. 
(D) Immunoprecipitated erbB3E933Q has higher basal and ligand-dependent kinase activity in the in 
vitro kinase assay compared to erbB3wt. 
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phosphotidylinositol-3-kinase (PI3K). Cells expressing erbB3WT or erbB3E933Q were 
stimulated over the same range of doses, followed by immunoprecipitation of erbB3 from 
cell lysates and western blotting to measure co-precipitated p85 regulatory subunits of 
PI3K. The amount of p85 recovered in ErbB3 immune complexes paralleled the degree 
of phosphorylation of ErbB3 in the CHO transfectants, with more p85 recovery at low 
ligand doses for ErbB3E933Q than for ErbB3WT (Figure 5.7B). Cells expressing ErbB3E933Q 
also had a more robust activation of the downstream serine/threonine kinase, AKT, as 
measured by phosphorylation of AKT S473 (Figure 5.7C). The phosphoAKT/total AKT 
ratio was higher at times after HRG stimulation of CHO cells expressing ErbB3E933Q, 
compared to cells expressing the wildtype receptor. Figure 5.7D reports results of in vitro 
kinase assays for erbB3WT and erbB3E933Q immune complexes, isolated independently 
from the cell lysates of the two transfected CHO cell lines after 2 min challenge with 
12nM HRG. Greater activity is shown for mutant erbB3, despite modest differences in 
phosphorylation at this dose. Together, these results indicate that the E933Q substitution 
is an example of a class of gain-of-function mutations (Jaiswal et al, 2013) for which the 
mathematical model might provide valuable insight.  
As a prelude to simulations, we applied our existing experimental methods to 
determine if the E933Q mutation might alter basic parameters in the model such as the 
diffusion rate, homodimer lifetime or dephosphorylation kinetics. Results of these 
experiments are shown in Figure 5.8A-D. Liganded erbB3 homodimers are slow <0.05 
for all pairs composed of either WT or E933Q forms (Figure 5.7A). However, we 
observed slightly faster monomer diffusion coefficients for erbB3E933A, whether co- 
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Figure 5.8: Single particle tracking of HA-erbB3E933Q. (A) Diffusion by state comparing HA-erbB3 
E933Q to HA-erbB3 wt. E933Q shows faster diffusion when separated or co-confined, but both 
unliganded and liganded interacting pairs diffuse slower than interacting HA-erbB3 wt pairs. (B) 
Unliganded dimer pairs are short lived as shown by the histogram of dimer lifetimes. Unliganded 
receptor pairs have an off rate of 0.42 sec-1 that is comparable to the wild type value. (C) Liganded 
HA-erbB3 E933Q receptor pairs are longer lived as seen with the wildtype receptor and have an off 
rate of 0.19 sec-1 that is equivalent to the wild type value. (D) Normalized phosphorylation levels for 
erbB3wt versus erbB3E933Q were plotted over time. As in Figure 5.4B, phosphorylation levels of both 
receptors were set to 1 for the two minute time point (maximum HRG stimulation).  Points were fit to 
a one-phase exponential decay curve to determine the dephosphorylation half-life. 
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confined in domains or widely separated (Figure 5.7A). The off-rate of 0.41/sec for 
unliganded erbB3E933Q homodimers (Figure 5.7B) is comparable to previously measured 
values for erbB3WT (Steinkamp et al, 2014), as is the 2-fold slower off-rate of 0.19/sec for 
liganded pairs (Figure 5.7C). The plot in Figure 5.8D (derived from data shown in 
Supplemental Figure 5.4) shows that dephosphorylation kinetics for WT and E933Q 
forms of erbB3 are the same.      
5.4 DISCUSSION 
Here we have presented a combination of experimental and quantitative methods to 
explore the relationship between erbB2 and erbB3, as well as set a framework for 
evaluation of the growing list of erbB3 mutations. Starting from observations in the 
experimental data about receptor dynamics and membrane landscape, we were able to 
develop a new algorithm to deduce confinement zone shapes to be used in conjunction 
with a spatial stochastic model. Our spatial stochastic model was then able to not only 
reproduce the receptor dynamics observed in experiments, but also give further insight 
into the complex interplay between erbB2 and erbB3. 
Previous work in both the experimental and modeling fields have given great insights 
to the erbB receptor family. Until recently it was believed that the kinase domain of 
erbB3 was completely dead. Shi et al. (2010) reported weak kinase activity for erbB3 
cytoplasmic tails tethered to liposomes. In conjunction with evaluating erbB2/3 
interactions by single molecule methods, we made the novel observation that erbB3 
kinase activity was significantly upregulated in an erbB2-dependent manner and linked to 
its phosphorylation state (Steinkamp et al 2014). Although the putative phosphorylation 
site that activates erbB3 has not yet been identified, the erbB2-mediated activation of 
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erbB3 is a major assumption in our mathematical model. We use spatial stochastic 
modeling to extend that erbB2/3 analysis one step further, quantifying the relative 
contributions of erbB2 and erbB3 based upon their dependency upon asymmetric 
orientation of their kinase domains and their relative phosphorylation states. Our model 
incorporates the relative dimer lifetimes and diffusion rates for each species, showing that 
the more transient nature of ErbB2-3 heterodimers is a critical factor in the signaling 
process.  
The results of our model indicate that erbB2 is critical to erbB3 activation. Dimer 
lifetime was also highlighted as an important factor in phosphorylation. ErbB3 
homodimers are extremely stable causing the homodimer to become a hindrance for 
erbB3 receptor phosphorylation. Simulations showed that erbB3 receptors quickly 
formed homodimers with one another before having the chance to interact with erbB2. 
This caused a lack of phosphorylation capacity between erbB3 receptors, since there was 
no activation by erbB2. The erbB3 receptors that were able to interact with erbB2 
receptors tended to interact again with other erbB2 receptors because the other erbB3 
receptors were tied up in unproductive homodimers. 
Our simulation results are in good agreement with the experimental data, giving 
confidence to broaden the model beyond wt ErbB3 interactions. As a preliminary 
exploration, we implemented a gain of function mutation that caused an increase in 
activity of the C-lobe of the mutant erbB3 receptor. Varying the intensity the mutation 
has on the phosphorylation rate gave insight into how this mutation would impact erbB2 
and erbB3 activation and reliance on one another. Our discovery of the E933Q erbB3 
gain of function mutation gave us experimental data to relate our mutation simulation to 
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real experimental data. Extending our model to look at the impact of erbB3 mutations is a 
characteristic of the experimental-modeling handshake. We can now use our model to 
make predications about how different mutations will affect the dynamics and kinetics 
between erbB2 and erbB3 receptors, giving experimentalists a good idea of which 
mutations may be advantageous to investigate further. Interesting mutation to study in 
future work, related to receptor activation, could cause a change in receptor conformation 
stability, longer or short dimer lifetimes, and/or different kinase domain activation levels. 
 
5.5 MATERIALS & METHODS 
5.5.1 Experimental 
5.5.1.1 Determination of the dephosphorylation rates for erbB2 and erbB3  
CHO cells stably transfected with a pcDNA3.1- HA-erbB2 construct were transiently 
transfected with a pcDNA3.1-erbB3-GFP construct and seeded into six well dishes. Two 
days after transfection, cells were serum starved for up to four hours, and then stimulated 
for two minutes at 37oC with 12 nM (75 ng/ml) heregulin-β (US Biologicals). Cells were 
then treated with 10 µM lapatinib (Santa Cruz) to inhibit erbB2 kinase activity and 
harvested 1-30 minutes after HRG activation. Controls were harvested at time 0 (no HRG 
stimulatiom), time 2 min. (HRG stimulation –lapatinib) and time 30 (HRG stimulation – 
lapatinib). Cells were harvested in lysis buffer and total protein levels were determined 
by BCA assay. 20 ug of total protein/sample was run on an acrylamide gel and 
transferred to nitrocellulose membranes using the iBlot system (Invitrogen). 
Phosphorylated erbB3 was detected using a PY1289-specific rabbit polyclonal antibody 
(Cell Signaling) and total erbB3 protein was detected using an anti-erbB3 monoclonal 
rabbit antibody (Cell Signaling). Phosphorylated erbB2 was detected using a PY1248-
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specific rabbit polyclonal antibody (Cell Signaling) and total erbB2 was detected using an 
anti-erbB2 monoclonal mouse antibody (Thermo Scientific). Secondary anti-rabbit and 
anti-mouse-HRP were from Santa Cruz Biotech. Blots were revealed using the 
SuperSignal West Pico Chemiluminescent Substrate (Pierce) and detected on a 
ChemiDoc Gel Imager (BioRad). Bands were quantified using ImageLab quantification 
software (BioRad). Data was plotted and fit to a one phase exponential decay curve using 
GraphPad Prism5. The dephosphorylation half-life was calculated from this curve. 
5.5.1.2 Immunoprecipitation  
CHO cells expressing ErbB constructs were serum starved for up to 4 hours. CHO 
ErbB3wt-mCitrine were stimulated with 12 nM HRG for 2 minutes.  All cells were 
washed with ice cold PBS on ice and lysed with cold NP-40 lysis buffer (Yang et al, 
2007). Protein concentrations in cleared lysates were measured by BCA assay (Pierce, 
Rockford, IL). Supernatants were precleared with Protein A-beads (Amersham GE 
Healthcare, Chicago, IL) and normal rabbit IgG (Cell Signaling) followed by overnight 
incubation at 4°C with primary antibodies against erbB2 (RB9040, Neomarkers) or 
erbB3 (sc285, Santa Cruz). Proteins in washed immune complexes were either 
resuspended in reaction buffer for the in vitro kinase assay or denatured and separated by 
SDS-PAGE, transferred to nitrocellulose membranes, and probed with anti-PY20 (Sanat 
Cruz) to detect all phosphorylated proteins in the IP or with primary antibodies against 
erbB2 or erbB3 and HRP-conjugated secondary antibodies. Blots were revealed and 
detected as above.   
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5.5.1.3 Sequencing of erbB3 from SKBR3 cells 
mRNA was extracted from SKBR3 cells using the RNeasy Mini Kit (QIAGEN, 
Chartsworth, CA). Pairs of primers were designed to span the ErbB3 tyrosine kinase 
domain:  5’-CTC TGG ACC CCA GTG AGA AG-3’ and 5’-GGG AGT ACA AAT TGC 
CAA GG-3’; 5’-GGT CAG CCA CAC CAA AAT CT-3’ and 5’- CAG ATA CCG TGG 
TGG GTC TC-3’. After amplification using a QIAGEN One-step RT-PCR kit, PCR 
products were separated by agarose gel electrophoresis, extracted with the QIAquick gel 
extraction kit, and sequenced using the above primer sets.   
5.5.1.4 In vitro kinase assay 
The in vitro kinase assay was performed as detailed in (Steinkamp et al, 2014).  
Briefly, CHO cells expressing either erbB3wt-mCitrine or ErbB3E933Q-mCitrine were 
serum starved then stimulated for 2 minutes with 12 nM HRG-β for maximal erbB3 
activation. Lysates were immunoprecipitated with the anti-ErbB3 polyclonal rabbit 
antibody, sc-285 (Santa Cruz Biotech). 
5.5.1.5 Single particle tracking 
The E933Q mutation was introduced into an expression vector pcDNA3.1-HA-erbB3 
and stably transfected into CHO parental cells. CHO HA-erbB3E933Q cells were sorted 
for high expression after labeling with an anti-HA-Alexa488 antibody (Cell Signaling). 
Single particle tracking experiments were performed as in (Steinkamp et al, 2014). 
Briefly, CHO HA-erbB3E933Q cells were plated in 8-well chambers (LabTek) the day 
before imaging. Heregulin was biotinylated using NHS-ester chemistry with Biotin-XX-
SE (Invitrogen) and purified from free biotin on a G25 column by gravity flow. 
Biotinylated HRG and biotinylated anti-HA Fab were conjugated to streptavidin QDots 
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(Invitrogen) QD655 and QD585, in a 1:1 molar ratio in PBS + 0.1% BSA by rotating for 
1 hour or more at 4oC. Cells were serum starved for 1 hour and then moved into imaging 
medium, Tyrodes buffer supplemented with 1% BSA and 20 mM glucose. Cells were 
labeled with 100 pM QD-anti-HA Fab for 15 min. or with 20 pM QD-HRG for 5 min 
before washing and imaging at 20 frames/s on an Olympus IX71 inverted microscope 
with a 60× 1.2 N.A. water objective. An objective heater (Bioptechs, Butler, PA) was 
used to stabilize chamber temperature at 34-35 °C. A mercury lamp with a 436/10 nm BP 
excitation filter provided wide-field excitation. Emission was collected by an electron 
multiplying CCD camera (Andor iXon 887) using a DuoView image splitter (Optical 
Insights) to image both the QD585 (585/20 BP) and QD655 (655/40 BP) probes. Image 
processing was performed using Matlab (The MathWorks, Inc., Natick, MA) functions in 
conjunction with the image processing software DIPImage (Delft Univ. of Technology). 
Single molecule localization, trajectory elongation, and 2-channel image registration 
were performed as previously described (Low-Nam et al, 2011; Smith et al, 2010; 
Steinkamp et al, 2014).  
5.5.1.6 State determination of receptor pairs  
Receptor interactions were identified using a three-state Hidden Markov Model 
(HHM) (Low-Nam et al, 2011). The separation between two color QD pairs (one QD585 
and one QD 655) is determined and pairs that are less than 1 micron apart are considered 
candidate pairs. Distribution of the displacements between the QDs is modeled by a zero 
mean Gaussian distribution in each (x,y) dimension using σdimer and σdomain respectively.  
The value σdimer for erbB3 was estimated by combining information from EGFR crystal 
structure measurements, homology modeling, and the size of QDs (Steinkamp et al, 
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2014). For the Separated state in the model, the probability density is calculated as a 
function of the observed distance in the previous frame and a characteristic diffusion 
constant. Rate constants are determined by maximizing the likelihood over all 
interactions of two QDs for a specific condition. Standard errors for parameters are 
calculated as (Hi,i-1)-0.5 where H is the Hessian matrix of the negative log-likelihood and 
i denotes one of the estimated rate constants. The Viterbi algorithm (Forney, 1973) is 
used to identify the most likely state within individual QD interactions. Diffusion by state 
was calculated based on the mean square displacement of all tracks per condition. 
5.5.2 Modeling 
5.5.2.1 Modeling Biological Assumptions 
Our model assumes that erbB3 dimerization occurs through conventional interactions 
between dimerization arms of the extracellular domains (Yarden & Sliwkowski, 2001).   
This premise is supported by evidence that blockade of the erbB2 dimerization arm with 
2C4 antibodies ablates its transactivation of erbB3 (Steinkamp et al, 2014; Zhang et al, 
2009), as well as homology models of erbB3 based upon the structure of EGFR (not 
shown). We do not formally consider the possibility that erbB3 may engage in homo-
interactions through other interfaces (Zhang et al, 2012), due to the lack of available 
kinetic parameters. We also do not consider the intriguing possibility for higher order 
oligomers (Kani et al, 2005; Kozer et al, 2013), since the sparse labeling of SPT renders 
it highly unlikely that such events can be captured and measured using our available 
technologies.      
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5.5.2.2 Non-spatial modeling of dephosphorylation kinetics 
We used BioNetGen to create a non-spatial version of our model to investigate the 
dephosphorylation kinetics. Dephosphorylation is a space independent reaction, therefore 
we used a non-spatial model to allow us to look over a longer period of simulation time 
to see the impact. The parameters and reaction network are the same as the parameters 
used for the spatial stochastic model. 
5.5.2.3 Spatial stochastic model for homo and heterodimerization. 
Domain Reconstruction Algorithm. To score each point in each trajectory from a 
single file and channel, the length of the jump is compared for varying step sizes. 
Compiling and comparing these scores against one another reveals a bimodal distribution 
in the scores. The local minimum of the modes is used as a cutoff score. This score 
separates the trajectory points in to confined points and free points. This step takes the 
dynamic SPT data and creates a subset of static data. The slow points are considered to 
be representative of confined areas on the membrane. The slow points are then clustered 
to determine confinement areas or domains. A characteristic length study is first done to 
determine the characteristic length that best describes the distance between points in a 
cluster.  This length is varied from 0nm to 1000nm. Over this range the average perimeter 
of the clusters is computed. The perimeter reaches a local minimum over this range. The 
characteristic length where this minimum is reached is used as the characteristic length. 
The characteristic length is then used to create the clusters. Each cluster is then used to 
create a contour that will define the final confinement area. The contour is created by 
“inflating” the cluster. The outside points of the cluster are extended outward by ½ the 
characteristic length. This allows some give in the confinement area to consider that these 
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points could have bounced off a structure and would not have sat directly next to the 
confining structure. The extended points are then connected to create a contour. This is 
the final domain structure. 
Reaction Network Generation. Our reaction network definition begins with the 
interaction model proposed by Steinkamp et al. (2014). In this model, ErbB2 receptors 
dimerize with ErbB3, allowing ErbB2 to activate (Phosphorylate) ErbB3. These dimer 
interactions appear to be transient, and quickly fall apart. The activated ErbB3 receptor is 
then free to homo-dimerize with another ErbB3. The activated state of the ErbB3 allows 
it to illicit kinase activity from the unphosphorylated ErbB3 causing activation and 
therefore phosphorylation. We extend this model slightly by implementing the 
asymmetric phosphorylation model used in our previous ErbB1 activation paper (Pryor et 
al, 2013).  
Receptor Diffusion and Reaction Kinetics. Receptors diffuse according to 
Brownian motion through a combination of specific diffusion coefficients calculated 
from SPT experiments and normally distributed random variables. Diffusion is 
interrupted when a membrane domain is encountered in the receptors path.  To account 
for this obstacle two tolls are considered, entrance into the domain and exit from the 
domain. The entrance and exit rates of the domains are converted to probabilities using 
the simulation time-step. When a receptor attempts to enter or exit a domain, the relevant 
probability is evaluated and the receptor is allowed to either leave the domain or the 
receptor is reflected back into the domain. 
Receptor reactions are treated differently depending on their reaction order. 1st order 
reactions are treated similarly to the domain entrance/exit tolls. The reaction rate is 
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converted to a probability using the time-step and evaluated. If the probability is met, the 
reaction occurs, if it is not met, no reaction occurs. Second order reactions are a bit more 
complicated. These reactions are diffusion limited, and therefore the spatial aspect of the 
model must be taken into consideration. The solution to this problem, proposed by 
Andrews and Bray (2004), is to use a binding radius and unbinding radius, if the reaction 
is reversible (Andrews & Bray, 2004). The binding radius is a function of simulation 
time-step, receptor diffusion coefficients, and receptor on rates. At the end of a receptors 
diffusion step, the area around the receptor bounded by the binding radius is scanned for 
other receptors. If an available receptor is found within the binding radius, a reaction 
occurs. There is no probability associated with second order reactions; likelihood of 
reaction is taken into consideration through the binding radius. If a reverse reaction is 
possible, an unbinding radius is implemented. The length of the unbinding radius is 
picked such that an unrealistic number of repeated interactions are minimized. Andrews 
and Bray suggest the binding to unbinding radius ratio be 20% as a starting point. 
5.6 NOTES 
This work is currently being prepared for submission for peer review. 
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CHAPTER 6: DISCUSSION 
6.1 SUMMARY 
The focus of this dissertation was to integrate data from live cell imaging into a 
spatial stochastic model to be used to study the kinetics and dynamics of the ErbB family 
of tyrosine kinase receptors. We started by building a spatial stochastic model using an 
EM image as our simulation space and parameters derived from SPT tracking of ErbB1 
receptors. We were able to validate our model by replicating the SPT data. We used that 
model to investigate how membrane landscape and receptor interactions impact receptor 
state in ErbB1 receptors. We then moved on to analyze SPT even further to uncover 
anomalous diffusion characteristics and how the membrane landscape related to those 
dynamics. Taking the SPT analysis a step further, we developed an algorithm to 
reconstruct confinement zones directly from the SPT data. Finally, we used the 
reconstructed confinement zones from ErbB2 and ErbB3 tracking data to create a 
simulation space for our stochastic model, while extending the spatial stochastic model to 
a heterogeneous population to study ErbB2 and ErbB3 interaction dynamics. 
6.2 SIGNIFICANCE 
Our spatial stochastic model agrees well with existing experimental data, and enabled 
us to look deeper into the mechanisms behind erbB receptor signaling beyond current 
experimental capabilities. Through each of our modeling studies we were able to 
highlight the importance of the cellular membrane landscape and how it impacts receptor 
activation for signaling. We also characterized the distribution of confinement zones on 
the membrane landscape and the size and shape of the confining areas present, gaining 
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important insight as to what to type of structures could contribute to the confinement 
zones.  
6.2.1 Spatial Stochastic Model 
Our spatial stochastic model directly used SPT experimental data without the need to 
do any parameter fitting, giving our model a very strong connection to the biology it was 
built to simulate. Our model is extremely useful for studying how different protein 
dynamics, typically studied without the ability to consider the impact of one another, 
come together. This view allows us to get a more comprehensive look at how all the 
factors impact receptor signal initiation. Our model nicely lends itself to be built upon 
further in the future to either study erbB receptors more in-depth or branch out to a 
different transmembrane protein system.   
6.2.2 ErbB1 Receptor State Dependence on Membrane Landscape 
Through our ErbB1 study, we showed that spatial aspects of the cellular membrane 
are a critical element to take into consideration when investigating membrane receptor 
dynamics. These findings are very important for the membrane and erbB receptor 
research communities, as this is a source of debate. We show that confinement zones on 
the membrane create small zones of high-density receptors, causing an increase in 
receptor interactions. These interactions lead to higher dimer phosphorylation and 
activation, impacting the extent of down stream signaling in cells.  
6.2.3 Anomalous Diffusion, Membrane Landscape, and Domain Reconstruction 
Building off the conclusion of the ErbB1 study, we decided to delve deeper into the 
cellular membrane landscape. Analysis of SPT tracking data of FcεRI receptors revealed 
non-Brownian motion features. We found that these diffusion characteristics could be 
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contributed to a membrane landscape consisting of attractive domains, but not for a 
landscape made up of corrals. Insight into the size and distribution of these confinement 
zones is useful for future work determining the actual structure or structures that cause 
these diffusion anomalies in cell membranes. 
6.2.4 ErbB2 – ErbB3 Interactions and ErbB3 Gain of Function Mutation 
In our ErbB2/3 study, we employed a combination of experimental and modeling 
methods. We were first able to use our SPT analysis to show that erbB2 and erbB3 
receptors have significantly different diffusion characteristics. Building from the previous 
ErbB3 kinase activity study by Steinkamp et al. (2014), we showed that erbB3 can 
sustain activation after being activated by erbB2, indicating erbB3 receptors have kinase 
activity, and were able to relate erbB2 phosphorylation to erbB3 phosphorylation to 
calculate a phosphorylation rate multiplier for erbB3. These results alone have an 
enormous impact on the current understanding of erbB3 activation and signaling.  
Applying this information to our spatial stochastic model, we were able to confirm the 
dependence of erbB3 activation on erB2 interactions. We also concluded that the stability 
of erbB3 homodimers is actually an obstruction to erbB3 activation. 
Agreement between the erbB2/3 experimental results and our model provide a high 
level of confidence in our model predictions. We decided to extend the model beyond wt 
interactions, and investigate how a gain of function mutation in the kinase tail of erbB3 
would alter erbB2 and erbB3 phosphorylation. We found that, while erbB2 
phosphorylation was not drastically impacted, erbB3 phosphorylation showed a strong 
dependence on the kinase domain activity. We were also able quantify how strong the 
gain of function would have to be to eliminate erbB3 dependence on erbB2 activation. 
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We discovered an E933Q amino acid swap gain of function mutation in erbB3, which 
allowed us to study the kinetics and dynamics of the mutated receptor. We show that this 
mutation does not impact erbB3 homodimer lifetimes; we therefore conclude that this 
mutation may cause an uptick in kinase activity, allowing us to compare out experimental 
results with our model predictions. The ability of the model to predict outcomes of 
mutations provides great insight in to what types of mutations could be advantageous to 
study more in-depth.  
6.3 FUTURE DIRECTIONS 
Our spatial stochastic model can continue to be used and extended for deeper research 
into erbB receptor dynamics, or can be modified to study an entirely different membrane 
protein system. The Domain Reconstruction Algorithm can also be used to study and 
characterize other proteins whose diffusion can be tracked individually, in real time. Here 
we discuss a few possibilities for the future use of our model.  
6.3.1 Current Path Forward: ErbB3 Mutation Study 
In our erbB2/3 study, we used our model to investigate a mutation in the kinase 
domain of erbB3. We propose, and are currently in the process of, using the model to 
look into other gain of function mutations for erbB3. Jaiswal et al. (2013) compiled a list 
of known erb3 mutation, we add our E933Q gain of function mutation to this list. We can 
then use our model to investigate mutations that have yet to be discovered. The model 
will give insight into the type of gain of function mutation that will have the greatest 
impact on erbB3 activation. These mutations can then be replicated in real erbB3 
receptors and studied for different therapeutic uses.  
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Examples of possible high impact mutations that would change receptor activation 
include alterations in receptor conformation flux, dimer lifetimes, and/or receptor kinase 
activity. Altering the stability of unliganded erbB3 receptors through receptor 
conformation decreases erbB3’s dependence on ligand. A more stable unliganded 
receptor would allow higher dimerization rates with other erbB2 and erbB3 receptors in 
the absence of ligand. Changing the lifetime of erbB3 homo and hetero-dimers would 
impact the ability of erbB3 receptors to become phosphorylated. In our wt erbB2-3 
model, we showed that the long dimer lifetimes of erbB3 dimers negatively impacts 
erbB3’s ability to become activated. Varying the dimer lifetimes of hetero and homo-
dimers would allow for a balance to be struck to either up-regulate or down-regulate 
receptor phosphorylation. Finally, a mutation in the kinase domain, similar to the E933Q 
mutation we found, would directly alter receptor activity. We believe our E933Q 
mutation causes an uptick in activity in the C-lob of the erbB3 receptor, making it a 
stronger activator in receptor phosphorylation. The mutation we propose here to study 
would be located in the N-lobe of the kinase domain, making the erbB3 receptor a strong 
receiver.  
6.3.2 For Future Investigators 
We originally built the Domain Reconstruction Algorithm with characterizing erbB2 
and erbB3 domains in mind, however it is easy to see that this algorithm can be used for 
any type of trajectory data. The analysis can be used to characterize confinement zones 
for other transmembrane proteins, such as MET, FcεRI, or Toll-like Receptors. A useful 
project for the DRA would be to characterize the confinement zone characteristics for a 
specific protein for various cell lines. This would give insight into how much the cellular 
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membrane landscape varies between cells, and also how the membrane landscapes vary 
between “normal” cells and cancerous cells. It can also be extended to characterize 
confinement of other types of proteins that can be tracked individually. This algorithm 
can even be extended beyond biological systems, to characterize diffusion characteristics 
of particles or diffusion-limited chemical species. 
Beyond using the spatial stochastic model to investigate different erbB3 mutation 
scenarios, the model can quickly be altered to investigate the interaction dynamics of 
another diffusion dependent protein family that forms dimers. No change to the actual 
code would be necessary, only the input parameters dictating diffusion and receptor 
reactions would need to be updated to match the protein system.  
To extend the model further, protein families that form higher order oligomers could 
be studied by altering the dimerization rule in the model. This would be an interesting 
next step for the model, as oligomerization of erbB receptors has been a popular research 
focus (Kani et al, 2005; Kozer et al, 2013). This rule change for the model would also 
allow the model to be used to study other proteins known to form oligomers, such as 
FcεRI.  
A more drastic change to the model would be to add a 3D component to represent the 
cytoplasm. This addition would allow for investigation deeper into the proteins involved 
in the signaling cascade initiated through membrane receptor activation. Members of our 
group previously explored this type of model using a lattice-based spatial stochastic 
model (Costa et al, 2009b). Since this work was published, experimental methods have 
improved, giving more precise parameters for model building.     
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6.4 PERSPECTIVES 
During this dissertation we worked hard to directly integrate experimental data with our 
modeling methods. In each study we used experimental data to create our model, then 
extended the model beyond current experimental capabilities. This extension shows the 
usefulness of modeling for scientific research. Models give us deeper insight and greater 
flexibility when studying the intricate relationships and mechanisms of physical 
processes. Integration of experiments and modeling is a crucial step for the future of 
scientific research. Creating a continuous cycle of experiments and modeling will allow 
us to expedite scientific discoveries by using models to predict interesting and relevant 
mechanisms to study leading to novel experiment development. 
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APPENDICES 
APPENDIX A: Simulation Space Program Scripts 
SIMULATION IMAGE IMPORTER 
 
%% EM Image Importer m-file 
% Final Version by Meghan McCabe Pryor April 16th, 2014 
%% Fresh Start 
clear all; close all; clc 
%% Input information 
% Name of save file 
datafilename='EMFileName'; 
% Name of image to be used for particle positions 
photoname='5-10957Large_ScaleBar.jpg'; 
% Unit conversion for scale bar on image 
scalebar=0.1; % Enter in units of um 
%% Check File Name Existance 
% To avoid overwritting past data files 
if exist(strcat(datafilename,'.mat'),'file') == 2 
    % Check before overwritting savefilename 
    choice1 = questdlg('Data Filename already used, are you sure you want to overwrite 
the file?', ... 
        'Save Name Check', ... 
        'Yes','No','No'); 
    switch choice1 
        case 'Yes' 
             
        case 'No' 
            disp('Please rename the save file name and re-start the simulation.') 
            return 
    end 
end 
%% Data Import 
choice2 = questdlg('Do you want to include domains?', ... 
    'Domain Check', ... 
    'Yes','No','No'); 
 
switch choice2 
    case 'Yes' 
        %% 
        % Import image and show 
        EM = imread(photoname); 
        imshow(EM) 
        hold on 
        %% 
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        % How many domains? 
        prompt = {'How many domains are there?'}; 
        dlg_title = '# of Domains'; 
        num_lines = 1; 
        answer = inputdlg(prompt,dlg_title,num_lines); 
        numdomain=str2double(answer{1}); 
        %% 
        % Measure scale bar distance 
        h1=msgbox('Scale Bar Length (2 Clicks)'); 
        uiwait(h1) 
        [d1 d2] = ginput(2); 
        %% 
        % Measure x axis and y axis 
        h2=msgbox('x-axis Length (2 Clicks)'); 
        uiwait(h2) 
        [px nay] = ginput(2); 
        h3=msgbox('y-axis Length (2 Clicks)'); 
        uiwait(h3) 
        [nax py] = ginput(2); 
        %% 
        % Measure x axis and y axis 
        r=zeros(1,3); 
        for i = 1:numdomain 
            h5=msgbox(sprintf('x-axis Length of Domain %.0f (2 Clicks)',i)); 
            uiwait(h5) 
            [idpx nay] = ginput(2); 
            dpx(i,:)=idpx'; 
            h6=msgbox(sprintf('y-axis Length of Domain %.0f (2 Clicks)',i)); 
            uiwait(h6) 
            [nax idpy] = ginput(2); 
            dpy(i,:)=idpy'; 
            dxmin=idpx(1); 
            dymin=idpy(2); 
            dxmax=idpx(2); 
            dymax=idpy(1); 
            plot([dxmin dxmax dxmax dxmin dxmin], [dymax dymax dymin dymin 
dymax],'b') 
            %% 
            % Measure distance ***Press Return when finished clicking*** 
            h4=msgbox(sprintf('Particle Placement in Domain %.0f (Right Click when 
finished)',i)); 
            uiwait(h4) 
            iXp=[]; 
            iYp=[]; 
            %key = ''; 
            key = 1; 
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            while key == 1%strcmp(key,'') 
                [Xp Yp key] = ginput(1); 
                iXp=[iXp Xp]; 
                iYp=[iYp Yp]; 
                plot(iXp,iYp,'r.') 
                %key = get(gcf,'CurrentKey'); 
            end 
            %key=set(gcf,'CurrentKey',''); 
            key = 1; 
            [m n] = size(r); 
            r(m+1:m+length(iXp),:)=[iXp' iYp' i*ones(length(iXp),1)]; 
        end 
        r(1,:)=[]; 
        %% 
        % Measure distance ***Press Return when finished clicking*** 
        h4=msgbox(sprintf('Free Particle Placement (Right Click when finished)')); 
        uiwait(h4) 
        key=1; 
        iXpfree=[]; 
        iYpfree=[]; 
        while key == 1; %strcmp(key,'') 
            [Xpfree Ypfree key] = ginput(1); 
            iXpfree=[iXpfree Xpfree]; 
            iYpfree=[iYpfree Ypfree]; 
            plot(iXpfree,iYpfree,'r.') 
            %key = get(gcf,'CurrentKey'); 
        end 
        key=1; 
        %% 
        % Scale Units 
        unit=abs(d1(2)-d1(1))/scalebar; % Converts bewteen pixels and um [=] # pixels/um 
        xlimmax=px(2)/unit; % x limit in um 
        ylimmax=py(1)/unit; % y limit in um 
        xlimmin=px(1)/unit; % x limit in um 
        ylimmin=py(2)/unit; % y limit in um 
        % Domain limits 
        dxmin=dpx(:,1)/unit; 
        dymin=dpy(:,2)/unit; 
        dxmax=dpx(:,2)/unit; 
        dymax=dpy(:,1)/unit; 
        %% 
        % Add free data points to domain data points 
        rcombine(:,1) = [r(:,1)' iXpfree]'; 
        rcombine(:,2) = [r(:,2)' iYpfree]'; 
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r(length(r(:,1))+1:length(rcombine),:)=[rcombine(length(r(:,1))+1:length(rcombine),:) 
zeros(length(rcombine)-length(r(:,1)),1)]; 
        %% 
        % Scale collected data 
        iX=rcombine(:,1)./unit; 
        iY=rcombine(:,2)./unit; 
        close all 
        %% 
        % Plot initial data compared to image 
        figure 
        subplot(1,2,1); 
        plot(iX,iY,'.', [dxmin dxmax dxmax dxmin dxmin]', [dymax dymax dymin dymin 
dymax]') 
        xlim([xlimmin xlimmax]) 
        ylim([ylimmin ylimmax]) 
        set(subplot(1,2,1),'YDir','reverse') 
        subplot(1,2,2) 
        imshow(EM) 
        hold on 
        plot(rcombine(:,1),rcombine(:,2),'.') 
        hold off 
    case 'No' 
        %% 
        % Import image and show 
        EM = imread(photoname); 
        imshow(EM) 
        %% 
        % Measure scale bar distance 
        h1=msgbox('Scale Bar Length (2 Clicks)'); 
        uiwait(h1) 
        [d1 d2] = ginput(2); 
        %% 
        % Measure x axis and y axis 
        h2=msgbox('x-axis Length (2 Clicks)'); 
        uiwait(h2) 
        [px nay] = ginput(2); 
        h3=msgbox('y-axis Length (2 Clicks)'); 
        uiwait(h3) 
        [nax py] = ginput(2); 
        %% 
        % Measure distance ***Press Return when finished clicking*** 
        h4=msgbox('Particle Placement (Hit Enter when finished)'); 
        uiwait(h4) 
        [iXp iYp] = ginput; 
        %% 
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        % Scale Units 
        unit=abs(d1(2)-d1(1))/scalebar; % Converts bewteen pixels and um [=] # pixels/um 
        xlimmax=px(2)/unit; % x limit in um 
        ylimmin=py(2)/unit; % y limit in um 
        xlimmin=px(1)/unit; % x limit in um 
        ylimmax=py(1)/unit; % y limit in um 
        %% 
        % Scale collected data 
        iX=iXp./unit; 
        iY=iYp./unit; 
        close all 
        %% 
        % Plot initial data compared to image 
        figure 
        subplot(1,2,1); 
        plot(iX,iY,'.') 
        xlim([xlimmin xlimmax]) 
        ylim([ylimmin ylimmax]) 
        set(subplot(1,2,1),'YDir','reverse') 
        subplot(1,2,2) 
        imshow(EM) 
        hold on 
        plot(iXp,iYp,'.') 
        hold off 
end 
NP=length(iX); 
%% Save Imported Data 
save(datafilename) 
 
DOMAIN RECONSTRUCTION ALGORITHM 
 
The scripts presented in this appendix are still a work in progress. The script posted here 
are up-to-date as of the writing of this document. 
Domains_V006.m 
% Labels points based on step size distributions % 
% 
% V001 - can make histograms or not, labels points based on a percentage 
% cutoff 
% 
% V002 - file and folder name separate, can use rankings 
% 
% V003 - added combination scoring 
% 
% V003a - cleaning up 
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%       - multi zoom saves 
% 
% V004 - multi-file processing 
%      - analyze a set of files defined by a string token 
%      - output two-channel results in a single proecessed data file 
%      - build a cumulative step distribution from all files (by channel) 
%      - for each file and channel, do the scoring and short points 
%      - cluster the short points 
%      - put out detailed clustering data for one length (MyLength) 
% 
% V005  
%     - add domain diameter to geometric measures of domains 
%     - length study option for short points 
%     - two different MyLength values for the two channels (V005a) 
% 
% V006 
%    TODO: 
%     - area calculation for all (short and other) points -- done 
%     - put out detailed clustering data for selected lengths 
%     - use this to pick a common cutoff (one for each channel) - do this by hand? 
% 
%     Beyond this: 
%     - look at overlap of trajectories and domains 
%     - overlay plots with trajectories, domains from 1 or 2 channels 
%     - estimate fraction of area covered by domains 
%     - something else..? 
 
%%  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%                      *** EDIT THIS AS NEEDED ***                           % 
 
% folder for source files 
FolderPath    = 'CHO/CHO_HA-ErbB2_ErbB3_ErbB3/'; 
%FolderPath    = 'CHO/CHO_HA-ErbB2-ErbB3_ERBB2/'; 
 
% String pattern to help pick out a group of files % 
%         make it blank ('') to process all the files 
SpecialString =  '';%'2013-3-29';%'2013-3-29-10-42';%'2012-12-19';%'';% 
 
% extensions for source files (two channels) 
Ext={'.HMMData_ch1_StDis2.mat','.HMMData_ch2_StDis2.mat'}; 
 
 
% length parameters used to define clusters and contours 
%MyLength={0.0305,0.0570}; %{0.0570,0.0305}; %  %0.070;%0.035; 
159 
MyLength={0.1,0.1}; 
 
% for the length study option  
% (substring to be found in the file names, set it to 'zumm' 
% to turn off length study, set it equal to SpecialString to 
% make it default 
LS_SpecialString = 'zumm';%;'-3-29';  
 
% folder for output files 
% OutputFolder = 'Scratch/SampleRunsForPlots_ErbB32/'; 
OutputFolder = 'Scratch/Run005a/'; 
 
% extension+tag for processed files 
OutputExt = {... 
    sprintf('_DomRec_L%dnm.mat',floor(1000*MyLength{1})), 
    sprintf('_DomRec_L%dnm.mat',floor(1000*MyLength{2}))}; 
 
% ** Processing / Analysis Parameters **  
 
% step count values we expect in the input files 
SelectStepVals=[1 2 5 10 20 50 100 200]; 
 
% Step Count Values (1,2,5,10,20,50,100,200) 
% that will be used in building the score, for example: 
% [3] means we only use the 5 step values 
% [3 4 4 5] means 5 steps, 10 with double weight, and 20 
%ScorePattern=[4 5 6]; 
ScorePattern=[1 2 3 3 4 4 5 5 5 6 6 7 7 8 8];% a combo score I liked 
 
% cutoff used to define the short points (score below means short - max is 1) 
CutFactor = 1.01;%0.65; 
 
%   ** Optional Figures and Data Outputs **  % 
 
MakePlot1001 = false; % cumulative step distribution plot 
MakePlot404  = false; % individual histogram of scores (one per file) 
MakePlot405  = false; % cumulative histogram of scores (one for the entire group) 
MakePlot2001 = false; % length study plot  
 
FILEOUTPUT   = false; % text file outputs of contours and points etc 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%% 
 
% get a file list  
DirOut = dir([FolderPath '*' SpecialString '*' Ext{1}]); 
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FileCount = size(DirOut,1); 
 
FileTrajectoryCount = zeros(FileCount,2); % counts the points in each channel of each 
file 
FilePointCount = zeros(FileCount,2); % counts the points in each channel of each file 
 
ShortFileNames = cell(FileCount,1); 
 
 
%% Global step size statistics %% 
 
% Initialize the global step statistics object 
% NOTE: make sure there is enough space 
 
StepCounts=zeros(2,8); % keeps track of the number of values in the statistic 
 
StepStats = cell(2,8);% holds the values of the step sizes 
 
 
 
% best guesses for the size of the statistics 
 
SSizes=[450000, 250000, 110000, 65000, 35000, 15000, 7000, 3000]; 
for ich=1:2, 
    for isz=1:8, 
        StepStats{ich,isz} = zeros(SSizes(isz),1); 
    end; 
end; 
 
tic 
% Collect metadata for the step statistics 
for ifile=1:FileCount % initial loop through files (defined by the short name) 
     
    % short file name from the dir() output 
    %q=strsplit(DirOut1(ifile).name,'.');% works only in v2013 or later 
    q=strread(DirOut(ifile).name,'%s','delimiter','.');% may be obsolete, use the above 
     
    ShortFileNames{ifile} = q{1}; 
     
    fprintf('%s\n',ShortFileNames{ifile}); 
     
    for ich=1:2 % loop through channels 
         
        File = [FolderPath ShortFileNames{ifile} Ext{ich}]; 
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        if ~exist(File,'file'), % get trajectory, point and step info from the file 
            fprintf('File %3d ch%d: %s not found\n',ifile, ich, File); 
        else 
            fprintf('ch%d: ',ich); 
            load(File);             
             
            FileTrajectoryCount(ifile,ich)=size(Trajectories,1); 
            for TrNo = 1:FileTrajectoryCount(ifile,ich); %loop over trajectories and count the 
points in them 
                FilePointCount(ifile,ich) = FilePointCount(ifile,ich)+Trajectories{TrNo,2}; 
            end; 
             
            fprintf('TrCt:%3d PtCt:%4d 
',FileTrajectoryCount(ifile,ich),FilePointCount(ifile,ich)); 
             
            % error check: the pixel size should come with the data 
            if ~exist('PixelSize','var'), fprintf('    Domains **error**    No PixelSize 
found!\n'); return; end; 
             
            L2ConversionFactor=PixelSize^2; 
             
            % add the step values to the global statistics 
            for ist=1:8; 
                 
                StValueCount = StepDistributions{ist,2}; 
                StValueDist = L2ConversionFactor * StepDistributions{ist,3}(:,1); % step 
values 
                 
                %fprintf('%5d ',StepDistributions{is,1}); 
                fprintf('%6d ',StValueCount); 
                fprintf('%7.3f ',max(StValueDist)); 
                 
                MinInd=StepCounts(ich,ist)+1; 
                MaxInd=StepCounts(ich,ist)+StValueCount; 
                StepStats{ich,ist}(MinInd:MaxInd) = StValueDist; 
                 
                StepCounts(ich,ist)=StepCounts(ich,ist)+StValueCount; 
                 
                %MaxStepValues(ich,is)=max(MaxStepValues(ich,is),max(StValueDist)); 
                 
                 
            end; % loop over select step counts 
  
            fprintf('\n'); 
        end; % if file was found 
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    end % loop over channels 
end % loop over file [names] 
 
 
% Build cumulative step distributions and histograms 
 
StepRange = cell(2,8); % bin definitions 
StepHist = cell(2,8);  % histograms 
 
if MakePlot1001, figure(1001); clf; end;% optional global step distribution plot 
 
for ich=1:2 % double loop for step statistics 
    for ist=1:8 
         
        % clip off the unused pieces of StepStats 
        StepStats{ich,ist}=StepStats{ich,ist}(1:StepCounts(ich,ist)); 
         
        % define the value range 
        MaxV = 20*mean(StepStats{ich,ist}); % upper end 
        DV = MaxV/1000;                     % bin size 
        StepRange{ich,ist} = 0:DV:MaxV;     % range 
         
        Missed=length(find(StepStats{ich,ist}>MaxV)); %  values left out 
         
        % do the histogram 
        W = histc(StepStats{ich,ist},StepRange{ich,ist}); % histogram 
        StepHist{ich,ist} = cumsum(W)/StepCounts(ich,ist);% cumulative fractions 
         
        if MakePlot1001, % optional cumulative step statistics plot 
            figure(1001) 
            subplot(2,4,ist) 
            if ich==2, hold on; end; 
            %stairs(StepRange{is,ich},log(W/DV)/log(10),'Color',[ich-1,0,2-ich]); 
            %semilogy(StepRange{is,ich},W/DV,'Color',[ich-1,0,2-ich]); 
            semilogx(StepRange{ich,ist},StepHist{ich,ist},'Color',[ich-1,0,2-ich]); 
            if ich==2, % format and embellish 
                xstring='Sq.dis (\mum)'; 
                tstring='CDF'; 
                nstring=sprintf('%d steps',SelectStepVals(ist)); 
                if SelectStepVals(ist)==1, nstring='1 step'; end; 
                xf=0.0001; yf=0.925; 
                ylim([0 1.2]); 
                nmin=floor(log(DV)/log(10)); 
                nmax=ceil(log(MaxV)/log(10)); 
                xlim([10^nmin 10^nmax]); 
                set(gca,'XTick',[10.^(nmin:nmax)]); 
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legend(sprintf('Ch1:%d',StepCounts(1,ist)),sprintf('Ch2:%d',StepCounts(2,ist))); 
                legend('Location','SouthEast'); 
                FormatThisFigure; 
                 
            end 
        end 
         
    end 
end 
 
if MakePlot1001, FigureName=[OutputFolder 'CumulativeStepStats_' SpecialString]; 
SaveThisFigure; end; 
 
%return % optional stop before building the individual scores 
% done collecting step statistiscs 
 
 
%%  Analysis of trajectory files 
 
% Variables for point scoring 
OverallPointCount = sum(FilePointCount,1); 
OverallShortPoints = 
{zeros(OverallPointCount(1),1),zeros(OverallPointCount(2),1)};%cell(2,1); 
OverallBiRanks = {zeros(OverallPointCount(1),3),zeros(OverallPointCount(2),3)}; 
%cell(2,1); 
BiRankCount = zeros(2,1); 
 
for ifile=1:FileCount % main analysis loop over trajectory files.. 
     
    SPC = cell(2,2); 
     
    for ich=1:2       % ..and over channels 
         
        File= [FolderPath ShortFileNames{ifile} Ext{ich}]; 
         
        % Length study is done for a subset of the files 
        LENGTHSTUDY=false; 
        if ~isempty(strfind(File,LS_SpecialString)), LENGTHSTUDY=true; end; 
         
        fprintf('File:%3d ch.%1d : ',ifile,ich); 
         
        load(File); 
        fprintf('.'); 
        NTr = size(Trajectories,1); 
        TrajectoryRanks = cell(NTr,1); 
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        if ~exist('PixelSize','var'), % the pixel size should come with the data 
            fprintf('    Domains **error**    No PixelSize found!\n   File: %s',File); 
            return; 
        end; 
         
        L2ConversionFactor=PixelSize^2; % convert into physical units 
         
        % this will hold the output set of points 
        AllShortPoints = zeros(FilePointCount(ifile,ich),3); 
        ShortPointCount = 0; 
         
        AllPoints = zeros(FilePointCount(ifile,ich),3); 
         
         
        % collect the ranks for all points in this file/channel combination 
        CumulativeBiRanks = zeros(FilePointCount(ifile,ich),1); 
        PointCount = 0; 
         
        for TrNo = 1:NTr; % loop over trajectories 
             
            ThisTrace = Trajectories{TrNo,3}; 
             
            ThisTrace(:,1:2) = PixelSize * ThisTrace(:,1:2);%convert the xy coordinates into 
\mum 
             
            TraceLength =   size(ThisTrace,1);% length of this trace 
             
             
            %% find the forward and reverse step sizes for the trajectory % 
             
            % these will hold the ranks for each number of steps 
            FwRanks = zeros(length(SelectStepVals),TraceLength); 
            BkRanks = zeros(length(SelectStepVals),TraceLength); 
             
            for ist=1:length(SelectStepVals) % loop over the 8 step numbers 
                 
                FBSqDist = zeros(TraceLength,2);% forward and backward square 
displacements 
                 
                StCount=SelectStepVals(ist); % step count for this step number 
                 
                for ip=1:TraceLength % loop over all entries in the trajectory 
                     
                    % point StCount after the current frame 
                    IFw = find(ThisTrace(:,3)==ThisTrace(ip,3) + StCount,1); 
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                    if ~isempty(IFw), FBSqDist(ip,1) = sum( (ThisTrace(ip,1:2) - 
ThisTrace(IFw,1:2)).^2); end; 
                     
                    % point StCount before the current frame 
                    IBk = find(ThisTrace(:,3)==ThisTrace(ip,3) - StCount,1); 
                    if ~isempty(IBk), FBSqDist(ip,2) = sum( (ThisTrace(ip,1:2) - 
ThisTrace(IBk,1:2)).^2); end; 
                     
                end 
                 
                % convert the recorded distances into bins in Range 
                FBRanks = min(ceil(FBSqDist/StepRange{ich,ist}(2)),... 
                    length(StepRange{ich,ist})); 
                 
                % convert the (nonzero) bin indices into percentages using AllRanks 
                FBRanks(FBRanks(:,1)~=0,1) = 
StepHist{ich,ist}(FBRanks(FBRanks(:,1)~=0,1)); 
                FBRanks(FBRanks(:,2)~=0,2) = 
StepHist{ich,ist}(FBRanks(FBRanks(:,2)~=0,2)); 
                 
                % put the info into the multi-step size rank structures 
                FwRanks(ist,:) = FBRanks(:,1); 
                BkRanks(ist,:) = FBRanks(:,2); 
                 
                 
            end 
             
            %% build a unique score for each point 
             
            BothPresent=FwRanks>0 & BkRanks>0; 
             
            BiRank=zeros(size(FwRanks)); 
            BiRank(BothPresent) = (FwRanks(BothPresent)+BkRanks(BothPresent))/2.0; 
             
             
            WeightedRank = sum(BiRank(ScorePattern,:),1) ./ 
sum(BiRank(ScorePattern,:)~=0,1); 
            %StDBiRank = sqrt( sum(BiRank.*BiRank,1) ./ sum(BiRank~=0,1) - 
MeanBiRank .* MeanBiRank ); 
             
             
            TrajectoryRanks{TrNo} = WeightedRank'; 
            %TrajectoryRanks{TrNo,2} = StDBiRank; 
             
            %% identify the points associated with shorter step sizes 
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            ShortPoints = find(WeightedRank>0 & WeightedRank < CutFactor)'; 
             
            AllShortPoints(ShortPointCount+(1:size(ShortPoints,1)),:) =... 
                [ThisTrace(ShortPoints,1:2) TrNo*ones(size(ShortPoints,1),1)]; 
             
            ShortPointCount = ShortPointCount + size(ShortPoints,1); 
             
            AllPoints(PointCount+(1:TraceLength),:) =... 
                [ThisTrace(:,1:2) TrNo*ones(size(ThisTrace,1),1)]; 
             
             
             
            CumulativeBiRanks(PointCount+(1:TraceLength)) = TrajectoryRanks{TrNo}; 
            PointCount = PointCount + TraceLength; 
             
        end 
         
        fprintf('.'); 
         
        AllShortPoints=AllShortPoints(1:ShortPointCount,:); 
        AllPoints=AllPoints(1:PointCount,:); 
         
        if CutFactor>1, AllShortPoints=AllPoints; end; 
         
        % keep this for channel to channel comparisons 
        SPC{ich,1}=AllShortPoints; 
         
        if MakePlot404, % individual histogram of scores 
            figure(404) 
            if ich==1, clf; else hold on; end; 
            hr=0:0.01:1; 
            w=hist(CumulativeBiRanks,hr); 
            if ich==1, stairs(hr,w,'b'); else stairs(hr,w,'r'); end; 
             
            if ich==1, 
                ystring='Frequency'; 
                xstring='Score'; 
                title(sprintf('Scores %s',ShortFileNames{ifile}),'interpreter','none'); 
                FormatThisFigure; 
            end 
             
            if ich==2, 
                legend('ch 1','ch 2'); 
                FormatThisFigure; 
                FigureName=[OutputFolder ShortFileNames{ifile} '_Scores_both_Pt' 
sprintf('%d',ScorePattern)]; 
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                SaveThisFigure; 
            end 
        end 
         
        CleanBiRanks=CumulativeBiRanks(~isnan(CumulativeBiRanks)); 
         
        MinInd=BiRankCount(ich)+1; 
        MaxInd=BiRankCount(ich)+length(CleanBiRanks); 
         
        OverallBiRanks{ich}(MinInd:MaxInd)=CleanBiRanks; 
        BiRankCount(ich)=MaxInd; 
         
        OutFileName=[OutputFolder ShortFileNames{ifile} sprintf('.ch%d',ich) 
OutputExt{ich}]; 
        save(OutFileName, 'ShortFileNames', 'Trajectories', 'PixelSize', 'StepRange', 
'StepHist', 'WeightedRank', 'AllShortPoints'); 
        %save(OutFileName); 
         
        %% Clustering (still inside the loop over files + channels) 
                 
        fprintf('.'); 
        % 
        RootFileName = [OutputFolder ShortFileNames{ifile} sprintf('.ch%d',ich)]; 
         
        % list of distances to look at for clusters 
        DVecLong = 0.001:0.001:1; 
         
        % Clustering 
        MyZ = linkage(AllShortPoints(:,1:2)); 
        T = cluster(MyZ,'cutoff',DVecLong,'criterion','distance'); 
        fprintf('.'); 
         
         
        % pull out the cluster arrangement with the chosen length scale 
        BestInd=find(DVecLong>=MyLength{ich},1); 
        BestLength=DVecLong(BestInd); 
        Clusters=T(:,BestInd); 
         
        % keep this for channel to channel comparisons 
        SPC{ich,2}=Clusters; 
         
        fprintf('.'); 
         
        % cell array to collect the cluster info 
        % {<number of points>, <Nx2 array of points>} 
        % for: (1) actual points, (2) tight contour, (3) fat contour 
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        ClustersAndContours=cell(max(Clusters), 6); 
         
        % count the points in each cluster 
        CC=zeros(max(Clusters),1); % holds cluster sizes, should be replaced eventually 
        for IC=1:max(Clusters) 
            CC(IC)=sum(Clusters==IC); 
        end 
         
        % This will collect area and perimeter info 
        % inside A / P, est. padding A /P , padded polyline A / P 
        ClusterAP = zeros(max(Clusters), 8); 
         
        %% Contour building loop over clusters %% 
        for ISCC=1:max(Clusters); 
            %% Tight contour 
            % Pick out a cluster 
            Chozen = find(Clusters==ISCC); 
             
            MyPoints = AllShortPoints(Chozen,1:2); 
             
            % record the points of this cluster 
            ClustersAndContours{ISCC,1}=CC(ISCC); 
            ClustersAndContours{ISCC,2}=MyPoints(:,1:2); 
             
            % Build the tight contour 
            BestLength2=BestLength*1.01; 
             
            [Contour, Diam] = TightContour(MyPoints, BestLength2); 
             
            % record the tight contour - no repeat of the first point 
            ClustersAndContours{ISCC,3}= size(Contour,1); 
            ClustersAndContours{ISCC,4}= MyPoints(Contour,1:2);            
            %% Build the fat contour 
             
            MinAngle = pi / 6; % for spokes in circles added around corners 
             
            FatContour = FatContourBuild(MyPoints(Contour,1:2), BestLength2, MinAngle); 
             
            % record the fat contour - skip the repeat of the first point 
            ClustersAndContours{ISCC,5}=size(FatContour,1)-1; 
            ClustersAndContours{ISCC,6}=FatContour(1:end-1,:);           
            %% Geometry - areas and perimeters 
             
            % area inside the tight contour - assumed closed 
            ClusterAP(ISCC,1) = polyarea(MyPoints(Contour,1), MyPoints(Contour,2)); 
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            % length of inner perimeter 
            ClusterAP(ISCC,2) = sum(sqrt(sum((MyPoints(Contour([2:end 1]),:) - 
MyPoints(Contour,:)).^2,2))); 
             
            % estimation of padding area (add rectangles + a circle) 
            ClusterAP(ISCC,3) = ClusterAP(ISCC,1) + ClusterAP(ISCC,2) * BestLength2/2 
+ pi*(BestLength2/2)^2; 
             
            % estimation of padded contour length (innner perimeter + circle 
            ClusterAP(ISCC,4) = ClusterAP(ISCC,2) + pi * BestLength2; 
             
            % area of fat contour 
            ClusterAP(ISCC,5) = polyarea(FatContour(:,1),FatContour(:,2)); 
             
            % perimeter of fat contour 
            ClusterAP(ISCC,6) = sum(sqrt(sum((FatContour(2:end,:)-FatContour(1:end-
1,:)).^2,2))); 
             
            % cluster diameter (no padding) 
            ClusterAP(ISCC,7) = Diam; 
             
            % cluster diameter (with padding) 
            ClusterAP(ISCC,8) = Diam + BestLength;             
        end 
        fprintf('.'); 
        OutFileName=[OutputFolder ShortFileNames{ifile} sprintf('.ch%d',ich) 
OutputExt{ich}]; 
        save(OutFileName, 'T', 'MyLength', 'BestLength', 'Clusters', 'ClustersAndContours', 
'ClusterAP', '-append'); 
        fprintf('.'); 
         
        if FILEOUTPUT , 
             
            % metadata output 
            % point count, perimeter, area, etc. 
            fout = fopen([RootFileName 
sprintf('_%dnm_meta.txt',floor(1000*BestLength))],'w'); 
             
            for ISC=1:max(Clusters) 
                 
                %if DEMO && ISC>12, break; end; % loop limited to the 12 
                 
                fprintf(fout,'%3d ', ISC); % cluster index 
                 
                fprintf(fout,'%4d ',ClustersAndContours{ISC,1});% original (slow) point count 
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                fprintf(fout,'%4d ',ClustersAndContours{ISC,3});% point count on tight 
contour 
                fprintf(fout,'%4d ',ClustersAndContours{ISC,5});% point count on padded 
contour 
                 
                fprintf(fout,'%6.4f %6.4f %10.8f %6.4f %6.4f %6.4f %6.4f %6.4f\n', 
ClusterAP(ISC,[1 3 5 2 4 6 7 8])); 
                 
            end 
             
            fclose(fout); 
             
            % contour output 
            % polylines for each contour 
            fout=fopen([RootFileName 
sprintf('_%dnm_contours.txt',floor(1000*BestLength))],'w'); 
             
            % number of clusters on a separate line 
            fprintf(fout,'%4d\n',max(Clusters)); 
             
            % write out the fat contours only 
             
            for ISC=1:max(Clusters) 
                % if DEMO && ISC>12, break; end; % loop limited to the 12 
                % point counts from all contours on a single line 
                fprintf(fout,'%4d', ClustersAndContours{ISC,5}); 
            end 
             
            fprintf(fout,'\n'); 
             
            for ISC=1:max(Clusters) 
                % if DEMO && ISC>12, break; end; % loop limited to the 12 
                % pull out the contour data 
                FatContourOut = ClustersAndContours{ISC,6}; 
                % x coordinates on a single line 
                fprintf(fout,'%8.5f ',FatContourOut(:,1)); 
                fprintf(fout,'\n'); 
                % y cordinates on a single line 
                fprintf(fout,'%8.5f ',FatContourOut(:,2)); 
                fprintf(fout,'\n'); 
            end 
             
            fclose(fout); 
             
        end; 
        fprintf('.\n'); 
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        if LENGTHSTUDY, 
            tic 
            % loop over characteristic lengths 
            APtot=zeros(length(DVecLong),8); 
            for Ind=1:length(DVecLong) 
                Clusters=T(:,Ind); 
                APtot(Ind,5)=max(Clusters); 
                DiamVals = zeros(max(Clusters),1); 
                for ICl=1:max(Clusters) 
                    BestLength=DVecLong(Ind); 
                    MyPoints=AllShortPoints(Clusters==ICl,1:2); 
                    [Contour, DiamVals(ICl)] = TightContour(MyPoints, 1.01*BestLength); 
                     
                    % area inside the tight contour - assumed closed 
                    AreaIn = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));% area 
inside the tight contour - assumed closed 
                    % length of inner perimeter 
                    PerimIn = sum(sqrt(sum((MyPoints(Contour([2:end 1]),:) - 
MyPoints(Contour,:)).^2,2))); 
                    % estimation of padding area (add rectangles + a circle) 
                    AreaTot = AreaIn + PerimIn * BestLength/2 + pi*(BestLength/2)^2; 
                    % estimation of padded contour length (innner perimeter + circle 
                    PerimTot = PerimIn + pi * BestLength; 
                     
                    APtot(Ind,1:4)=APtot(Ind,1:4)+[AreaIn, AreaTot, PerimIn, PerimTot]; 
 
                     
                end 
 
                APtot(Ind,6:8)=[mean(DiamVals),median(DiamVals),max(DiamVals)]; 
                 
                fprintf('L=%3dnm NCl=%3d Ain=%6.3f Atot=%6.3f Pin=%5.3f Ptot=%5.3f 
AvDiam=%5.3f\n',... 
                    floor(DVecLong(Ind)*1000), max(Clusters), APtot(Ind,1:4), APtot(Ind,6)); 
                   
            end 
            toc 
             
            save(OutFileName, 'APtot','-append'); 
             
            if MakePlot2001, % length study plot 
                 
                figure(2001); clf; 
                subplot(2,2,1) %  
                plot(DVecLong,APtot(:,2)); 
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                tstring='Aggregate Domain Area'; 
                xstring='L (\mum)'; ystring='\mum^2'; 
                FormatThisFigure; 
                subplot(2,2,2) %  
                plot(DVecLong,APtot(:,4)); 
                tstring='Aggregate Perimeter'; 
                xstring='L (\mum)'; ystring='\mum'; 
                FormatThisFigure; 
                subplot(2,2,3) %  
                plot(DVecLong,APtot(:,5)); 
                xlim([0 0.2]); 
                tstring='Number of clusters'; 
                xstring='L (\mum)'; ystring='Count'; 
                FormatThisFigure; 
                subplot(2,2,4) %  
                plot(DVecLong,APtot(:,6),'b-');hold on; 
                plot(DVecLong,APtot(:,7),'r-'); 
                legend('mean','median'); 
                tstring='Diameter'; 
                xstring='L (\mum)'; ystring='\mum'; 
                FormatThisFigure; 
                 
                FigureName=[OutputFolder ShortFileNames{ifile} 
sprintf('_ch%d_LengthStudy',ich)];                 
                SaveThisFigure; 
            end 
             
            %return 
        end % LENGTHSTUDY 
         
    end % end loop over channels 
     
    % channel comparisons here 
    Overlap_V001; 
     
%     fout = fopen([OutputFolder ShortFileName... 
%         
sprintf('_Overlaps_%dnm_%dnm.txt',floor(1000*MyLength{1}),floor(1000*MyLength{
2}))]... 
%         ,'w'); 
%     
 
% save overlap info in both channel files 
for ich=1:2 
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     OutFileName=[OutputFolder ShortFileNames{ifile} sprintf('.ch%d',ich) 
OutputExt{ich}]; 
        save(OutFileName,'TotalOverlap', 'OvlAreas', '-append');           
             
end 
         
end % end loop over files 
 
if MakePlot405, % two channel summary histogram of global scores 
     
    for ich=1:2  
         
        OverallBiRanks{ich}=OverallBiRanks{ich}(1:BiRankCount(ich)); 
        figure(405) 
        if ich==1, clf; else hold on; end; 
        hr = 0:0.01:1; 
        w=hist(OverallBiRanks{ich},hr); 
        if ich==1, stairs(hr,w,'b'); else stairs(hr,w,'r'); end; 
        xstring='Score'; 
        ystring='Counts'; 
        if ich==2, 
            tstring='HA HRG Pattern: '; 
            tstring = [tstring sprintf('%d',ScorePattern)]; 
            legend('ch1','ch2'); 
            FormatThisFigure; 
            FigureName=sprintf('HA_HRG_%s_both_Pt',SpecialString); 
            FigureName=[OutputFolder FigureName sprintf('%d',ScorePattern)]; 
            SaveThisFigure; 
        end 
         
    end 
     
end 
 
toc 
 
return 
 
ContourV004.m 
%% Cluster calls and contour finding for 'short' points from an SPTData file %% 
 
%% Development history / features 
% ** Version 1 ** 
% * loads the result of the first two sets of processing steps performed 
%   on a single movie file 
% * requires a set of points, organized in a distance based cluster 
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%   structure, and a length parameter value 
% * makes a plot of the points, colored by the cluster assignment 
% * performs the contour finding for a set of selected clusters 
% * plots the clusters andthe contours un a multi-plot 
% * Contour finding algorithm: 
%   - starts from the rightmost point 
%     (could be any point on the convex hull) 
%   - uses a reference direction 
%     + initially the RD is the positive x 
%   - Update steps: 
%     + subsequently, RD is 60 degrees to the left of the direction 
%       pointing from the current to the previous point 
%     + identify all points within L of the current point 
%     + calculates their angle w.r.to RD 
%     + next point is the one with the smallest such angle 
%   - Stopping criteria 
%     + The initial point is hit 
%       TODO: change this to crossing the initial segment in the same direction 
%     + Number of steps exceeds nuber of points 
% 
% ** Version 2 ** 
%    Contour algorithm 
%    * make sure it works for small clusters 
%    * change stopping criterion to segment 
%    * add expanded footprint (rectangles and circles) 
%    * build polyline contour of expanded footprint 
% 
% ** Version 3 ** 
% 
%    Contour algorithms 
%    * more options for initial point, direction? -- later 
%    * connect to convex hull somehow? - not necessary 
%    * add universal self intersection check (uses polyxpoly() ) -- done 
%    * convert to function -- done 
%    * calculate area, perimeter, density, etc. -- done 
% 
% 
%% Switches for behavior and output control %% 
 
if ~exist('TOP12PLOTS','var'), TOP12PLOTS=true; end;% plots the top 12 clusters 
Fig.5002 
if ~exist('CLUSTERCONTOURPLOTS','var'), CLUSTERCONTOURPLOTS=true; 
end;% Fig 5003 
if ~exist('OVERLAYPLOTS','var'), OVERLAYPLOTS=false; end;% if true, used hold 
on; if false uses clf 
if ~exist('FILEOUTPUT','var'), FILEOUTPUT=true; end; % outputs cluster info 
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if ~exist('LENGTHSTUDY','var'), LENGTHSTUDY=false; end; % loops over length 
values and stops 
 
%RootFileName='ClusterDemoFile_Ch2'; 
%RootFileName=['Scratch/' ShortFileName]; 
RootFileName = 'Scratch/TestFile'; 
 
RootFileName = ShortFileName; 
 
MyLength=0.035;% 
ContourColor=[0 0 0]; 
 
% list of distances to look at for clusters 
DVecLong = 0.001:0.001:1; 
 
tic 
 
% Clustering 
MyZ = linkage(AllShortPoints(:,1:2)); 
MyT = cluster(MyZ,'cutoff',DVecLong,'criterion','distance'); 
T=MyT; 
 
toc 
 
if LENGTHSTUDY, 
    tic 
    % loop over characteristic lengths 
    APtot=zeros(length(DVecLong),5); 
    for Ind=1:length(DVecLong) 
        Clusters=T(:,Ind); 
        APtot(Ind,5)=max(Clusters); 
        for ICl=1:max(Clusters) 
            BestLength=DVecLong(Ind); 
            MyPoints=AllShortPoints(Clusters==ICl,1:2); 
            Contour = TightContour(MyPoints, 1.01*BestLength); 
             
            % area inside the tight contour - assumed closed 
            AreaIn = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));% area inside the 
tight contour - assumed closed 
            % length of inner perimeter 
            PerimIn = sum(sqrt(sum((MyPoints(Contour([2:end 1]),:) - 
MyPoints(Contour,:)).^2,2))); 
            % estimation of padding area (add rectangles + a circle) 
            AreaTot = AreaIn + PerimIn * BestLength/2 + pi*(BestLength/2)^2; 
            % estimation of padded contour length (innner perimeter + circle 
            PerimTot = PerimIn + pi * BestLength; 
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            APtot(Ind,1:4)=APtot(Ind,1:4)+[AreaIn, AreaTot, PerimIn, PerimTot]; 
             
        end 
         
        fprintf('L=%3dnm NCl=%3d Ain=%6.3f Atot=%6.3f Pin=%5.3f Ptot=%5.3f\n',... 
            floor(DVecLong(Ind)*1000), max(Clusters), APtot(Ind,1:4)); 
         
         
         
    end 
    toc 
     
    figure(2001) 
     
    FileName=[ShortFileName sprintf('_ch%d_LengthStudy',Channel)]; 
     
    save(FileName); 
     
    return 
end 
 
 
% pull out the cluster arrangement with the chosen length scale 
if exist('MyLength','var'), 
    BestInd=find(DVecLong>=MyLength,1); 
    BestLength=DVecLong(BestInd); 
    Clusters=T(:,BestInd); 
end 
 
 
 
 
 
%% Preliminaries 
 
% cell array to collect the cluster info 
% {<number of points>, <Nx2 array of points>} 
% for: (1) actual points, (2) tight contour, (3) fat contour 
ClustersAndContours=cell(max(Clusters), 6); 
 
% count the points in each cluster 
CC=zeros(max(Clusters),1); % holds cluster sizes, should be replaced eventually 
for IC=1:max(Clusters) 
    CC(IC)=sum(Clusters==IC); 
end 
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% find the top 12 clusters by size 
Q = [[1:max(Clusters)]',CC]; 
Q = sortrows(Q,-2); 
SpecialClusters = Q(1:12,1); 
 
% This will collect area and perimeter info 
% inside A / P, est. padding A /P , padded polyline A / P 
ClusterAP = zeros(max(Clusters), 6); 
 
if CLUSTERCONTOURPLOTS, 
    figure(5003); 
    if OVERLAYPLOTS, hold on;  else clf;  end; 
    plot(AllShortPoints(:,1),AllShortPoints(:,2),'ro','MarkerSize',1); 
end 
 
%% Contour building loop over clusters %% 
for ISCC=1:max(Clusters); 
     
    %% Pick out a cluster %% 
    Chozen = find(Clusters==ISCC); 
     
    % this is nonempty if this cluster is on the list 
    ISC=find(SpecialClusters==ISCC,1); 
     
     
    MyPoints = AllShortPoints(Chozen,1:2); 
     
    % record the points of this cluster 
    ClustersAndContours{ISCC,1}=CC(ISCC); 
    ClustersAndContours{ISCC,2}=MyPoints(:,1:2); 
     
    % Build the tight contour 
    BestLength2=BestLength*1.01; 
     
    Contour = TightContour(MyPoints, BestLength2); 
     
     
    % record the tight contour - no repeat of the first point 
    ClustersAndContours{ISCC,3}= size(Contour,1); 
    ClustersAndContours{ISCC,4}=MyPoints(Contour,1:2); 
     
    % Build the fat contour 
     
    MinAngle = pi / 6; % for spokes in circles added around corners 
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    FatContour = FatContourBuild(MyPoints(Contour,1:2), BestLength2, MinAngle); 
     
    if TOP12PLOTS && ~isempty(ISC), % make a plot for this cluster 
        figure(5002); 
        subplot(4,3,ISC,'replace') 
         
        % plot the points in the cluster 
        plot(MyPoints(:,1),MyPoints(:,2),... 
            'ro','MarkerSize',2,'MarkerFaceColor',[0.9 0.9 0],'LineWidth',0.5); 
         
        hold on 
         
        % plot the tight contour (close it) 
        Inds=Contour([1:end,1]);% normal 
        %StopInd=min(size(Contour,1),30);Inds=Contour(1:StopInd);%debug 
        plot(MyPoints(Inds,1),MyPoints(Inds,2),... 
            'bo-','MarkerSize',2,'LineWidth',0.5); 
         
        % plot the fat contour (it is closed already) 
        plot(FatContour(:,1),FatContour(:,2),'k-'); 
         
        % format and embellish 
        axis equal 
        tstring=sprintf('#%d (%d pts.)', ISCC, CC(ISCC)); 
        title(tstring); 
        FormatThisFigure;% makes the output nicer 
    end; 
     
     
    % record the fat contour - skip the repeat of the first point 
    ClustersAndContours{ISCC,5}=size(FatContour,1)-1; 
    ClustersAndContours{ISCC,6}=FatContour(1:end-1,:); 
     
    %% geometry - areas and perimeters 
     
    % area inside the tight contour - assumed closed 
    ClusterAP(ISCC,1) = polyarea(MyPoints(Contour,1), MyPoints(Contour,2)); 
     
    % length of inner perimeter 
    ClusterAP(ISCC,2) = sum(sqrt(sum((MyPoints(Contour([2:end 1]),:) - 
MyPoints(Contour,:)).^2,2))); 
     
    % estimation of padding area (add rectangles + a circle) 
    ClusterAP(ISCC,3) = ClusterAP(ISCC,1) + ClusterAP(ISCC,2) * BestLength2/2 + 
pi*(BestLength2/2)^2; 
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    % estimation of padded contour length (innner perimeter + circle 
    ClusterAP(ISCC,4) = ClusterAP(ISCC,2) + pi * BestLength2; 
     
    % area of fat contour 
    ClusterAP(ISCC,5) = polyarea(FatContour(:,1),FatContour(:,2)); 
     
    % perimeter of fat contour 
    ClusterAP(ISCC,6) = sum(sqrt(sum((FatContour(2:end,:)-FatContour(1:end-
1,:)).^2,2))); 
     
     
     
    if CLUSTERCONTOURPLOTS, 
         
        figure(5003) 
        hold on 
        if ClustersAndContours{ISCC,1} > 0, plot(FatContour(:,1),FatContour(:,2),'-
','Color',ContourColor); end; 
         
        figure(1003) 
        hold on 
        if ClustersAndContours{ISCC,1} > 0, plot(FatContour(:,1),FatContour(:,2),'-
','Color',ContourColor); end; 
    end 
     
end 
 
 
 
if TOP12PLOTS, 
    figure(5002); 
    FigureName=[RootFileName sprintf('_%dnm_TopClusters',floor(1000*BestLength))]; 
    SaveThisFigure; 
end; 
 
 
if CLUSTERCONTOURPLOTS, 
    figure(5003) 
    %axis([22 23 15.5 16.5]) 
    FormatThisFigure; 
    FigureName=[RootFileName '_AllContours']; 
    %savefig(FigureName); 
    SaveThisFigure; 
     
end 
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if FILEOUTPUT , 
     
    % metadata output 
    % point count, perimeter, area, etc. 
    fout = fopen([RootFileName sprintf('_%dnm_meta.txt',floor(1000*BestLength))],'w'); 
     
    for ISC=1:max(Clusters) 
         
        %if DEMO && ISC>12, break; end; % loop limited to the 12 
         
        fprintf(fout,'%3d ', ISC); % cluster index 
         
        fprintf(fout,'%4d ',ClustersAndContours{ISC,1});% original (slow) point count 
        fprintf(fout,'%4d ',ClustersAndContours{ISC,3});% point count on tight contour 
        fprintf(fout,'%4d ',ClustersAndContours{ISC,5});% point count on padded contour 
         
        fprintf(fout,'%6.4f %6.4f %6.4f %6.4f %6.4f %6.4f\n', ClusterAP(ISC,[1 3 5 2 4 
6])); 
         
    end 
     
    fclose(fout); 
     
    % contour output 
    % polylines for each contour 
    fout=fopen([RootFileName 
sprintf('_%dnm_contours.txt',floor(1000*BestLength))],'w'); 
     
    % number of clusters on a separate line 
    fprintf(fout,'%4d\n',max(Clusters)); 
     
    % write out the fat contours only 
     
    for ISC=1:max(Clusters) 
        % if DEMO && ISC>12, break; end; % loop limited to the 12 
        % point counts from all contours on a single line 
        fprintf(fout,'%4d', ClustersAndContours{ISC,5}); 
    end 
     
    fprintf(fout,'\n'); 
     
    for ISC=1:max(Clusters) 
        % if DEMO && ISC>12, break; end; % loop limited to the 12 
        % pull out the contour data 
        FatContourOut=ClustersAndContours{ISC,6}; 
        % x coordinates on a single line 
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        fprintf(fout,'%8.5f ',FatContourOut(:,1)); 
        fprintf(fout,'\n'); 
        % y cordinates on a single line 
        fprintf(fout,'%8.5f ',FatContourOut(:,2)); 
        fprintf(fout,'\n'); 
    end 
     
    fclose(fout); 
     
end; 
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APPENDIX B: Spatial Stochastic Model Program Script 
ReceptorInfo Module 
MODULE ReceptorInfo 
  
 ! General Constants 
 DOUBLE PRECISION, PARAMETER :: Pi = 3.14159265 
  
 ! Species  
 ! 
 ! (1) ErbB2 
 ! (2) ErbB3 
 ! (3) ErbB2.ErbB3 
 ! (4) ErbB3.ErbB3 
 ! (5) ErbB2.ErbB2 
  
 ! Species Info 
 INTEGER :: NumBaseSpecies 
 INTEGER :: NumPhosStates 
 INTEGER :: NumLigandStates 
 INTEGER :: NumMonomerSpecies 
 ! Species during simulation 
 INTEGER, POINTER :: SpeciesCount(:) 
  
 ! Species matrix f(monomer species, monomer species) 
 INTEGER, POINTER :: SpeciesMatrix(:,:) ! 2,2 
 ! Dimer Allowed to form f(species,ligandcount) 
 LOGICAL, POINTER :: DimerForm(:,:) ! 5,3 
 ! Diffusion Coefficients [=] um^2/s, f(species, phosphorylation) 
 ! *** Parameters from Mara, lumped Monomer/Dimer together*** 
 ! Unphosphorylated Species 
 DOUBLE PRECISION, POINTER :: DiffCoeff(:,:) ! 5,3 
 ! Phosphorylation Rate [=] 1/s, f(species, phosphorylation) 
 ! *** Parameters from Shankaran et al (2006) BiophysJ *** 
 ! No Phosphorylation 
 DOUBLE PRECISION, POINTER :: PhosRate(:,:) ! 5,3 
 ! Dephosphorylation Rate [=] 1/s, f(species,phosphorylation) 
 ! *** Parameters from Shankaran et al (2006) BiophysJ *** 
 DOUBLE PRECISION, POINTER :: DePhosRate(:,:) ! 5,3 
 ! Dimer Off Rate [=] 1/s, f(species,ligand) 
 ! *** Parameters from Mara, unless noted *** 
 ! No Ligand 
 DOUBLE PRECISION, POINTER :: DimOffRate(:,:) ! 5,3 
 ! Dimer Binding Radius [=] um, f(proposed species type, phosphorylation)  
 ! Dimers forming with No Phos 
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 DOUBLE PRECISION, POINTER :: BindRadius(:,:) ! 5,3 
 ! Dimer UnBinding Radius [=] um, f(proposed species type, proposed ligand 
count)  
 ! Dimers forming with No Ligand 
 DOUBLE PRECISION, POINTER :: UnBindRadius(:,:) ! 5,3 
 ! Domain Escape Rate [=] 1/Frame, f(species) 
 ! *** Shalini Data for now *** 
 DOUBLE PRECISION, POINTER :: EscapeRate(:) ! 5 
 ! Receptor Flux Probability  
 DOUBLE PRECISION, POINTER :: RecFlip(:) ! 2 
 ! Phosphorylation Multiplier 
 DOUBLE PRECISION, POINTER :: PhosMulti(:,:) ! 2,3 
 ! Dephosphorylation Multiplier 
 DOUBLE PRECISION, POINTER :: DephosMulti(:,:) ! 2,3 
  
 Type Molecule 
  
  ! Species [1-5] 
  INTEGER :: OriginalSpecies 
  INTEGER :: Species 
  ! Ligand State [0 1] 
  INTEGER :: Ligand 
  ! Phos State [0 1] 
  INTEGER :: Phosphate 
  ! Position(2) 
  DOUBLE PRECISION :: Position(2) 
  ! Initial Position(2) 
  DOUBLE PRECISION :: InitialPosition(2) 
  ! Bound Partner 
  INTEGER :: BoundBuddy 
  ! Domain 
  INTEGER :: Domain 
  ! Active Receptor Receptor in dimer that is in active conformation 
  INTEGER :: ActiveTail 
   
 END TYPE Molecule 
  
 TYPE MoleculeData 
   
  ! Dimer Lifetime  
  DOUBLE PRECISION :: DimerStart 
  ! Phosphorylation Lifetime 
  DOUBLE PRECISION :: PhosStart 
  ! Last Jump Size [=] um 
  DOUBLE PRECISION :: JumpSize(3) 
  ! Tail has been phosphorylated in this dimer lifetime 
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  INTEGER :: PhosSuccess 
   
 END TYPE MoleculeData 
  
 !TYPE DomainLimits 
!   
!  DOUBLE PRECISION, POINTER :: xmin 
!  DOUBLE PRECISION, POINTER :: xmax 
!  DOUBLE PRECISION, POINTER :: ymin 
!  DOUBLE PRECISION, POINTER :: ymax 
!   
! END TYPE DomainLimits 
!  
! TYPE DomainVertices 
!   
!  DOUBLE PRECISION, POINTER :: XCoord(:) => null() 
!  DOUBLE PRECISION, POINTER :: YCoord(:) => null() 
!   
! END TYPE DomainVertices 
  
 TYPE DomainInfo 
   
  DOUBLE PRECISION, POINTER :: xmin 
  DOUBLE PRECISION, POINTER :: xmax 
  DOUBLE PRECISION, POINTER :: ymin 
  DOUBLE PRECISION, POINTER :: ymax 
  DOUBLE PRECISION, POINTER :: XCoord(:) => null() 
  DOUBLE PRECISION, POINTER :: YCoord(:) => null() 
  
 END TYPE DomainInfo 
  
 TYPE MembraneLimits 
  
  DOUBLE PRECISION :: xlimmin  
  DOUBLE PRECISION :: xlimmax 
  DOUBLE PRECISION :: ylimmin 
  DOUBLE PRECISION :: ylimmax 
  
 END TYPE MembraneLimits 
  
 TYPE SimulationData 
   
  DOUBLE PRECISION :: Length ! Seconds 
  DOUBLE PRECISION :: TimeStep ! Seconds 
  DOUBLE PRECISION :: RTimeStep ! TimeStep per Receptor 
  DOUBLE PRECISION :: CurrentTimeStep 
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  DOUBLE PRECISION :: FrameRate ! Frames per Second 
  INTEGER :: NumberReceptors 
  INTEGER, POINTER :: NumberDomains(:) ! => null() 
  CHARACTER(80) :: OutputDirectory 
  INTEGER, POINTER :: NumberVertices(:,:) ! => null() 
   
 END TYPE SimulationData  
  
 TYPE SpeciesData 
  
  INTEGER :: Liganded(3) 
  INTEGER :: Phosphorylated(3) 
  
 END TYPE SpeciesData 
  
 TYPE(Molecule), POINTER :: Receptor(:) 
 TYPE(MoleculeData), POINTER :: ReceptorData(:) 
 TYPE(DomainInfo), POINTER :: Domain(:,:) 
 !TYPE(DomainLimits), POINTER :: Domain(:)  
 !TYPE(DomainVertices), POINTER :: Vertex(:) 
 TYPE(SpeciesData), POINTER :: Species(:)  
 TYPE(MembraneLimits) :: Membrane 
 TYPE(SimulationData) :: Simulation 
 
END MODULE ReceptorInfo 
 
BoundaryCondition Module 
MODULE BCCheck 
 
CONTAINS 
 
 SUBROUTINE PeriodicBC(i,xjump,yjump) 
  
  USE ReceptorInfo 
   
  IMPLICIT NONE 
   
  DOUBLE PRECISION, INTENT(IN) :: xjump, yjump! Proposed x jump, 
Proposed y jump 
  INTEGER, INTENT(IN) :: i ! current receptor 
  DOUBLE PRECISION :: x, y ! proposed new position 
   
  ! Calculate new receptor position 
  x = xjump + Receptor(i)%Position(1) 
  y = yjump + Receptor(i)%Position(2) 
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  !! Periodic Boundary Conditions 
  ! Check & Apply Periodic Boundary Condition 
  ! Check x move  
  IF (x < Membrane%xlimmin) THEN ! Add width of box 
   ! Define X New Coordinate 
   Receptor(i)%Position(1)=x+(Membrane%xlimmax-
Membrane%xlimmin) 
  ELSE IF (x > Membrane%xlimmax) THEN ! Subtract width of box 
   ! Define X New Coordinate 
   Receptor(i)%Position(1)=x-(Membrane%xlimmax-
Membrane%xlimmin) 
  ELSE ! remains unchanged 
   ! Define X New Coordinate 
   Receptor(i)%Position(1)=x 
  END IF 
  ! Check y move 
  IF (y < Membrane%ylimmin) THEN ! Add length of box 
   ! Define Y New Coordinate 
   Receptor(i)%Position(2)=y+(Membrane%ylimmax-
Membrane%ylimmin) 
  ELSE IF (y > Membrane%ylimmax) THEN ! Subtract length of box 
   ! Define Y New Coordinate 
   Receptor(i)%Position(2)=y-(Membrane%ylimmax-
Membrane%ylimmin) 
  ELSE ! remains unchanged 
   ! Define Y New Coordinate 
   Receptor(i)%Position(2)=y 
  END IF 
   ! No periodic condition applied to allow for free diffusion 
  
 END SUBROUTINE PeriodicBC 
  
 SUBROUTINE ReflectiveBC(i,xjump,yjump) 
   
  ! Condition: Only for receptors in domains, does not work for free 
receptors 
   
  USE ReceptorInfo 
    
  IMPLICIT NONE 
   
  DOUBLE PRECISION, INTENT(IN) :: xjump, yjump 
  INTEGER, INTENT(IN) :: i ! Current receptor 
  DOUBLE PRECISION :: x, y ! Proposed move 
   
  IF (Receptor(i)%Domain == 0) THEN 
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   WRITE(*,*) 'ERROR : FREE RECEPTOR PASSED TO 
ReflectiveBC Subroutine' 
  END IF 
   
  ! Check & Apply Reflective Boundary Condition 
  x=Receptor(i)%Position(1)+xjump 
  y=Receptor(i)%Position(2)+yjump 
  !WRITE(*,*) 'x = ', x, 'y = ', y 
  ! Check x move  
  IF (x < 
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%xmin) THEN  
   ! Define X New Coordinate 
  
 Receptor(i)%Position(1)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%xmin& 
   &-xjump-Receptor(i)%Position(1) 
  ELSE IF (x > 
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%xmax) THEN  
   ! Define X New Coordinate 
  
 Receptor(i)%Position(1)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%xmax& 
   &-xjump-Receptor(i)%Position(1) 
  END IF 
  ! Check y move 
 
  IF (y < 
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%ymin) THEN 
   ! Define Y New Coordinate 
  
 Receptor(i)%Position(2)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%ymin& 
   &-yjump-Receptor(i)%Position(2) 
  ELSE IF (y > 
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%ymax) THEN 
   ! Define Y New Coordinate 
  
 Receptor(i)%Position(2)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%ymax& 
   &-yjump-Receptor(i)%Position(2) 
  END IF 
  
 END SUBROUTINE ReflectiveBC 
  
 SUBROUTINE DomainCheck(i,xjump,yjump,domainnum,DomainChange) 
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 USE ReceptorInfo 
  
 IMPLICIT NONE 
  
 INTEGER, INTENT(IN) :: i ! Current receptor 
 INTEGER, INTENT(OUT) :: domainnum ! domain where proposed coordinates 
fall, if 0 not in a domain 
 DOUBLE PRECISION, INTENT(IN) :: yjump, xjump 
 INTEGER :: k, numdomains, j, kk, nverts, ReceptorDomain, c, jjj ! Counter 
 DOUBLE PRECISION :: x, y ! proposed new location 
 LOGICAL, INTENT(OUT) :: DomainChange 
 LOGICAL :: 
xmincheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies))  
 LOGICAL :: 
ymincheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies)) 
 LOGICAL :: 
xmaxcheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies)) 
 LOGICAL :: 
ymaxcheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies)) 
  
 x=Receptor(i)%Position(1) + xjump 
 y=Receptor(i)%Position(2) + yjump 
 DomainChange = .FALSE. 
 ReceptorDomain = Receptor(i)%Domain 
 numdomains = Simulation%NumberDomains(Receptor(i)%OriginalSpecies) 
 !ALLOCATE(xmincheck(Simulation%NumberDomains), 
xmaxcheck(Simulation%NumberDomains)) 
 !ALLOCATE(ymincheck(Simulation%NumberDomains), 
ymaxcheck(Simulation%NumberDomains)) 
 ! Check where the new coordinate falls in the simulation space 
 domainnum = 0 !Receptor(i)%Domain 
 IF (numdomains /= 0) THEN 
  !WRITE(*,*) 'Check if Receptor is in a Domain. Receptor Species =', 
Receptor(i)%OriginalSpecies, 'numdomains =',  numdomains 
  ! Create boolean vectors for each domain edge 
  DO jjj = 1, numdomains 
   xmincheck = x >= 
Domain(jjj,Receptor(i)%OriginalSpecies)%xmin 
   xmaxcheck = x <= 
Domain(jjj,Receptor(i)%OriginalSpecies)%xmax 
   ymincheck = y >= 
Domain(jjj,Receptor(i)%OriginalSpecies)%ymin 
   ymaxcheck = y <= 
Domain(jjj,Receptor(i)%OriginalSpecies)%ymax 
  END DO 
  !WRITE(*,*) x, y  
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  !WRITE(*,*) xmincheck, xmaxcheck, ymincheck, ymaxcheck 
  DO k = 1,numdomains 
   IF (xmincheck(k) .AND. xmaxcheck(k) .AND. ymincheck(k) 
.AND. ymaxcheck(k)) THEN 
    !WRITE(*,*) 'Receptor MAY be in a domain' 
    domainnum = k 
    ! Check if receptor is actually in polygon 
    nverts = 
Simulation%NumberVertices(k,Receptor(i)%OriginalSpecies) 
    kk = nverts - 1 
    j = 1 
    c = 0 
    DO WHILE (j < nverts) 
      
     ! ,Receptor(i)%OriginalSpecies 
      
     !IF (((Vertex(k)%YCoord(j) > y) .NEQV. 
(Vertex(k)%YCoord(kk)>y)) .AND. & 
!     (x<(Vertex(k)%XCoord(kk)-
Vertex(k)%XCoord(j))*(y-Vertex(k)%YCoord(j))& 
!     /(Vertex(k)%YCoord(kk)-
Vertex(k)%YCoord(j))+Vertex(k)%XCoord(j))) THEN 
     IF 
(((Domain(k,Receptor(i)%OriginalSpecies)%YCoord(j) > y) .NEQV. & 
    
 &(Domain(k,Receptor(i)%OriginalSpecies)%YCoord(kk)>y)) .AND. & 
    
 (x<(Domain(k,Receptor(i)%OriginalSpecies)%XCoord(kk)-& 
    
 &Domain(k,Receptor(i)%OriginalSpecies)%XCoord(j))*& 
     &(y-
Domain(k,Receptor(i)%OriginalSpecies)%YCoord(j))& 
    
 /(Domain(k,Receptor(i)%OriginalSpecies)%YCoord(kk)-& 
    
 &Domain(k,Receptor(i)%OriginalSpecies)%YCoord(j))+& 
    
 &Domain(k,Receptor(i)%OriginalSpecies)%XCoord(j))) THEN 
      c = c + 1  
     END IF 
     kk = j 
     j = j + 1 
    END DO 
    IF (MOD(c,2) /= 0) THEN 
     !WRITE(*,*) 'Receptor IS in a domain' 
     IF (domainnum /= ReceptorDomain) THEN 
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      DomainChange = .True. 
     END IF 
    ELSE 
     !WRITE(*,*) 'Receptor IS NOT in a domain' 
     domainnum = 0  
    END IF  
   END IF 
  END DO  
 END IF 
 IF (domainnum == 0 .AND. domainnum /= ReceptorDomain) THEN 
   DomainChange = .True. 
 END IF 
 !WRITE(*,*) 'Domain Change?', DomainChange, 'New Domain', domainnum, 
'Old Domain', Receptor(i)%Domain  
  
 END SUBROUTINE DomainCheck 
  
 SUBROUTINE DomainEscape(EscapeProb,i,xjump,yjump,domainnum) 
   
  ! Condition: Only for receptors in domains, does not work for free 
receptors 
   
  USE ReceptorInfo 
  USE mtmod 
   
  IMPLICIT NONE 
   
  DOUBLE PRECISION, INTENT(IN) :: EscapeProb, xjump, yjump 
  INTEGER, INTENT(IN) :: i, domainnum ! Current receptor, anticipated 
domain 
  INTEGER :: domainnum2 
  LOGICAL :: DomainChange2 
   
  DomainChange2 = .False. 
   
  IF (Receptor(i)%Domain == 0 .AND. EscapeProb < 1) THEN 
   WRITE(*,*) 'ERROR : FREE RECEPTOR PASSED TO 
DomainEscape Subroutine' 
  END IF 
   
  !IF (Receptor(i)%Species == 3) THEN 
!   IF (Receptor(i)%Domain > 0 .AND. 
Receptor(Receptor(i)%BoundBuddy)%Domain > 0) THEN 
!    WRITE(*,*) 'Dimer with Receptors in their own domains', 
Receptor(i)%OriginalSpecies,& 
!    & Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies 
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!   END IF 
!  END IF 
  
  IF (EscapeProb >= grnd()) THEN ! Escape! 
   IF (EscapeProb /= 1) THEN 
    !WRITE(*,*) 'ESCAPE! Successful Domain Change' 
   END IF  
   IF (domainnum == 0) THEN ! Moving to free membrane, check 
periodic BC 
    !WRITE(*,*) 'Periodic Check' 
    CALL PeriodicBC(i,xjump,yjump) 
   ELSE ! Moving to another domain 
    !WRITE(*,*) 'Auto Assign' 
    Receptor(i)%Position(1)=Receptor(i)%Position(1)+xjump 
    Receptor(i)%Position(2)=Receptor(i)%Position(2)+yjump 
    Receptor(i)%Domain=domainnum  
   END IF 
    
  ELSE ! Reflect back into domain 
   !WRITE(*,*) 'Reflective Check' 
   CALL ReflectiveBC(i,xjump,yjump)  
  END IF  
  
  IF (Receptor(i)%Species == 3) THEN ! Heterodimer 
     
    ! Check of opposite species leaves its own domain 
    CALL 
DomainCheck(Receptor(i)%BoundBuddy,xjump,yjump,domainnum2,DomainChange2) 
     
    ! Update bound receptors position 
   
 Receptor(Receptor(i)%BoundBuddy)%Position(1)=Receptor(i)%Position(1)+xju
mp 
   
 Receptor(Receptor(i)%BoundBuddy)%Position(2)=Receptor(i)%Position(2)+yju
mp 
     
    ! Update bound buddy domain information 
    IF (DomainChange2) THEN 
     !WRITE(*,*) 'Dimer with Receptors in their own 
domains', Receptor(i)%OriginalSpecies,& 
     !& 
Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies 
     !WRITE(*,*) 'New Domain 1', 
Receptor(i)%Domain, 'Domain 2', Receptor(Receptor(i)%BoundBuddy)%Domain 
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 Receptor(Receptor(i)%BoundBuddy)%Domain=domainnum2 
      
     !WRITE(*,*) '-----------------------------^^^^^^^------
------------'  
     !WRITE(*,*) 'Domain Change for BoundBuddy?', 
DomainChange2 
     !WRITE(*,*) 'domainnum =', domainnum, 
'domainnum2 =', domainnum2 
     !WRITE(*,*) 'New Domain 1', 
Receptor(i)%Domain, 'New Domain 2', Receptor(Receptor(i)%BoundBuddy)%Domain 
     !WRITE(*,*) '---------------------------------------------
---------'  
    END IF 
     
   END IF 
  
 END SUBROUTINE DomainEscape    
   
END MODULE BCCheck  
ReceptorReactions Module 
MODULE ReceptorReactions 
 
CONTAINS 
  
 ! Diffusion (Dimerization Possible) 
 SUBROUTINE ReceptorDiffuse(i,Reaction) 
  
  USE ReceptorInfo 
  USE mtmod 
  USE BCCheck 
 
  IMPLICIT NONE 
   
  INTEGER, INTENT(IN) :: i 
  DOUBLE PRECISION :: r1, r2, w1, w2, xjump, yjump, DiffSTD, 
EscapeProb 
  INTEGER :: LigandCount, PhosphateCount, domainnum, domainnum2 
  LOGICAL :: DomainChange, DomainChange2, Dimer, Reaction 
   
  ! Calculate Ligand count and phosphate count of current receptor and its 
partner (if applicable) 
  Reaction = .False. 
  Dimer = .False. 
  DomainChange2 = .False. 
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  IF (Receptor(i)%BoundBuddy > 0) THEN ! Dimer 
   Dimer = .True. 
   LigandCount = Receptor(i)%Ligand + 
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1 
   PhosphateCount = Receptor(i)%Phosphate + 
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1 
  ELSE ! Monomer 
   LigandCount = Receptor(i)%Ligand + 1 
   PhosphateCount = Receptor(i)%Phosphate + 1 
  END IF 
   
  ! Calculate Escape Probability 
  EscapeProb = 
EscapeRate(Receptor(i)%Species)*Simulation%FrameRate*Simulation%TimeStep 
   
  ! Calculate Diffusion Deviation, DiffCoeff(Species,Phosphate)  
  ! ***increase phosphate count by 1 due to array indexing starting at 1 not 
0*** 
 
 DiffSTD=sqrt(2*DiffCoeff(Receptor(i)%Species,PhosphateCount)*Simulation%
TimeStep) 
   
  !!! randomly make a trajectory for particles using mtmod.f90 for random 
numbers !!! 
  !! Generate random number & Normally distribute random number ! 
http://www.taygeta.com/random/gaussian.html 
  !* Generate x move 
  r1=2*grnd()-1 
  r2=2*grnd()-1 
  ! Check unit circle, if not in reject and try again 
  w1=r1*r1+r2*r2 
  DO WHILE (w1 > 1) 
   ! Generate random number again  
   r1=2*grnd()-1 
   r2=2*grnd()-1 
   ! Unit circle check 
   w1=r1*r1+r2*r2 
  END DO 
  w2=sqrt((-2*log(w1))/w1) 
  ! Normally distributed random # for distance 
  xjump=r1*w2 
 
  ! Generate y move 
  r1=2*grnd()-1 
  r2=2*grnd()-1 
  ! Check unit circle, if not in reject and try again 
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  w1=r1*r1+r2*r2 
  DO WHILE (w1 > 1) 
   ! Generate random number again  
   r1=2*grnd()-1 
   r2=2*grnd()-1 
   ! Unit circle check 
   w1=r1*r1+r2*r2 
  END DO 
  w2=sqrt((-2*log(w1))/w1) 
  yjump=r2*w2 
   
  ! Account for diffusion coefficient based on species type 
  yjump=yjump*DiffSTD 
  xjump=xjump*DiffSTD 
   
  !! Add new normaly distributed distance to previous distance 
  ! Define Move Distance 
  ReceptorData(i)%JumpSize(1)=xjump ! dx(j,i)=xjump 
  ReceptorData(i)%JumpSize(2)=yjump ! dy(j,i)=yjump 
  ! Overall Distance Interval Calculation 
  ReceptorData(i)%JumpSize(3)=sqrt(yjump**2+xjump**2) ! 
d(j,i)=sqrt(yjump**2+xjump**2) 
  ! Assign move distances to bound receptor if necessary 
  IF (Dimer) THEN 
  
 ReceptorData(Receptor(i)%BoundBuddy)%JumpSize(:)=ReceptorData(i)%Jump
Size(:) 
  END IF 
 
  ! Determine if the particle leaves the domain or stays in the domain 
  CALL DomainCheck(i,xjump,yjump,domainnum,DomainChange) 
   
  IF (DomainChange) THEN ! Changing domains 
   ! Check if leaving or entering domain 
   IF (Receptor(i)%Domain > 0) THEN ! Leaving domain 
    ! Check if receptor escapes, if yes move to new domain 
    CALL 
DomainEscape(EscapeProb,i,xjump,yjump,domainnum) 
   ELSE ! Free receptor moving to domain, always allowed 
    ! execute with escape prob = 1 
    CALL DomainEscape(1.0d0,i,xjump,yjump,domainnum) 
   END IF  
  ELSE ! Not Changing domains 
   ! execute with escape prob = 1 just updates position or calls 
periodic if needed 
   CALL DomainEscape(1.0d0,i,xjump,yjump,domainnum)  
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  END IF 
   
  IF (.NOT. Dimer) THEN ! Monomer, Check for dimerization 
   CALL BindReaction(i,Dimer) 
   Reaction = Dimer 
  END IF 
   
  IF (Dimer .AND. Receptor(i)%Species > 3) THEN ! Homodimers 
   IF (Receptor(i)%BoundBuddy == 0) THEN 
    WRITE(*,*) 'ERROR : Monomer being treated as Dimer in 
ReceptorDiffuse Subroutine' 
   END IF  
   ! Update boundbuddy info 
  
 Receptor(Receptor(i)%BoundBuddy)%Position(1)=Receptor(i)%Position(1) 
  
 Receptor(Receptor(i)%BoundBuddy)%Position(2)=Receptor(i)%Position(2) 
  
 Receptor(Receptor(i)%BoundBuddy)%Domain=Receptor(i)%Domain 
   
  END IF 
   
 END SUBROUTINE ReceptorDiffuse  
  
 ! Dimerization Reaction 
 SUBROUTINE BindReaction(i,Reaction) 
   
  ! CONDITION: Can only be called for monomer species!!! 
   
  USE ReceptorInfo 
  USE mtmod 
 
  IMPLICIT NONE 
  
  INTEGER, INTENT(IN) :: i ! current particle 
  LOGICAL, INTENT(OUT) :: Reaction 
  LOGICAL :: monomercheck(Simulation%NumberReceptors), DimerPoss, 
PhosCheck 
  INTEGER :: PickedSpecies, Phosphate(Simulation%NumberReceptors), 
LigandCount(Simulation%NumberReceptors) 
  INTEGER :: NewSpecies, k 
  DOUBLE PRECISION :: x_POI, y_POI, 
distsq(Simulation%NumberReceptors), rannum 
  Reaction = .FALSE. 
  PhosCheck = .TRUE. 
  ! Error check 
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  IF (Receptor(i)%BoundBuddy > 0) THEN 
   WRITE(*,*) 'ERROR : DIMER SPECIES PASSED TO 
BindReaction Subroutine' 
  END IF 
  x_POI=Receptor(i)%Position(1) 
  y_POI=Receptor(i)%Position(2) 
  PickedSpecies = Receptor(i)%Species ! Always a monomer 
   
  ! Calculate distance between picked receptor and other receptors 
  distsq=sqrt((Receptor%Position(1)-x_POI)**2+(Receptor%Position(2)-
y_POI)**2) 
  ! Determine monomers 
  monomercheck = Receptor%Species <= SIZE(SpeciesMatrix,1) 
  ! Calculate proposed phosphate & species, Add 1 for index counting 
starting at 1, 0 phosphates accessed by variable(1) 
  Phosphate = Receptor(i)%Phosphate+Receptor%Phosphate + 1 
  LigandCount = Receptor(i)%Ligand+Receptor%Ligand + 1 
  DO k = 1,Simulation%NumberReceptors  
   IF (monomercheck(k)) THEN 
    NewSpecies = 
SpeciesMatrix(PickedSpecies,Receptor(k)%Species) 
    DimerPoss = DimerForm(NewSpecies,LigandCount(k)) 
     
    IF (DimerPoss .AND. distsq(k) <= 
BindRadius(NewSpecies,Phosphate(k)) .AND. k/=i) THEN 
      
     rannum = 0 
     IF (LigandCount(k) < 3) THEN 
      rannum = grnd() 
     END IF  
 
     IF (rannum <= RecFlip(PickedSpecies)) THEN ! 
Check conformation of first monomer 
      rannum = 0 
      IF (LigandCount(k) == 1) THEN 
       rannum = grnd() 
      END IF 
       
      IF (rannum <= 
RecFlip(Receptor(k)%Species)) THEN ! Check conformation of second monomer 
        
       Reaction = .True. 
      
 SpeciesCount(PickedSpecies)=SpeciesCount(PickedSpecies)-1 
      
 SpeciesCount(Receptor(k)%Species)=SpeciesCount(Receptor(k)%Species)-1 
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       ! Record Dimer Start Time 
       Receptor(i)%Species = NewSpecies 
       Receptor(k)%Species = NewSpecies 
       ReceptorData(i)%DimerStart = 
Simulation%CurrentTimeStep 
       ReceptorData(k)%DimerStart = 
Simulation%CurrentTimeStep 
       Receptor(i)%BoundBuddy=k 
       Receptor(k)%BoundBuddy=i 
      
 SpeciesCount(PickedSpecies)=SpeciesCount(PickedSpecies)+1 
       ! Pick active receptor of dimer 
       rannum = grnd() 
       IF (rannum <= .5) THEN 
        Receptor(i)%ActiveTail=i 
        Receptor(k)%ActiveTail=i 
       ELSE 
        Receptor(i)%ActiveTail=k 
        Receptor(k)%ActiveTail=k 
       END IF  
      END IF 
     END IF 
     RETURN  
    END IF 
   END IF 
  END DO 
 
 END SUBROUTINE BindReaction 
 
! Dimer dissociation Reaction 
 SUBROUTINE DissociationReaction(i) 
  
  USE ReceptorInfo 
  USE mtmod 
  USE BCCheck 
  
  IMPLICIT NONE 
  
  INTEGER, INTENT(IN) :: i 
  DOUBLE PRECISION :: placeangle, xjump, yjump, EscapeProb 
  INTEGER :: LigandCount, PhosphateCount, domainnum, k 
  LOGICAL :: DomainChange 
 
  
  ! We know dissociation will occur, need to sort out data information 
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 SpeciesCount(Receptor(i)%Species)=SpeciesCount(Receptor(i)%Species)-1 
  ! Calculate new postion for moving (unbinding) receptor 
  ! Randomly pick position to place chosen part 
  placeangle=2*Pi*grnd() ! Pick a number between 0 and 2*Pi 
  ! Calculate LigandCount 
  LigandCount = Receptor(i)%Ligand + 
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1 
  PhosphateCount = Receptor(i)%Phosphate + 
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1 
  ! Separate Receptors 
  xjump = 
cos(placeangle)*UnBindRadius(Receptor(i)%Species,LigandCount) 
  yjump = 
sin(placeangle)*UnBindRadius(Receptor(i)%Species,LigandCount) 
  IF (xjump == 0) THEN 
   WRITE(*,*) 'ERROR in DissociationReaction' 
  END IF  
  ! Check if moving receptor changes domains and update position 
accordingly 
  IF (Receptor(Receptor(i)%BoundBuddy)%Domain > 0) THEN ! Check if 
moves from domain 
   CALL 
DomainCheck(Receptor(i)%BoundBuddy,xjump,yjump,domainnum,DomainChange) 
   IF (DomainChange) THEN 
    ! Calculate Escape Probability 
    EscapeProb = 
EscapeRate(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)*Simulation%Frame
Rate*Simulation%TimeStep 
    CALL 
DomainEscape(EscapeProb,Receptor(i)%BoundBuddy,xjump,yjump,domainnum) 
   ELSE 
    CALL 
DomainEscape(1.0d0,Receptor(i)%BoundBuddy,xjump,yjump,domainnum) 
   END IF 
  END IF  
   
  ! Record Dimer lifetime 
  ! Receptor 1 receptor 2 Dimer Start, Dimer End, Difference 
  WRITE(4,*) 
i,Receptor(i)%BoundBuddy,Receptor(i)%Species,LigandCount,PhosphateCount,Recepto
rData(i)%DimerStart, & 
   
 &Simulation%CurrentTimeStep,Simulation%CurrentTimeStep-
ReceptorData(i)%DimerStart 
        
199 
  ! Update both receptors info back to monomer status 
 
 SpeciesCount(Receptor(i)%OriginalSpecies)=SpeciesCount(Receptor(i)%Origina
lSpecies)+1 
 
 SpeciesCount(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)=SpeciesC
ount(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)+1 
  Receptor(Receptor(i)%BoundBuddy)%Species = 
Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies 
  Receptor(Receptor(i)%BoundBuddy)%BoundBuddy = 0 
  ReceptorData(Receptor(i)%BoundBuddy)%DimerStart = 0 
  ReceptorData(Receptor(i)%BoundBuddy)%PhosSuccess = 0 
  ReceptorData(i)%PhosSuccess = 0 
  Receptor(i)%ActiveTail = 0 
  Receptor(Receptor(i)%BoundBuddy)%ActiveTail = 0 
  Receptor(i)%Species = Receptor(i)%OriginalSpecies 
  Receptor(i)%BoundBuddy = 0 
  ReceptorData(i)%DimerStart = 0 
   
   
 END SUBROUTINE DissociationReaction 
 
 ! Phosphorylation 
 SUBROUTINE Phosphorylate(i) 
 
  USE ReceptorInfo 
  USE mtmod 
  
  IMPLICIT NONE 
  
  INTEGER, INTENT(IN) :: i ! Particle number,  
   
  IF (Receptor(i)%Species <= SIZE(SpeciesMatrix,1)) THEN 
   WRITE(*,*) 'ERROR : in Phosphorylate subroutine, monomer 
species' 
  END IF  
  !! Symmetric Model !! 
  ! update phosphate 
  !Receptor(i)%Phosphate = 1 
  !Receptor(Receptor(i)%BoundBuddy)%Phosphate = 1 
  !IF (Receptor(i)%Species == 4) THEN  
   WRITE(*,*) 'In Function: PHOSPHORYLATE! Species: ', 
Receptor(i)%Species!, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount 
   !WRITE(*,*) 'Species = ', Receptor(i)%Species,'UnbindProb =', 
UnbindProb, 'PhosProb =', PhosProb, 'DephosProb =', DephosProb  
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   WRITE(*,*) 'Ligand Count (+1 for indexing)=', 
Receptor(i)%Ligand + Receptor(Receptor(i)%BoundBuddy)%Ligand + 1  
   WRITE(*,*) 'PhosState of ActiveTail =', 
Receptor(Receptor(i)%ActiveTail)%Phosphate      
  !END IF 
  !! Asymmetric Model 
  Receptor(Receptor(i)%ActiveTail)%Phosphate = 1 
  ! update phos start 
  ReceptorData(Receptor(i)%ActiveTail)%PhosStart = 
Simulation%CurrentTimeStep 
  ReceptorData(Receptor(i)%ActiveTail)%PhosSuccess = 1 
  !ReceptorData(Receptor(i)%BoundBuddy)%PhosStart = 
Simulation%CurrentTimeStep 
   
  ! Record phosphorylation reaction information 
  ! Active Receptor (one phosphorylated), Active Receptor Original 
Species, Receiver Receptor, Receiver Phos state, timestamp 
  WRITE(8,*) Receptor(i)%ActiveTail, 
Receptor(Receptor(i)%ActiveTail)%OriginalSpecies,& 
  
 &Receptor(Receptor(i)%ActiveTail)%BoundBuddy,Receptor(Receptor(Receptor(
i)%ActiveTail)%BoundBuddy)%OriginalSpecies,& 
  
 &Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate, 
Simulation%CurrentTimeStep 
  
 END SUBROUTINE Phosphorylate 
 
 ! Dephosphorylation 
 SUBROUTINE DePhosphorylate(i) 
  
 ! Dephosphorylation Subroutine. Only dephosphorylates the picked receptor. If 
the  
 ! receptor is bound to another receptor, the bound receptor is left alone. 
  USE ReceptorInfo 
  USE mtmod 
 
  IMPLICIT NONE 
  
  INTEGER, INTENT(IN) :: i 
  
  Receptor(i)%Phosphate = 0 
   
  ! Record Phos lifetime 
  ! Receptor 1 receptor 2 Phos Start, Phos End, Difference 
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  WRITE(9,*) 
i,Receptor(i)%BoundBuddy,Receptor(i)%Species,ReceptorData(i)%PhosStart, & 
   
 &Simulation%CurrentTimeStep,Simulation%CurrentTimeStep-
ReceptorData(i)%PhosStart 
   
  ReceptorData(i)%PhosStart = 0 
    
 END SUBROUTINE DePhosphorylate 
  
END MODULE ReceptorReactions 
 
Main Spatial Stochastic Simulation Module 
 
PROGRAM ErbB23_Sim 
 
 ! Use mtmod to generate random number 
 USE mtmod 
 USE ReceptorInfo 
 USE BCCheck 
 USE ReceptorReactions 
  
 IMPLICIT NONE 
  
 INTEGER :: i, k, seed, LigandCount, PhosphateCount, datacutcount, datacut 
 INTEGER :: framecount, frames, DomainLimitsFile(2), DomainVertFile(2) 
 LOGICAL :: Reaction 
 INTEGER*8 :: NMoves, RMoves, j 
 CHARACTER*200 fnstring, fnstring2, fnstring3, fnstring4, fnstring5, fnstring6, 
fnstring7 ! Filename string 
 DOUBLE PRECISION :: UnbindProb, PhosProb, DephosProb, randnum 
  
 WRITE(*,*) 'Importing Parameter Data' 
  
 OPEN(4,file='ParameterInput') 
  
 READ(4,*) NumBaseSpecies, NumPhosStates, NumLigandStates, 
NumMonomerSpecies 
  
 ALLOCATE(SpeciesMatrix(NumMonomerSpecies,NumMonomerSpecies),Dime
rForm(NumBaseSpecies,NumLigandStates)) 
 ALLOCATE(DiffCoeff(NumBaseSpecies,NumPhosStates),PhosRate(NumBaseS
pecies,NumPhosStates)) 
 ALLOCATE(DePhosRate(NumBaseSpecies,NumPhosStates),DimOffRate(Num
BaseSpecies,NumLigandStates)) 
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 ALLOCATE(BindRadius(NumBaseSpecies,NumPhosStates),UnBindRadius(Nu
mBaseSpecies,NumLigandStates)) 
 ALLOCATE(EscapeRate(NumBaseSpecies),RecFlip(NumMonomerSpecies),Spe
ciesCount(NumBaseSpecies)) 
 ALLOCATE(PhosMulti(NumMonomerSpecies,NumPhosStates), 
DephosMulti(NumMonomerSpecies,NumPhosStates)) 
  
 SpeciesCount(:) = 0 
 ! Assign input values to parameters 
 DO k = 1,NumPhosStates 
  READ(4,*) DiffCoeff(:,k) 
 END DO 
 DO k = 1,NumPhosStates 
  READ(4,*) PhosRate(:,k) 
 END DO 
 DO k = 1,NumPhosStates 
  READ(4,*) DePhosRate(:,k) 
 END DO  
 DO k = 1,NumLigandStates 
  READ(4,*) DimOffRate(:,k) 
 END DO  
 DO k = 1,NumPhosStates 
  READ(4,*) BindRadius(:,k) 
 END DO  
 DO k = 1,NumLigandStates 
  READ(4,*) UnBindRadius(:,k) 
 END DO 
 READ(4,*) EscapeRate(:) 
 READ(4,*) RecFlip(:) 
 DO k = 1,NumMonomerSpecies 
  Read(4,*) SpeciesMatrix(:,k) 
 END DO 
 DO k = 1,NumLigandStates 
  READ(4,*) DimerForm(:,k) 
  !WRITE(*,*) DimerForm(:,k) 
 END DO 
! DO k = 1,NumPhosStates 
!  READ(4,*) PhosMulti(:,k) 
!  WRITE(*,*) 'Phos:',PhosMulti(:,k) 
! END DO   
! DO k = 1,NumPhosStates 
!  READ(4,*) DephosMulti(:,k) 
! END DO 
 CLOSE(4) 
 
 ! Read in Simulation input, initial receptor locations, & domain locations 
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 OPEN (1,file='BMIP') 
 OPEN (2,file='InitialParticleLoc') 
 OPEN (7,file='DomainVertices_1') 
 OPEN (3,file='DomainLimits_1') 
 OPEN (8,file='DomainVertices_2') 
 OPEN (4,file='DomainLimits_2') 
     
 DomainLimitsFile(1) = 3 
 DomainLimitsFile(2) = 4 
 DomainVertFile(1) = 7 
 DomainVertFile(2) = 8 
  
 ALLOCATE (Simulation%NumberDomains(NumMonomerSpecies)) 
  
 WRITE(*,*) 'Importing Input Data' 
  
 ! Read in values from input file 
 READ(1,107) Simulation%OutputDirectory ! HPC Path info 
 READ(1,100) Simulation%NumberReceptors ! # of particles 
 READ(1,101) Simulation%TimeStep ! Time step [s] 
 READ(1,102) 
Membrane%xlimmax,Membrane%ylimmax,Membrane%xlimmin,Membrane%ylimmin ! 
simulation boundaries  
 READ(1,*) Simulation%FrameRate ! data print frequency 
 READ(1,106) Simulation%Length  
 READ(1,109) Simulation%NumberDomains(:) ! simulation length [s], # of 
domains [ErbB2 ErbB3] 
  
 ALLOCATE 
(Receptor(Simulation%NumberReceptors),ReceptorData(Simulation%NumberReceptors
)) 
 ALLOCATE (Species(NumBaseSpecies)) 
 ALLOCATE 
(Simulation%NumberVertices(Simulation%NumberDomains(2),NumMonomerSpecies)) 
  
  
 DO k = 1,NumBaseSpecies 
  Species(k)%Liganded(:)=0 
  Species(k)%Phosphorylated(:)=0 
 END DO 
  
 WRITE(*,*) 'Importing Individual Receptor Data' 
  
 ! Read intial position of Receptor  
 DO k = 1,Simulation%NumberReceptors 
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  READ(2,103) 
Receptor(k)%InitialPosition(1),Receptor(k)%InitialPosition(2), & 
     &Receptor(k)%Domain, 
Receptor(k)%OriginalSpecies, Receptor(k)%Ligand, & 
     &Receptor(k)%BoundBuddy  
  103 FORMAT(F18.16,F18.16,I3,I2,I2,I4) 
 
 SpeciesCount(Receptor(k)%OriginalSpecies)=SpeciesCount(Receptor(k)%Origin
alSpecies)+1 
 
 Species(Receptor(k)%OriginalSpecies)%Liganded(Receptor(k)%Ligand+1)= & 
 
 &Species(Receptor(k)%OriginalSpecies)%Liganded(Receptor(k)%Ligand+1)+1 
 END DO 
 CLOSE(2) 
  
 !WRITE(*,*) Receptor(:)%Domain 
  
 Receptor(:)%Species = Receptor(:)%OriginalSpecies 
 Receptor(:)%Position(1) = Receptor(:)%InitialPosition(1) 
 Receptor(:)%Position(2) = Receptor(:)%InitialPosition(2) 
 
100 FORMAT(I10) 
101 FORMAT(F10.7) 
102 FORMAT(F7.4,F7.4,F7.4,F7.4) 
105 FORMAT(I10) 
106 FORMAT(F6.2) 
107 FORMAT(a) 
109 FORMAT(I3,I3) 
 CLOSE(1) 
  
 WRITE(*,*) 'Importing Domain Data' 
  
 ALLOCATE (Domain(Simulation%NumberDomains(2),NumMonomerSpecies)) 
 ALLOCATE 
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%xmin) 
 ALLOCATE 
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%xmax) 
 ALLOCATE 
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%ymin) 
 ALLOCATE 
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%ymax) 
  
 ! Read in number of vertices for each dom  
 READ(DomainVertFile(1),*) 
Simulation%NumberVertices(1:Simulation%NumberDomains(1),1) 
205 
 READ(DomainVertFile(2),*) Simulation%NumberVertices(:,2) 
    
 DO i = 1,2 
  DO j = 1,Simulation%NumberDomains(i) 
    
   ! Import Domain mins and maxes 
   ALLOCATE (Domain(j,i)%xmin) 
   ALLOCATE (Domain(j,i)%xmax) 
   ALLOCATE (Domain(j,i)%ymin) 
   ALLOCATE (Domain(j,i)%ymax) 
   READ(DomainLimitsFile(i),*) Domain(j,i)%xmin, 
Domain(j,i)%xmax, Domain(j,i)%ymin, Domain(j,i)%ymax 
    
   ! Import Domain Vertices 
   ALLOCATE 
(Domain(j,i)%XCoord(Simulation%NumberVertices(j,i))) 
   ALLOCATE 
(Domain(j,i)%YCoord(Simulation%NumberVertices(j,i))) 
    
   READ(DomainVertFile(i),*) Domain(j,i)%XCoord 
   READ(DomainVertFile(i),*) Domain(j,i)%YCoord 
   
  END DO 
 END DO 
 
 CLOSE(3) 
 CLOSE(4) 
 CLOSE(7) 
 CLOSE(8) 
  
 WRITE(*,*) 'Initializing Files' 
  
 ! Create output files 
  
 WRITE(fnstring3,9000) TRIM(Simulation%OutputDirectory) 
 WRITE(fnstring4,9001) TRIM(Simulation%OutputDirectory) 
 WRITE(fnstring5,9002) TRIM(Simulation%OutputDirectory) 
 WRITE(fnstring6,9003) TRIM(Simulation%OutputDirectory) 
 WRITE(fnstring7,9004) TRIM(Simulation%OutputDirectory) 
 
9000 FORMAT(a,'/TrueDimerLifetimes') 
9001 FORMAT(a,'/MSDData') 
9002 FORMAT(a,'/PhosReactions') 
9003 FORMAT(a,'/PhosLifetimes') 
9004 FORMAT(a,'/DomainExitInfo') 
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 OPEN(4,file=fnstring3) ! dimer lifetimes from the actual simulation, not the 
frame rate 
 OPEN(7,file=fnstring4) ! MSD info written to according to frame rate, calculated 
each dt 
 OPEN(8,file=fnstring5) ! time to phosphorylation for each dimer 
 OPEN(9,file=fnstring6) ! Phosphorylation time 
 OPEN(10,file=fnstring7) ! Exit rate info for Adam 
  
 ! Initialize variables 
 Simulation%CurrentTimeStep = 0 
 Receptor(:)%Phosphate = 0 
 ReceptorData(:)%DimerStart = 0 
 ReceptorData(:)%PhosStart = 0 
 ReceptorData(:)%JumpSize(1) = 0 
 ReceptorData(:)%JumpSize(2) = 0 
 ReceptorData(:)%JumpSize(3) = 0 
 Receptor(:)%ActiveTail = 0 
 ReceptorData(:)%PhosSuccess = 0 
  
 ! Account for double picking of a dimer on rates **Need to make general** 
 DimOffRate((NumMonomerSpecies+1):NumBaseSpecies,:)=DimOffRate((Num
MonomerSpecies+1):NumBaseSpecies,:)/2 
 PhosRate((NumMonomerSpecies+1):NumBaseSpecies,:)=PhosRate((NumMono
merSpecies+1):NumBaseSpecies,:)/2 
 DePhosRate((NumMonomerSpecies+1):NumBaseSpecies,:)=DePhosRate((Num
MonomerSpecies+1):NumBaseSpecies,:)/2 
  
 ! Initialize Random Seed and Seed Random Number Generator 
 CALL SYSTEM_CLOCK(COUNT=seed) 
 ! Seed grnd() 
 CALL sgrnd(seed) 
 ! Calculate number of moves 
 NMoves = Simulation%Length/Simulation%TimeStep 
 ! Divid number of moves among all receptors 
 RMoves = NMoves*Simulation%NumberReceptors 
 ! Calculate time step per Receptor 
 Simulation%RTimeStep=Simulation%TimeStep/Simulation%NumberReceptors 
 ! Calculate datacut frequency 
 frames = INT(Simulation%FrameRate*Simulation%Length) 
 datacut = INT((RMoves)/(Simulation%FrameRate*Simulation%Length)) 
 framecount = 0 
 datacutcount=0 
 WRITE(*,*) 'Main Loop Started' 
 ! MAIN SIMULATION LOOP 
 DO j = 1,RMoves  
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  ! Update time 
  Simulation%CurrentTimeStep=Simulation%CurrentTimeStep + 
Simulation%RTimeStep 
  ! Pick current receptor 
  i=1+INT((Simulation%NumberReceptors-1)*grnd())  
  ! initialize probabilites 
  PhosProb = 0 
  UnbindProb = 0 
  DephosProb = 0 
  ! Move receptor 
  CALL ReceptorDiffuse(i,Reaction) 
 
  IF (.NOT. Reaction) THEN ! Check for other possible Reactions 
(Dissociation, Phosphorylation, Dephosphorylation) 
   !WRITE(*,*) 'Check for other reaction' 
   IF (Receptor(i)%BoundBuddy > 0) THEN ! Dimer 
    LigandCount = Receptor(i)%Ligand + 
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1 
    PhosphateCount = Receptor(i)%Phosphate + 
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1 
   ELSE ! Monomer 
    LigandCount = Receptor(i)%Ligand + 1 
    PhosphateCount = Receptor(i)%Phosphate + 1 
   END IF 
   ! Calculate Unbinding Probability f(species, ligand) 
   UnbindProb = 
DimOffRate(Receptor(i)%Species,LigandCount)*Simulation%TimeStep 
   !WRITE(*,*) 'Current Species =', Receptor(i)%Species, 'Original 
Species =', Receptor(i)%OriginalSpecies 
   !WRITE(*,*) 'LigandCount =', LigandCount, 'PhosphateCount', 
PhosphateCount 
   !WRITE(*,*) 'Active Tail =', Receptor(i)%ActiveTail 
   ! Calculate Phosphorylation Probability f(species, receiver 
phosphorylation state) 
   IF (Receptor(i)%ActiveTail > 0) THEN ! Dimer, ActiveTail is the 
receptor in the dimer that is active (to be phosphorylated) 
    !WRITE(*,*) 'Active Tail Species =', 
Receptor(Receptor(i)%ActiveTail)%OriginalSpecies 
    !WRITE(*,*) 'Receiver Phosphorylation State =', 
(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate + 1) 
    !PhosProb = 
PhosMulti(Receptor(Receptor(i)%ActiveTail)%OriginalSpecies,PhosphateCount) & 
    !
 &*PhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep 
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 PhosProb=PhosRate(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)
%OriginalSpecies,& 
    
 &(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate + 
1))*Simulation%TimeStep  
   ELSE 
!    PhosProb = 
PhosMulti(Receptor(i)%OriginalSpecies,PhosphateCount) & 
!    
 &*PhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep 
   
 !PhosProb=PhosRate(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies,& 
    !
 &(Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1))*Simulation%TimeStep 
    PhosProb = 0 
   END IF  
   ! Avoid double phosphorylation in a single lifetime 
   IF (ReceptorData(i)%PhosSuccess == 1) THEN 
    PhosProb = 0 
   END IF 
    
   ! Calculate Dephosphorylation Probability f(species) 
   !DephosProb = 
DephosMulti(Receptor(i)%OriginalSpecies,PhosphateCount) & 
   !
 &*DePhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep 
   IF (Receptor(i)%Phosphate == 1) THEN 
   
 DephosProb=DePhosRate(Receptor(i)%OriginalSpecies,PhosphateCount)*Simul
ation%TimeStep 
   END IF  
    
   !IF (Receptor(i)%Species == 4) THEN 
!    WRITE(*,*) 'Species = ', 
Receptor(i)%Species,'UnbindProb =', UnbindProb, 'PhosProb =', PhosProb, 'DephosProb 
=', DephosProb  
!    WRITE(*,*) 'Ligand Count =', LigandCount 
!    WRITE(*,*) 'PhosState of ActiveTail =', 
Receptor(Receptor(i)%ActiveTail)%Phosphate 
!   END IF 
   ! Calculate total probability 
   !ProbTot=UnbindProb+PhosProb+DephosProb 
   ! Normalize probabilities 
   !UnbindProbNorm=UnbindProb/ProbTot 
   !PhosProbNorm=PhosProb/ProbTot 
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   !DesphosProbNorm=DephosProb/ProbTot 
   ! Find reaction based on probability 
   !WRITE(*,*) 'Ceiling: ', 
CEILING(UnbindProb+PhosProb+DephosProb), 'Sum: ', 
UnbindProb+PhosProb+DephosProb 
   IF (CEILING(UnbindProb+PhosProb+DephosProb)>0) THEN 
    ! Generate random number 
    randnum=grnd() 
    IF (randnum > 0 .AND.randnum <= PhosProb) THEN 
     ! Phosphorylate 
     !IF (Receptor(i)%Species == 4) THEN  
!      WRITE(*,*) 'Out of Function: 
PHOSPHORYLATE! Species: ', Receptor(i)%Species!, 'Ligand Count: ', LigandCount, 
'Phos Count: ', PhosphateCount 
!      !WRITE(*,*) 'Species = ', 
Receptor(i)%Species,'UnbindProb =', UnbindProb, 'PhosProb =', PhosProb, 'DephosProb 
=', DephosProb  
!      WRITE(*,*) 'Ligand Count (+1 for 
indexing)=', Receptor(i)%Ligand + Receptor(Receptor(i)%BoundBuddy)%Ligand + 1  
!      WRITE(*,*) 'PhosState of ActiveTail =', 
Receptor(Receptor(i)%ActiveTail)%Phosphate      
!     END IF 
     !Write(*,*) 'Min Prob: 0, Max Prob: ', PhosProb 
     !WRITE(*,*) 'Unbind: ', UnbindProb, '**Phos: ', 
PhosProb, 'Dephos: ', DephosProb, 'Rand #: ', randnum 
      
      
     IF (Receptor(Receptor(i)%ActiveTail)%Phosphate 
== 0) THEN  
      CALL Phosphorylate(i) 
     END IF  
    ELSEIF (randnum > PhosProb .AND.randnum <= 
UnbindProb+PhosProb) THEN 
     ! Unbind 
     !WRITE(*,*) 'UNBIND! Species: ', 
Receptor(i)%Species, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount 
     !Write(*,*) 'Min Prob: ', PhosProb, ' Max Prob: 
',UnbindProb+PhosProb 
     !WRITE(*,*) '**Unbind: ', UnbindProb, 'Phos: ', 
PhosProb, 'Dephos: ', DephosProb, 'Rand #: ', randnum 
     CALL DissociationReaction(i) 
    ELSEIF (randnum > UnbindProb+PhosProb 
.AND.randnum <= UnbindProb+PhosProb+DephosProb) THEN   
     ! Dephosphorylate 
     !WRITE(*,*) 'DEPHOSPHORYLATE! Species: ', 
Receptor(i)%Species, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount 
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     !Write(*,*) 'Min Prob: ', UnbindProb+PhosProb, ' 
Max Prob: ', UnbindProb+PhosProb+DephosProb 
     !WRITE(*,*) 'Unbind: ', UnbindProb, 'Phos: ', 
PhosProb, '**Dephos: ', DephosProb, 'Rand #: ', randnum 
     CALL Dephosphorylate(i) 
    END IF 
   END IF 
  END IF  
  ! Record keeping code 
  datacutcount=datacutcount+1 
   
  !WRITE(*,*) 'DataCut:', datacutcount, '/', datacut 
  !WRITE(*,*) 'FrameCount:', framecount 
   
  !!!!! 
  ! Check if the data should be written to a file 
  IF (datacutcount == datacut) THEN 
   framecount=framecount+1 
   ! generate filename for data storage 
   IF (framecount < 10) THEN 
     WRITE(fnstring, 7001) 
TRIM(Simulation%OutputDirectory), framecount 
  
   ELSE IF (framecount < 100) THEN 
    WRITE(fnstring, 7002) 
TRIM(Simulation%OutputDirectory), framecount 
 
   ELSE IF (framecount < 1000) THEN 
    WRITE(fnstring, 7003) 
TRIM(Simulation%OutputDirectory), framecount 
 
   ELSE IF (framecount < 10000) THEN 
    WRITE(fnstring, 7004) 
TRIM(Simulation%OutputDirectory), framecount 
 
   ELSE IF (framecount < 100000) THEN 
    WRITE(fnstring, 7005) 
TRIM(Simulation%OutputDirectory), framecount 
 
   ELSE 
    WRITE(fnstring, 7006) 
TRIM(Simulation%OutputDirectory), framecount 
 
   END IF 
 
   OPEN(77,file=fnstring) 
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   !WRITE(*,*) 'New Data File' 
   WRITE(77,*) 'Rows: Receptor Columns: Receptor #, x, y, dx, dy, 
d, monomer/dimer, & 
   &ligand, Bound Particle #, Domain, Phosphorylation state' 
 
   ! Write data to file 
   DO i = 1,Simulation%NumberReceptors 
    IF (Receptor(i)%Species <= NumMonomerSpecies) THEN 
     WRITE(77,*) i, Receptor(i)%Position(1), 
Receptor(i)%Position(2), ReceptorData(i)%JumpSize(1), & 
      &ReceptorData(i)%JumpSize(2), 
ReceptorData(i)%JumpSize(3), 1, Receptor(i)%Ligand, & 
      &Receptor(i)%BoundBuddy, 
Receptor(i)%Domain, Receptor(i)%Phosphate 
    ELSE 
     WRITE(77,*) i, Receptor(i)%Position(1), 
Receptor(i)%Position(2), ReceptorData(i)%JumpSize(1), & 
      &ReceptorData(i)%JumpSize(2), 
ReceptorData(i)%JumpSize(3), 2, Receptor(i)%Ligand, & 
      &Receptor(i)%BoundBuddy, 
Receptor(i)%Domain, Receptor(i)%Phosphate 
    END IF 
   END DO 
     
   CLOSE(77) 
 
   datacutcount=0 
   !WRITE(*,*) 'Species Count: ', SpeciesCount(:) 
  END IF 
  
7001   FORMAT(a,'/Data_Files/ParticleData.',I1); 
7002   FORMAT(a,'/Data_Files/ParticleData.',I2); 
7003   FORMAT(a,'/Data_Files/ParticleData.',I3); 
7004   FORMAT(a,'/Data_Files/ParticleData.',I4); 
7005   FORMAT(a,'/Data_Files/ParticleData.',I5); 
7006   FORMAT(a,'/Data_Files/ParticleData.',I6); 
 
 
 END DO 
 CLOSE(4) 
 CLOSE(8) 
 CLOSE(9) 
 WRITE(*,*) 'Simulation Completed' 
  
END PROGRAM ErbB23_Sim 
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APPENDIX C: Chapter 3 Supplement 
The foundation of this model is a Brownian motion simulator with three separate 
modules (Figure A.1A).  The first module performs initial data processing in Matlab 
using graphical user interface (GUI, Figure A.1B). This function facilitates design of the 
membrane simulation space based upon an EM image, providing the number of receptors, 
their distribution on the membrane, the estimated area and position of confinement zones. 
Module 2 is executed in FORTRAN for Brownian motion simulation, dimerization and 
phosphorylation; the reactions are governed by modified Smoluchowski kinetics. Module 
3 performs post data processing in Matlab.  
Particle Diffusion. Particle diffusion is based on Brownian motion.  Brownian 
motion is represented in a simulation by picking a random number from a normal 
distribution and applying that value to the root mean square (RMS) step length, creating 
the stochastic nature of diffusion (Andrews & Bray, 2004; Kusumi et al, 1993; Popov & 
Agmon, 2001). 
 
where x and y are the particle’s Cartesian coordinates, RMS is the root mean square 
step, Dt is the time step, and ξx and ξy are the normally distributed random numbers.  
Periodic boundary conditions are used for the boundaries of the simulation space.  
Confinement zones, as imported from the EM image, create a hurdle for the diffusing 
particles during the simulation.  Particles are free to diffuse into confinement zones,  
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Figure A.1: Model workflow and user interface. (A) Model workflow from user initiation through 
final output.  Initialization of the simulation occurs through a graphical user interface (GUI) 
allowing the user to vary different simulation conditions. Input data collected through the GUI is 
then passed through to the main simulator, which executes the desired simulation.  Finally, the 
simulation output is passed to post processing scripts to run relevant analysis and generate plots. (B) 
Graphical user interface used to pass through variable model inputs to control simulation conditions. 
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however receptors must pay a “toll” to escape the confinement zone.  A probability is 
calculated using escape rates calculated from the Single Particle Tracking (SPT) 
experiments and the time step, similar to the previous version of the model by Hsieh et al. 
(Hsieh et al, 2008): 
 
However, this probability has been simplified further to: 
 
due to the small time step.  If a confined particle is set to diffuse out of a confinement 
zone, and this escape probability is not met, the confinement zone assumes a reflective 
boundary condition, trapping the particle inside. 
Kinetics. Modified Smoluchowski kinetics are used to simulate particle kinetics (see 
Andrews and Bray (Andrews & Bray, 2004)).  During simulation, rules for dimerization 
and phosphorylation determine the course of the receptor in question. The simulator 
focuses on one receptor at a time, picking every receptor once over a fixed time step.  
Receptors are picked randomly, allowing the order the receptors are moved or reacted to 
be different for each time step.  Once a receptor is picked, a series of reactions are 
considered before the fate of the receptor is implemented. There are four possible 
reactions that can take place, dimerization, dimer dissociation, phosphorylation, and 
dephosphorylation. Dimerization is treated as a second-order reaction, while dimer 
dissociation, phosphorylation, and dephosphorylation are all treated as first-order 
reactions.   
Dimerization 
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A receptor’s likelihood to dimerize with another receptor is based on a distance 
termed the binding radius.  The binding radius takes into account the dimer on rate, 
diffusion coefficient of the receptors that will comprise the dimer, and the simulation 
time step (Andrews & Bray, 2004).  While the binding radius is not a physical radius, the 
use of this radius allows the simulation to be closer to the physical situation than previous 
methods using probabilities (Andrews & Bray, 2004; Erban & Chapman, 2009; Gillespie, 
1977; Hsieh et al, 2008; Popov & Agmon, 2001). When the chosen receptor is moved, 
the final position is scanned for other receptors that are within the binding radius.  If a 
receptor is within this distance, then the receptors will form a dimer.  Determination of 
the binding radius is discussed in model parameters below.  
Dimer Dissociation, Phosphorylation, & Dephosphorylation 
Dimer dissociation and dephosphorylation are first order reactions.  Dimer 
phosphorylation may be considered second-order due to the dimer and phosphate 
reacting, however here phosphate is assumed to be in excess, therefore the reaction can 
be approximated as first-order.  First-order reactions are implemented through a 
probability calculated using the reaction rate and simulation time step:   
  
This probability has been simplified further, as in Hsieh et al (Hsieh et al, 2008) and 
Andrews and Bray (Andrews & Bray, 2004): 
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When dimer dissociation occurs, an unbinding radius is used to set the dissociating 
receptors apart.  The unbinding radius is calculated such that the occurrence of an 
unrealistic amount of repeated interactions is minimized:  
 
where σb is the binding radius and σu is the unbinding radius.  The default ratio of binding 
radius to unbinding radius is 0.2. 
Model Parameters.  The majority of parameters needed for the model are directly 
measured using SPT experiments (Low-Nam et al, 2011).  These parameters include 
dimer off rates, diffusion coefficients, and confinement zone escape rates.  
Phosphorylation and dephosphorylation rates were measured by Kleiman et al (Kleiman 
et al, 2011).  The most elusive model parameter is the dimer on rate, which cannot 
currently be accurately measured through SPT.  Martin-Fernandez (Martin-Fernandez et 
al, 2002) found 14% of receptors on a membrane participate in preformed dimers at 
steady state.  Using this information, a binding radius is calculated by iterating the 
binding radius over a large range until the percent of preformed dimers converged to 
approximately 14% during 4 minute simulations.  This binding radius is then used to 
back calculate the dimer on rate using SMOLDYN (Andrews & Bray, 2004).  
Model Validation. Parameters were validated by comparison to experimental data.  
This is shown in Figure 3.1EF, where simulated diffusion coefficients and off rates match 
well with the experimental values in Low-Nam et al. (Low-Nam et al, 2011). Plots in 
Figure A.2A show good comparison of phosphorylation kinetics in the model versus 
experimentally measured values in MCF7 cells (Verveer et al, 2000). In addition,  
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Figure A.2: ErbB1 Receptor Phosphorylation (A) Average phosphorylation population over a 60 
second simulation as compared to experimental data from Verveer et al. (Verveer et al, 2000) (B) 
Average phosphorylation population for a 10% LR simulation and 100% LR simulation. (C) 
Comparison of the simulated phosphorylation lifetime in simulation against experimental values 
reported by Kleiman et al. (8). (D) Percent of total monomers relative to ligand occupancy, over a 4 
minute simulation with 50% LR.      
A B 
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Figure A.2C below reports model validation for phosphorylation lifetimes, as 
compared to experimental values reported for dephosphorylation of EGFR after acute 
exposure to the kinase inhibitor Gefitinib (Kleiman et al, 2011). Figure A.2D shows a 
shift in available monomer equilibrium for a 50% LR simulation.  Initially the simulation 
has equal amounts of unliganded monomer (R) and liganded monomer (LR) available. As 
reactions occur and receptors transition to different states, the equilibrium of available 
monomer transitions from equal amounts, to an excess of R monomers. LRLR dimers 
form whenever two LR monomers are within the binding radius. LRR dimers have a 
0.1% chance of forming within the binding radius, compared to a 0.01% chance for RR 
dimer, due to the conformational flux of R monomers.  
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Figure A.3: Details of the experimental data and analysis method. A. Raw trajectories as captured by 
single particle tracking analysis. Positions are determined by fitting a distribution to the light 
intensity captured in a set of neighboring pixels. Trajectories in this recording extend over a 
rectangle of approximately 25µm Å~ 45µm B. Detail of the trajectories shown in A. Red circles label 
points that are associated with 2-step displacements in the lower 70% of 2-step displacements in the 
entire recording. The labelled points indicate limited movement. Different trajectories (represented 
by color) tend to slow down in the same locations. As the trajectories are not simultaneous (due to the 
imaging method), this may indicate that the regions of slow movement are localized. C. Given an 
incomplete record of a trajectory, for every integer multiple of the time step, we choose as many non-
overlapping pairs of recorded positions as possible. 
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Figure S1: Details of the experimental data and analysis method. A. Raw trajectories as captured by single
particle tracking analysis. Positions are determined b fitting a distribution to the light intensity captured
in a set of neighboring pixels. Trajectories in this recording extend over a rectangle of approximately
25µm ⇥ 45µm B. Detail of the trajectories shown in A. Red circles label points that are associated with
2-step displacements in the lower 70% of 2-step displacements in the entire recording. The labelled points
indicate limited movement. Different trajectories (represented by color) tend to slow down in the same
locations. As the trajectories are not simultaneous (due to the imaging method), this may indicate that the
regions of slow movement are localized. C. Given an incomplete record of a trajectory, for every integer
multiple of the time step, we choose as many non-overlapping pairs of recorded positions as possible.
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Figure A.4: Details of the numerical simulation. A. At each iteration, a tentative new position is 
generated for each particle. The new position is accepted if there is no barrier between it and the 
current position; otherwise it is accepted with probability pcross. In case of rejection, the particle 
keeps its current position for another time step. B. The simulation landscape consists of unevenly 
spaced rectangular barriers, induced by two sets of barrier coordinates, {XB1, · · · ,XBNB} and {YB1 , 
· · · ,YBNB}; domains are rectangles of the form [XBk,XBk+1] Å~ [YBl ,YBl+1]. Barrier permeabilities 
may depend on the direction of the attempted crossing. C-D. Sensitivity to the simulation time step 
tsim. The MSD versus time distribution (C, top) varies only slightly when tsim varies over several 
orders of magnitude. The bottom panel shows slope-intercept pairs corresponding to the first 10 
(observation) time steps tobs (upward pointing triangles, lower group) and steps 20-100 (left pointing 
triangles, upper group). The fixed time displacement distributions are also robust (D). 
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Figure S2: Details of the numerical simulation. A. At each iteration, a tentative new position is generated
for each particle. The new position is accepted if there is no barri r between it and the current position;
othe wise it is ccepted with probability pcross. In case of r jection, the particle keeps its current posit on for
another time st p. B. The s mulation landscape consists of unevenly paced rectangular barriers, induced by
two sets of barrier coordin tes, {XB1 , · · · ,XBNB} and {YB1 , · · · ,YBNB}; domains are rectangle of the form
[XBk ,X
B
k+1]⇥ [YBl ,YBl+1]. Barrier permeabilities may dep nd n the direction of the attempted crossing.
C-D. Sensitivity to the simulation time step tsim. The MSD versus time distribution (C, top) varies only
slightly when tsim varies over several orders of magnitude. The bottom panel shows slope-intercept pairs
corresponding to the first 10 (observation) time steps tobs (upward pointing triangles, lower group) and steps
20-100 (left pointing triangles, upper group). The fixed time displacement distributions are also robust (D).
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Figure A.5: Corrections for time averaging and localization uncertainty. Simulation results with and 
without corrections for localization uncertainty and / or recording time averaging (results shown in 
Fig. 4 have both corrections). A. Mean square displacement (MSD) versus time. The experimental 
data, a simple Brownian (zero intercept) as well as a linear fit to it are shown for comparison. The 
right panel shows that same results at a higher resolution. B. Distribution of square displacements 
after 20 steps, corresponding to 1.0s. In both types of results, time averaging tends to reduce, and 
localization uncertainty tends to increase the observed square displacements. 
Non-Brownian displacements and attractive microdomains 29
A
0 0.5 1 1.5 20
0.1
0.2
0.3
0.4
Observation time [s]
M
SD
 [µ
m
2 ]
 
 
Experiment
Fit (Brownian)
Fit w/ intercept
− TAv − LUnc
− TAv + LUnc
+ TAv − LUnc
+ TAv + LUnc
0 0.1 0.2 0.3 0.40
0.05
0.1
0.15
0.2
Observation time [s]
M
SD
 [µ
m
2 ]
 
 
B
0 0.5 1
0.1
1
10
100
(∆R)2 [µm2])
Pr
ob
ab
ilit
y d
en
sit
y
 
 
T=0.25 s
(5 steps)
Experiment
− TAv − LUnc
− TAv + LUnc
+ TAv − LUnc
+ TAv + LUnc
0 0.05 0.1 0.15 0.2
1
10
100
(∆R)2 [µm2])
Pr
ob
ab
ilit
y d
en
sit
y
 
 
T=0.25 s
(5 steps)
Figure S3: Corrections for time averaging and localization uncertainty. Simulation results with and without
corrections for localization uncertainty and / or recording time averaging (results shown in Fig. 4 have both
corrections). A. Mean square displacement (MSD) versus time. The experimental data, a simple Brownian
(zero intercept) as well as a linear fit to it are shown for comparison. The right panel shows that same results
at a higher resolution. B. Distribution of square displacements after 20 steps, corresponding to 1.0s. In both
types of results, time averaging tends to reduce, and localization uncertainty tends to increase the observed
square displacements.
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Figure A.6: Compiled ranks for all the points from SPT data for ErbB2 and ErbB3. A biomodal 
distribution is apparent for both speices. This is a compilation for tracking erbB2 with QD-655 and 
erbB3 with QD-585. 
 
 
Figure A.7: Amino acid substitution mutation in one of the erbB3 alleles in the widely-used SKBR3 
breast cancer cell line. 
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Figure A.8: ErbB3 E933Q Dephosphorylation. An activation/inhibition assay shows high levels of 
phosphorylated erbB3 up to the 5 minute time point. 
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